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Ca2+ manutention dans un model de souris de CPVT 
 
La tachycardie ventriculaire catécholergique (CPVT) est une maladie héréditaire qui se manifeste 
par des syncopes voire une mort subite, lors de stress émotionnel ou physique en absence 
d’altération morphologique du cœur. Bien qu’étant une maladie rare, qui touche 1 à 5 personnes sur 
10 000 en Europe, cette maladie n’est malheureusement diagnostiquée qu’après le décès d’un enfant 
ou jeune adulte dans une famille avec des causes inconnues. Une syncope ou la mort subite peuvent 
apparaitre dès l’âge de 7 ans. Pour 10-20% des patients, la première manifestation est la mort 
subite. Les arythmies les plus fréquentes sont la tachycardie ventriculaire bidirectionnelle, mais 
aussi la tachycardie supraventriculaire, la fibrillation atriale, et la dysfonction sinusale. Au repos, 
ces patients ont un électrocardiogramme normal, mais une tendance plus importante à la 
bradycardie. 
Des mutations dans 4 gènes ont été identifiées comme étant à l’origine de la CPVT. La plupart des 
mutations autosomiques dominantes identifiées (~60%, CPVT1) concernent le récepteur de la 
ryanodine type 2 (RyR2), canal de libération du Ca
2+ du réticulum sarcoplasmique (RS) cardiaque. 
D’autres mutations concernent des gènes codant pour des protéines régulatrices du RyR2 : la 
calséquestrine (CPVT2, autosomique récessive, qui apparait dans environ 2% de cas), la triadine 
(autosomique récessive) et la calmoduline1 (autosomique dominante).  
Nos collaborateurs ont identifié la mutation RyR2
R420Q chez une famille espagnole atteinte de 
CPVT. Ces patients ont une dysfonction du pacemaker (nœud sinusal, NSA) avec une bradycardie. 
Nous avons construit une souris portant cette mutation, et étudié l’activité du NSA en analysant le 
calcium intracellulaire, afin d’élucider les mécanismes impliqués dans cette bradycardie.  
Toutes les expériences ont été faites sur des souris, mâles et femelles, d’environ 6 mois, 
hétérozygotes pour la mutation (KI), et sur leurs frères et sœurs ne portant pas la mutation (WT).  
Tout d’abord, pour caractériser les souris, des électrocardiogrammes (ECG) ont été enregistrés en 
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télémétrie. Des capteurs ont été implantés chez la souris en subcutanée sous anesthésie sous 
isofluorane. Les enregistrements ont été faits au moins une semaine après la chirurgie, pour que les 
animaux récupèrent de l’opération. Une injection d'épinéphrine et de caféine (β+1β0 mg/Kg) en 
intra-péritonéal a été réalisée, afin de vérifier leur phénotype. Ceci a induit une tachycardie 
bidirectionnelle chez toutes les souris KI et aucune chez les WT, validant ainsi le modèle. Le 
rythme cardiaque était similaire pendant la période d’activité (nuit) chez les souris KI et WT, mais 
plus lent pendant la période de repos (jour) chez les femelles KI. Une stimulation sympathique avec 
injection d’isoprénaline (ISO 1 mg/kg) a accéléré le rythme de toutes les souris, mais de manière 
plus importante chez les souris KI. D’autre part, la stimulation parasympathique avec injection de 
carbachol (CCH 0,25 mg/kg) ralentit le rythme cardiaque de façon similaire chez toutes les souris. 
En présence d’ISO, un plus grand nombre de souris présentent des échappements jonctionnels, 
indiquant que l’absence d’activité du NSA durant ces battements. 
Afin d’analyser les mécanismes, nous avons disséqué le NSA et l'avons chargé avec un indicateur 
fluorescent du Ca2+ (le fluo-4) puis analysé les mouvements calciques spontanés par microscopie 
confocale. Cette technique, développée dans le laboratoire, est très délicate mais nous permet 
d’étudier les mouvements du Ca2+ dans la cellule du NSA dans son contexte naturel, sans dissocier 
le tissu. Ces données in-vitro ont montré une différence basale du rythme cardiaque entre mâles et 
femelles, avec une fréquence de transitoires [Ca2+]i plus lente chez les femelles. La présence de la 
mutation ralentie la fréquence des transitoires [Ca2+]i chez les deux sexes (WT : mâle 0,66 ± 0,03 s ; 
femelle 0,76 ± 0,03 s ; KI : mâle 0,76 ± 0,04 s ; femelle 0,94 ± 0,04 s). De plus, ces transitoires 
[Ca2+]i ont une plus faible amplitude et une prolongation du temps au pic (amplitude : WT 
3,82 ± 0,11 ; KI 3,55 ± 0,10 ; temps au pic : WT 46,95 ± 1,63 ms ; KI 52,41 ± 1,50 ms).  
Afin d’évaluer l’activité du RyR2, nous avons analysé les sparks Ca2+, qui sont des évènements 
élémentaires produits par l’activation d’un cluster de RyR2s. Nos analyses en microscopie confocale 
sur des NSA disséqués ont montré que la fréquence des sparks Ca2+ n'était que légèrement 
augmentée (WT : mâle 5,92 ± 1,33 sparks×s-1×100µm-1; femelle 6,30 ± 1,07 sparks×s-1×100µm-1; 
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KI : mâle 13,07 ± 2,32 sparks×s-1×100µm-1; femelle 8,03 ± 1,26 sparks×s-1×100µm-1). Par contre, la 
durée de ces sparks est fortement prolongée dans les cellules KI par rapport aux sparks Ca2+ 
enregistrés dans les cellules WT (WT : mâle 42,69 ± 0,47 ms ; femelle 36,52 ± 0,37 ms ; KI : mâle 
52,98 ± 0,38 ms ; femelle 58,17 ± 0,47 ms). Ceci produit une libération plus importante de Ca2+ 
dans chaque spark en moyenne. Ainsi, les cellules KI ont une fuite de Ca2+ par unité du temps 
pendant la diastole plus importante que les cellules WT (WT : mâle 1749,06 ± 28,01 Ca2+ release 
×s-1×100µm-1; femelle 1679,65 ± 25,09 Ca2+ release ×s-1×100µm-1; KI : mâle 5091,91 ± 56,82 Ca2+ 
release ×s-1×100µm-1; femelle 3300,64 ± 36,91 Ca2+ release ×s-1×100µm-1). Pour analyser la 
conséquence que cette augmentation de la libération du Ca2+ peut avoir, nous avons évalué la 
charge calcique du RS, qui était réduite, ceci pouvant ainsi réduire l’automatisme. De plus, les 
canaux calciques de type L du sarcolemme, aussi impliqués dans l’automatisme, sont inactivés par 
le calcium intracellulaire. L'analyse de ce courant par patch-clamp montre que les cellules isolées 
du NSA des souris KI ont une amplitude de courant plus faible. En revanche, cette diminution était 
dépendante du Ca2+ intracellulaire car elle disparait lorsqu’on tamponne le Ca2+ intracellulaire par le 
BAPTA.  
En résumé, la mutation RyR2
R420Q produit des sparks Ca2+ plus longs dans le temps, suggérant des 
ouvertures du canal plus longues, ce qui est directement impliqué dans la bradycardie du fait de la 
vidange du réservoir RS et l’inactivation des canaux calciques type L.  En conséquence, les 
thérapies en cours d’étude qui favoriseraient la stabilisation du RyRβ à l’état fermé pourraient ne 
pas être efficaces, et il faudrait plutôt essayer des thérapies qui faciliteraient la fermeture du canal, 
une fois qu'il est ouvert. 
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Chapter 1 Introduction 
The heart rhythm is initiated by the activity of sinoatrial node (SAN), which generates electrical 
impulses and spreads to the heart inducing heart contraction. Arrhythmias occur when SAN or 
spreading system has anomalies, or when the contraction is driven by a stimulus in another area 
(ectopic foci), referring abnormal rhythm of the heart beats.1 At intracellular levels, calcium (Ca2+) 
plays a key role in maintaining normal heart function, such as automatic pacing, action potential 
generation, excitation-contraction coupling (EC coupling). Thus, sick intracellular Ca2+ release in 
heart could cause cardiac arrhythmias.  
  This thesis seeks to elucidate the relationship between Ca2+ handling and cardiac arrhythmias, 
specifically, focusing on the role of the pathological changes in the intracellular Ca2+ regulation 
through Ca2+ release channel (ryanodine receptor 2, RyR2) modification contributing to the 
abnormal SAN function.  
1.1 Overview of heart function, action potentials and CICR 
The human heart beats about 105 times a day resulting in 2 billion heartbeats during a lifetime.2 
Sinoatrial node (SAN) is described as the primary and physiological pacemaker since its discovery 
more than a century ago.3 Under physiological condition, it spontaneously initiates regular 
electricity. SAN anticipates to atrioventricular (AV) node and Purkinje fibers network (PFN) 
electrical activity, considering that the two can also generate pacemaker activity, although they only 
drive the heart when the SAN is in pathological condition.4-6 For instance, AV node can become 
dominant during SAN block or heart failure, and PFN can also lead a viable rhythm during AV 
block. Thereby this system can maintain heartbeat when the SAN fails. 
SAN is located near the entrance of the superior vena cava (SCV) in the right atrium (Figure 1), 
bordered by the crista terminalis. As the impulse-generating tissue, it initiates the electrical impulse, 
which spreads across both right and left atrium and induces the atria depolarization and contraction, 
known as atrial systole. This process corresponds to P wave (~0.08s in humans) on the surface 
electrocardiogram (ECG) (Figure 2). When the impulse reaches the AV node (located near the AV 
valve, in the interatrial septum), it slows down because of the conduction property of AV node. This 
delay makes sure all the blood has been ejected to the ventricles before ventricular contraction. It 
corresponds to PR segment (~0.04s in humans), a flat line following the P wave, while the PR 
interval (~ 0.12s in humans) represents the duration from the beginning of atrial depolarization until 
ventricular depolarization. The AV node passes the signal to AV bundles (also known as His 
bundles), which bifurcates into left and right bundle branches. The signal then passes to Purkinje 
fibers and through both ventricles, inducing ventricular depolarization and contraction, known as 
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ventricle systole. Thereby the blood is pumped throughout the body. On the ECG, it is represented 
by QRS complex (~0.12s in humans). Meanwhile, the atrial repolarization occurs, although it’s 
buried in the QRS complex. The Q wave depicts the septum depolarization, from left to right. When 
the depolarization travels throughout the ventricles, the R wave and S wave show up. Then another 
flat line, ST segment (~0.08s in humans), indicates no large electrical vector, while ventricle is 
contracting. The ventricle repolarization represented by T wave (0.16s in humans). As the epicardial 
cells repolarize before the endocardial cells, the T wave reflects positively. 
 
Figure 1 The mammalian heart with the cardiac conduction system. SAN, sinoatrial node; SCV, superior vena cava; 
RA, right atrium; AVN, atrioventricular node; ICV, inferior vena cava; CVB, central fibrous body; TV, tricuspid valve; 
AVB, atrioventricular bundle; BB, bundle branches; PFN, Purkinje fibers network; LA, left atrium; PV, pulmonary 
veins; MV, mitral valve; RV, right ventricle; LV, left ventricle. (Panel A is adapted from Mangoni and Nargeot, 20086) 
Action potentials  
The cardiac action potential (AP) is the membrane potential (Em) waveform that is determined 
by a complex interplay of many ion channels and transporters, and the [Ca2+]i transient itself.
7 The 
cardiac AP morphology between cardiomyocytes varies dramatically in different regions of the 
heart according to the physiological characteristics (Figure 2).  
In order to maintain the heart rate, the SAN cells spontaneously generate regular and cyclic AP. 
Then, the electrical impulse propagates to atrium, AV node, Purkinje fiber and ventricle (Figure 2).  
In ventricular myocytes, the AP contains four phases. Between 2 consecutives AP, the resting 
membrane is maintained by IK1 of the Kir2.1 potassium channels. When a ventricular myocyte is 
excited by adjacent cells, voltage-dependent NaV1.5 sodium channels are activated resulting in a 
rapid inward Na+ current (INa) and concomitantly rapid membrane depolarization constituting the 
upstroke of the AP (phase 0). The membrane depolarization induces the slow deactivation of 
NaV1.5 channel and activation of voltage-dependent K
+ channels (KV4.3 and KV1.4), which 
generates a rapid repolarizating current (Ito) (phase 1). Then, the voltage-dependent Ca
2+ channels 
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(Cav1.2) are activated, producing an inward Ca
2+ current (ICa,L). The activation of outward 
rectifying K+ currents (IKur, IKr and IKs via KV1.4, KV11.1 and KV7.1, respectively) and ICa,L are at 
similar voltages, result in the plateau pase of AP (phase 2). Deactivation of Cav1.2 induces the 
predominance of K+ currents and further membrane depolarization (phase 3). In the end, Kir2.1 is 
re-activated, which generates the IK1 current and push the membrane potential back to the resting 
level.6, 8-10 
 
Figure 2 Electro-activity of the adult heart. Top: schematic of a human heart with illustration of typical action 
potential waveforms in different regions of the heart. Bottom: schematic of a surface electrocardiogram. (Adapted from 
Weisbrod et al., 201611) 
In myocytes, the membrane (including transverse tubules, t-tubules) depolarization during the 
action potential activates ICa,L inducing SR Ca
2+ release through ryanodine receptor 2 (RyR2), which 
is known as calcium induced calcium release (CICR) leading to myocytes and heart contraction.12, 13 
This process from electrical excitation of the myocytes to contraction of the heart is termed cardiac 
excitation-contraction coupling (EC coupling).7 The action potential and the following contraction 
are well studied in ventricular myocytes. However, the generation of electrical impulse in SAN cells 
is still under debate. As many ion channels expressed in ventricular myocytes are also expressed in 
SAN cell, the studies about SAN cells are always in comparison to ventricular myocytes. 
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Figure 3 Schematic of membrane clock and calcium clock mechanisms. Top: the red trace shows an example of a 
typical action potential of spontaneously beating rabbit SANC. The different phases of the AP are labeled, while phase 
4 also represents diastolic depolarization (DD). MDP, maximum diastolic potential. Middle: schematic representation of 
the timing and magnitude of the different components of the “membrane clock”. Bottom: the timing and magnitude of 
the important components of the “Ca2+ clock” are shown at the bottom. LCRs, local Ca2+ releases. L-type Ca2+ current, 
ICa,L. T-type Ca
2+ current, ICa,T. Potassium current, IK. NCX current, INCX. (Adapted from Monfredi et al., 2013
14) 
In automatic cells there is an additional phase of the AP, which is the slow depolarization 
(phase 4), which slowly depolarizes the membrane, until reaching threshold and producing another 
AP. In ventricular and atrial myocytes this phase does not exist and the myocytes are not automatic, 
as they need to be excited by other cells to generate an AP. The AP of SAN includes diastolic 
depolarization (DD, Figure 3, also referred to as phase 4), rapid depolarizing upstroke (phase 0) and 
repolarization (phase 2 and 3).15 Major ion currents involved in the AP are depicted in Figure 3, and 
further introduced in the next session. The morphology of AP in SAN cells is different from that of 
ventricular myocytes (Figure 3). The SAN cell doesn’t have real resting membrane potential. The 
more negative potential reached is named maximum diastolic potential. The phase 4 includes the 
slow increase in membrane potential toward an excitation threshold, at which the action potential 
fires.14, 16 Regarding the mechanisms of DD, one important factor involved is the funny current (If) 
carried by hyperpolarization-activated cyclic nucleotide-gated channels (HCN channels), which 
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depolarizes the membrane. Other  currents also contribute to the progression of depolarization, such 
as ICa,T, INCX and ICa,L carried respectively by T-type Ca
2+ channel (CaV3.1, CaV3.2), sodium-
calcium exchanger (NCX), L-type Ca2+ channel (CaV1.2, CaV1.3). The phase 4 consists of two 
components, a linear component (the first two-thirds of DD) and a nonlinear, exponentially rising 
component (the last third of DD). The nonlinear component is proposed to occur along with the 
subsequent cytosolic Ca2+ increase induced by local Ca2+ release by SR and concomitant inward 
NCX activation.17 The rapid upstroke (phase 0, Figure 3) of SAN AP is much faster than diastolic 
depolarization, but still slower than that of ventricular myocytes as it’s carried out by slow Ca2+ 
current in SAN instead of the fast Na+ current in ventricular myocytes. The initial repolarization 
phase (phase 1) in ventricular myocytes is completely absent, and the plateau of phase 2 is replaced 
by a slow velocity repolarization phase. In the end, the Em is driven to maximum diastolic potential 
(MDP) by potassium channels. The AP of SAN has a relatively positive MDP of around -50mV due 
to the absence of IK1.
6, 8, 9, 14, 16, 18 
1.2 Sinoatrial node (SAN) automaticity 
This session serves to introduce SAN action potential and the generation of pacemaker activity. 
For now, the mysterious ability of SAN generating the spontaneous rhythm is still under debate. 
There are two theories that can explain the SAN automaticity, the membrane clock theory, Ca2+ 
clock theory and the subsequent coupled clock theory, which are reviewed in this session.  
1.2.1 Membrane clock theory 
Before introducing the membrane clock, we will simply discuss the ion channels involved in 
membrane clock. 
1.2.1.1 Ion channels 
1.2.1.1.1 HCN channels 
HCN channels and If current 
The hyperpolarization-activated cyclic nucleotide-gated (HCN) channels belong to the 
superfamily of voltage-gated pore loop channels, expressed widely in nervous system and in heart. 
They are located on plasma membrane. As a voltage-gated channel, HCNs can sense the changes of 
the electrical membrane potential, be activated by membrane hyperpolarization (around -50/-65 
mV) and generate a unique inward current. Their activation could be facilitated by direct interaction 
with cyclic adenosine monophosphate (cAMP), via binding with the C-terminus of the channel. 
Other regulators have also been described, including phosphatidylinositol 4,5-bisphosphate (PIP2), 
kinases and phosphatases.19-22 
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HCN channels are tetramers (four subunits), and homologous to voltage-gated potassium 
channels. Like K+ channels, HCN channels are blocked by millimolar concentration of Cs+, and 
activated by excellular K+.23-27  But unlike K+ channels, they are not sensitive to Ba2+, 
tetraethylammonium (TEA) and 4-aminopyridine (4-AP), which are strong blockers of potassium 
channel.26  
Each HCN channel subunit consists of six transmembrane helices (S1-S6), including the voltage 
sensor (S4) and a glycine-tyrosine-glycine (GYG) sequence in the P loop between S5-S6. In 
potassium channels, the GYG sequence forms the highly selective filter for K+. However, HCN 
channels conduct both Na+ and K+, in spite of the greater permeability for K+, and even display a 
small permeability for Ca2+.28-30 Until now, the mechanisms about the specific permeation 
properties of HCN channels are still unclear. It has been found that the sequences in the P-loop and 
before GYG are different in K+ channels and in HCN channels, which are TT-V/I-GYG and LC-I-
GYG respectively.31-33 D’Avanzo et al. changed the residues closed to the selectivity filter in the 
HCN4 channel to match the K+ channels, and failed to increase K+ selectivity, suggesting the 
differences are outside the P-loop region.34 Macri et al. further investigated, showing that the 
cysteine doesn’t contribute to permeation.35 It was also proposed that the GYG sequence is 
coordinated in a less rigid model in HCN channels than in K+ channels, allowing the entrance of 
cations of different sizes.36  
Upon membrane hyperpolarization, HCN channels generate a unique and mixed inward current 
(termed Ih/If, Figure 3).
26, 36-39 If is first described in 1979, and referred by some researchers as 
pacemaker current, in respect that it plays an important role in control of cardiac and neuronal 
rhythmicity.28, 40-42 If current widely presents in cardiac pacemaker cells of most species. However, 
it is absent in some SAN cells from monkey and rat, although it is questioned that this could be 
artificial effect produced by dialysis of the intracellular medium with the pipette solution.43, 44 
The physiological contribution of If current in SAN pacemaker activity is still under debate. If is 
activated upon membrane hyperpolarization at the end of the repolarization phases of an action 
potential. When If is activated, it shifts the current flow from outward to inward (Figure 3), which 
reverses the action potential at maximum diastolic potential (MDP). It ends the repolarization 
process, and initiates the first part of depolarization process until the activation of voltage-
dependent Ca2+ channels is achieved (~ -40mV). The fact that blockade of If causes the 
prolongation of cycle length in SAN cells indicates that If participates to the generation of 
pacemaker activity.45, 46 For instance, Cs+ (2mM) decreases beating rate of rabbit SAN cells by 
30%.45 In human SAN cells, 2mM Cs+ is sufficient to slow DD slope and pacemaker activity (26% 
cycle length increase).47 
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However, it is notable that blockade of If only results in a modest prolongation of cycle length 
in SAN cell.48 The presence of Cs+ only induces slightly decrease of pacing rate, which has been 
seen as an indication that If is not the unique determinant for SAN automaticity.
45, 49 Yet, this idea is 
challenged by DiFrancesco and his coworkers, who mentioned that Cs+ does not fully block If and 
the blockage is voltage dependent. Thus the partially unblocked If would still be able to drive the 
automaticity, and the membrane potential changes further unblock If.
25 Although, Cs+ is also a K+ 
channel blocker which could indirectly affect If.
25  
Additions of other If blockers are also used to quantify whether this current is necessary for 
SAN automaticity generation, in which ivabradine is a specific organic blocker of If.
50 The blockers 
access to the binding site within the open pore of HCN channel and cannot leave the binding site 
when the channel is closed.51-54 A low concentration of ivabradine (<γ μM) specifically inhibits If 
without suppressing ICa,L or other membrane ion currents.
55, 56 Ivabradine slows automaticity by 
~β0% at concentration of γ μM in isolated rabbit SAN cells, and reduces the heart rate in vivo in 
mice and conscious dogs, but doesn’t block pacemaking.46, 57-59 Therefore, these data again suggest 
that If is probably not an absolute prerequisite for SAN automaticity. However, some researchers 
point out that the block/unblock by the blockers (ivabradine, UL-FS 49, etc) is coupled to ionic flow 
rather than voltage alone.51-54 The blockers are removed from the blocking site by strong 
hyperpolarization inducing inward large If.
51-54 It is also noticeable that γ μM ivabradine also 
perturbs Ca2+ clock with reduced SR Ca2+ load, slowed intracellular Ca2+ cycling kinetics, and 
prolonged the period of spontaneous LCRs occurrence during diastolic depolarization.60 A higher 
concentration of ivabradine (10 μM) also suppresses ICa,L.55 
The low activation voltage of If may also protect SAN cells from hyperpolarizing, bradycardiac 
effect of surrounding atrial myocardium.14 Thus, it was also proposed that If is responsible for a 
slower DD in the pacemaker range of < -65 mV of subsidiary pacemaker cells rather than of SAN 
cells, due to its low activation voltage and slow activation kinetics.61, 62 
The activation of If could be facilitated by direct interaction with cyclic adenosine 
monophosphate (cAMP), produced at the sarcolemma from adenosine triphosphate (ATP) by 
adenylate cyclases (ACs) in basal condition and during sympathetic/ parasympathetic stimulation. 
Activation or inhibition of ACs/cAMP is a consequence of sympathetic and parasympathetic 
response of the autonomic nervous system controlling the pacemaker activity. A small 
augmentation of cAMP increases If open probability. Besides, the If activation curve shifts 
positively under -adrenergic stimulation (or a rise in cAMP), and negatively upon muscarinic 
stimulation.6, 50, 63 The shift indirectly indicates the important role of If on pacemaking and during 
sympathetic/ parasympathetic activation. However, the responses are questioned by the evidence 
that the full range of responses to autonomic agonists is possible in the partial absence of If or when 
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If function is deficient.
64, 65 Cytosolic Ca2+ concentration and CaM (Calmodulin) are also reported to 
regulate If, but not CaMKII (Ca
2+/CaM activates Ca2+/calmodulin-dependent protein kinase II).66 
BAPTA (Ca2+ chelator) loading significant decreases the amplitude of If in guinea-pig SAN cells, 
and shifts the voltage-dependent activation to more negative potentials.66 Three CaM antagonists 
(W7, Calmidazolium and ophiobolin A) cause the same effect as BAPTA.66  
Kinetics and contributions to SAN automaticity of HCN isoforms   
Four members of this family (HCN 1-4) have been cloned so far.26, 27, 33, 67-69 HCN channels can 
be assembled into either homotetramers by identical (homomeric) type of subunits, or 
heterotetramers by different (heteromeric) types.70-75  
HCN channels present distinct biophysical properties, such as activation kinetics, sensitivity to 
cyclic nucleotides.6, 37, 67, 69 HCN1 channel shows fastest opening kinetics and the lowest sensitivity 
to cAMP.37, 38 However, HCN4 channel is the most slowly activation isoform, and markedly 
sensitive to cAMP.27, 33, 37, 67 HCN2 and HCN3 represent intermediate properties between HCN1 
and HCN4.27, 37, 76  
All four HCN channel isoforms have been detected in the heart.77, 78 In the SAN, HCN4 is the 
predominant isoform and account for 80% of If, whereas the expression of HCN1 and HCN2 are 
also found and responsible for the remaining 20%.77, 79-81 HCN3 was recently observed in rodent 
ventricular myocytes.78 Both heteromeric HCN1-HCN4 and heteromeric HCN2-HCN4 channel 
exist in native SAN tissues.70, 74  
In rabbit and mouse SAN, HCN1 was detected.77, 79, 80 HCN1 held >18% of the total HCN 
mRNA in rabbit SAN, although only a low level of HCN1 was found in mouse SAN.79, 81 Mice 
lacking HCN1 channel display congenital SAN dysfunction, characterized by bradycardia, sinus 
dysrhythmia, increased heart rate variability, prolonged sinoatrial node recovery time, increased 
sinoatrial conduction time, and recurrent sinus pauses.82 Therefore, HCN1 is required for stable 
heart rate and regular beat-to-beat variation.82  
HCN2 is the dominant ventricular isoform.77 Only a detectable amount of HCN2 was found in 
rabbit SAN (HCN4>>HCN1>>HCN2), but a moderate level was found in mouse SAN 
(HCN4>>HCN2>>HCN1).79, 81 Overexpression of HCN2 leads to elevation of If current and 
increase in spontaneous firing rate, but it is not clear whether overexpression of any other inward 
current generator would produce the similar result.83, 84 HCN2-deficient mice display modest 
cardiac dysrhythmia, in which the mean heart rate is not changed, but the heart rate variability is 
increased.85 Isolated SAN cells from HCN2-deficient mice present reduced Ih and slightly 
hyperpolarized maximum diastolic potential.85 These data suggest that HCN2 may provide a safety 
mechanism for the correct setting of the MDP.85, 86 Besides, the heart rate in response to 
9 
 
isoproterenol is increased similarly in HCN2-deficient and wildtype mice, indicating HCN2 is not 
required for sympathetic stimulation. It is also proposed that HCN2 and HCN1 probably are not 
essential for the development of cardiac conduction systerm and generation of automaticity, but for 
prevention of arrhythmias.85, 87  
 
Figure 4 Expression of HCN4 protein in human SAN. Low-power montage of immunolabeling of HCN4 protein 
(green signal). White dashed line highlights SAN. (Adapted from Chandler et al., 200988) 
HCN4 is the predominant isoform in human, rabbit, dog and rodent SAN, and is often used as a 
marker of pacemaking tissue (Figure 4).88 It plays an important role in SAN pacemaker activity. 
Firstly, global or heart-specific deletion of HCN4 channels induced embryonic lethality, while mice 
died from embryonic days 5.89, 90 HCN4-deficient embryos had significantly slower heart rate, 
suppression of If and AV block compared with wild type, which also indicates the essential role of 
HCN4 for the development of cardiac conduction systerm.89, 90 Secondly, to overcome the 
embryonic lethality, Herrmann et al. used temporally controlled deletion of HCN4.64 Cells isolated 
from HCN4 deletion mice showed reduced If (about 75%) and a slight response to isoproterenol.
64 
The mutant mice also presented cardiac arrhythmia characterized by recurrent sinus pauses.64 But 
the heart rate challenged by isoproterenol had no change.64 This result was then confirmed by Hoesl 
et al. who used temporally controlled HCN4 gene deletion technique, and found that application of 
isoproterenol accelerate the knock-out mice and wild-type mice to similar levels.65 Thus, it was 
proposed that HCN4 is necessary for generating and maintaining a stable cardiac rhythm, but not 
critical for acceleration of the heart rate.6, 64, 90 Moreover, HCN4 gene mutations are associated with 
arrhythmias.42, 91, 92 For instance, patient carrying HCN4 mutation L573X exhibits severe sinus 
bradycardia and intermittent episodes of atrial fibrillation, chronotropic incompetence during 
exercise.93 Up to date, 13 HCN4 mutations from 14 families were reported.42, 91, 92 In summary, all 
these evidences indicate the important contribution of HCN4 to SAN pacemaker activity.  
1.2.1.1.2 L-type Ca2+ channel (LTCC)  
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L-type Ca2+ channel is a voltage gated channel on sarcolemmal membrane expressed all over 
the heart.6, 13, 14, 94 LTCC is activated when membrane potential reaches ~ -50mV, and generates L-
type Ca2+ current (ICa,L). It exhibits fast Ca
2+- and slow voltage-dependent inactivation.95, 96 The fast 
Ca2+ dependent inactivation produces a negative feedback and limits its own Ca2+ entry, whereas 
the slow voltage-dependent inactivation results in a time dependent behavior and prevents the 
premature Ca2+ entry when cytosolic Ca2+ decreases.97 ICa,L is also regulated by PKA, CaMKII. The 
low activation voltage implicates the important role of ICa,L in generation and regulation of SAN 
automaticity by contributing to the diastolic depolarization, although ICa,L also participates in the 
rapid upstroke of the action potential (Figure 3).6, 98-101  
LTCCs are highly sensitive to dihydropyridines (DHPs), such as nifedipine and BAY K8644.6, 
102, 103 Blockade of ICa,L by nifedipine abolishes the spontaneous activity in both isolated SAN cells 
and in SAN center tissue without affecting T-type Ca2+ channel, but not in SAN periphery tissue.101, 
104 In contrast, blockade of Na+ current by tetrodotoxin has no effect on SAN center tissue, but 
slows spontaneous activity in periphery tissue.101 These results indicate the obligatory role of L-type 
Ca2+ current in generation of SAN automaticity in SAN center region, while Na+ current plays a 
major role in pacemaking in periphery. Indeed, LTCC antagonist nicardipine could induce 
bradycardia in anesthetized mice in vivo.105 A recent research showed colocalization between RyR2 
and LTCC (Cav1.2 or Cav1.3) in the SAN, which may be relevant to the functional role of RyR-
mediated Ca2+ release in pacemaking, in respect that ICa,L could induce Ca
2+ release through RyR2 
in ventricular myocytes (CICR).12, 13 In ventricular myocytes from failing heart, structural 
alterations, such as altered T-tubular structure and increased orphaned RyRs, contribute to the 
defect on the efficacy of ICa,L to release Ca
2+.106, 107 These results indicate the crucial role of LTCC 
to CICR and EC coupling in ventricular myocytes, and also suggest the potential importance of 
colocalization between RyR2 and LTCC in SAN.  
LTCCs are formed by five subunits, α1, , and , α2, δ.6, 7, 13 The α1 subunit forms the ion 
conducting pore and bears the main functional characteristics.7, 13 The architecture of α1 subunit is 
similar to tetrameric K+ channels and voltage-dependent Na+ channel. Each α1 subunit consists of 
four homologous domains (І-IV), and each domain contains six transmembrane helices (S1-S6) and 
a P-loop between S5 and S6. The charged S4 contributes as a voltage sensor, and the α2, δ,  and  
are auxiliary subunits.  
Four α1 subunits have been cloned for LTCC (termed Cav1.1, Cav1.2, Cav1.3 and Cav1.4, 
corresponding to α1S, α1C, α1D and α1F).108 Cav1.1 subunit is expressed in the skeletal muscle, while 
Cav1.4 is widely expressed in the retina, adrenal gland, bone marrow, spinal cord, muscle, spleen 
and immune cells.13 Cav1.2 and Cav1.3 are expressed in the brain, cardiovascular system and 
neuroendocrine cells.12, 13, 88, 109, 110 Cav1.2 is highly expressed in the whole heart, and Cav1.3 is 
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preferentially expressed in supraventricular regions, although the expression of Cav1.3 in SAN is 
lower than Cav1.2.
80, 111 Isolated SAN cells from Cav1.3 gene inactivation mice showed a ~70% 
reduction in ICa,L density, demonstrating the major contribution of Cav1.3 to total ICa,L in mouse 
SAN cells.6, 98, 112 CaV1.2-mediated ICa,L accounts for the residual ICa,L.
6 
The electrical characteristics of Cav1.2 and Cav1.3 mediated L-type Ca
2+ currents are also 
different (Table 1). Cav1.3 mediated current is activated at more negative voltage and more rapidly, 
while inactivation during depolarization is slower than Cav1.2 mediated current
113 and the 
dihydropyridine sensitivity for Cav1.3 is lower than Cav1.2.
113  
Table 1 Characteristics of the LTCC and TTCC isoforms involved in SAN automaticity. (Adapted from Mesirca et al., 
201513) 
 
Genetically modified mice are used to examine the role of Cav1.3 Ca
2+ channel in SAN 
automaticity. Cav1.3 deficient mice show SAN dysfunction, including bradycardia and 
arrhythmia.114 Consisting with that, Matthes et al. also found bradycardia in isolated heart of 
Cav1.3-knockout mice.
115 Isolated SAN cells from Cav1.3 deficient mice exhibit decreased 
pacemaking rate with shift in activation threshold of ICa,L.
116  Similarly, Mangoni et al. investigated 
SAN cells from Cav1.3 gene inactivation mice, and found slower pacemaker activity and 
arrhythmia.98 Moreover, Torrente et al. further found slower pacemaker activity in SAN cells from 
genetic Cav1.3 knock-out mice, associated with impaired [Ca
2+]i dynamics, reduced local [Ca
2+]i 
release events, and deficient synchronization.112 These results indicate that in SAN cells Cav1.3 
accounts for regulation of [Ca2+]i dynamics, triggering local [Ca
2+]i release, and thus controlling 
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pacemaker activity. In the other hand, DHP (isradipine) reduced the heart rate in knock-in 
Cav1.2
DHP-/- mice, in which the DHP sensitivity in Cav1.2 α1 was eliminated without effecting 
channel function and expression, indicating Cav1.3 is an important component of LTCC in SAN.
117 
The stronger colocalization of Cav1.3 with RyR2 also suggests the major impact of Cav1.3 on 
SAN.12 Besides SAN automaticity, Cav1.3 also plays functional roles in AVN pacemaking activity 
and conduction, and in atrial tissues.111, 115, 118, 119 AV conduction abnomalities were reported in 
CaV1.3-deficient mice.
115 In support of that, Marger et al. also reported that CaV1.3 is required for 
AVN cells spontaneous automaticity.119 Zhang et al. isolated AV node from CaV1.3 null mice, and 
found a significant decrease in the firing rate and a depolarizing shift in ICa,L, but no significant 
difference in density peak indicating the potential existence of compensatory changes.118 In atrial 
myocytes, the lack of CaV1.3 channels in null mutant mice results in a depolarizing shift in the 
voltage-dependent activation of ICa,L.
111 
Cav1.2 also contributes the L-type Ca
2+ current in SAN.12 BayK induced heart rate increase is 
absent in Cav1.2
DHP-/- mice, indicating the contribution of Cav1.2 to SAN automaticity regulation.
117 
However, more research is needed. 
1.2.1.1 3 T-type Ca2+ channel (TTCC) 
T-type Ca2+ channel (TTCC) is also a voltage gated channel on sarcolemmal membrane as 
LTCC. It is activated at more negative voltage (~-70 mV) than LTCC, and generates T-type Ca2+ 
current (ICa,T, Figure 3).
6, 13, 95 TTCC is expressed in embryonic and adult heart, including SAN, the 
AVN and the Purkinje fiber network, but not in other working cardiomyocytes.95, 120-128 
Comparation of the expression of CaV3.1 protein in human SAN, paranodal area and right atrium 
shows a significant higher expression of CaV3.1 in SAN and paranodal area than in right atrium 
(Figure 5).88 Comparation of ICa,T density in SAN between species indicates a reverse dependence 
upon the body size, i.e. ICa,T density is larger in small animals and become smaller as the body size 
increases.129 The ICa,T density sequence for different species is mouse>guinea pig>rabbit>pig, while 
it is substantial in mouse SAN cells and almost absent in porcine SAN cells.129 
In contrast to LTCC, TTCC displays slower activation, faster voltage dependent inactivation 
and lower channel conductance.96, 130 Besides, unlike LTCC, TTCC is insensitive to 
dihydropyridines, but sensitive to micromolar Ni2+ ions. Application of Ni2+ to SAN cells slows 
pacemaking.95, 100, 131 However, the mechanism under the contribution of TTCC to SAN 
automaticity is not fully understood. The low activation voltage may indicate its involvement in 
initiation of diastolic depolarization and SAN automaticity. Moreover, a research suggested that ICa,T 
triggers Ca2+ sparks from the SR, which in turn stimulate NCX activation and depolarize the 
pacemaker potential to threshold in cat SAN cells.131, 132 Although, one study found Ni2+ only 
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slightly decreased cycle length, and did not decrease the number of Ca2+ sparks in rabbit SAN cells, 
while a species dependent role of TTCC may exist.133 Notably, Ni2+ is also used as an inhibitor of 
NCX.  
 
Figure 5. Expression of CaV3.1 protein in human SAN, paranodal area and right atrium. The three high power 
images show the immunolabelled CaV3.1 (red signal) in the SAN, paranodal area and right atrium. The bar graph 
indicates the intensity of CaVγ.1 protein labeling in the three areas. Means+SEM (n=4) is shown. * and † represent 
significantly different (P<0.05) from SN (*) or PN (†) (one-way ANOVA); ‡ indicates significantly different (P<0.05) 
from PN (paired t-test). (Adapted from Chandler et al., 200988) 
TTCC is structurally homologous to LTCC. Three α1 subunits have been cloned for TTCC, 
termed Cav3.1, Cav3.2 and Cav3.3 corresponding to α1G, α1H, α1I.108 Cav3.1 is expressed in cardiac 
muscle, skeletal muscle and neurons, while Cav3.2 is expressed in cardiac muscle and neurons, and 
Cav3.3 is only expressed in neurons.
80, 108, 123, 124 The transcription level of Cav3.1 is higher than 
Cav3.2 in SAN.
134 Genetically modified mice have been used to understand the roles of TTCC 
isoforms.  
Genetic inactivation of Cav3.1 TTCC in mice causes bradycardia, delays atrioventricular 
conduction, and prolongs the SAN recovery time.123 Isolated SAN cells present slower pacemaker 
activity by 37% and a related reduction of the slope of the diastolic depolarization, and isolated 
AVN cells also show slower pacemaker activity.119, 123 Le Quang et al. used radiofrequency AVN 
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ablation to produce atrioventricular block in Cav3.1 deficient mice and discovered that loss of T-
type Ca2+ channels worsens bradycardia-related mortality, increases bradycardia-associated adverse 
remodeling, and enhances the risk of malignant ventricular tachyarrhythmias complicating AV 
block.135 Thereby, TTCC plays an important role in SAN spontaneous beating generation and 
infranodal escape automaticity. CaV3.1 inactivation completely abolished ICa,T suggesting CaV3.1 is 
the major component of ICa,T in adult mouse SAN cells.
123 
In contrast, no cardiac arrhythmias are observed in Cav3.2 deficient mice, and ECG waveform 
morphologies are normal, which indicates the insignificant contribution of Cav3.2 mediated T-type 
Ca2+ current to impulse initiation and conduction.136 However, a research shows a higher expression 
of Cav3.2 compared to Cav3.1 in embryonic myocardium, suggesting the functional role of Cav3.2 
in embryonic murine heart.137 The adult heart expresses more Cav3.1, switching transcription from 
Cav3.2 to Cav3.1 in the perinatal period.
137 
1.2.1.1 4 Sodium channel 
The upstroke of SAN AP is relatively slower than in ventricle, as it is driven by Ca2+ channels 
rather than Na+ channels attributed to the lack of Na+ channels in SAN cells. Recent evidences 
showed the existence of Na+ channels in SAN, although, with heterogeneous distribution.  
Two sodium currents have been identified in SAN brought out by two kinds of sodium 
channels: the TTX-resistant cardiac isoform (NaV1.5) inhibited by nanomolar concentration of 
tetrodotoxin (TTX), and the TTX-sensitive neuronal isofroms (NaV1.1 in rat, NaV1.1 and NaV1.3 in 
mouse) inhibited by micromolar TTX.6, 138, 139  
It was shown in different studies that NaV1.5 is absent in SAN center, but present in the 
periphery.138-140 The distribution of NaV1.5 in periphery indicates its potential contribution in 
electric impulse propagation.140  
The distribution of TTX-sensitive sodium channel is controversial. Honjo et al. showed that 
TTX-sensitive sodium current is absent in small cells from the SAN center, but present in the 
periphery.141 In support of this view, Kodama et al. found that blockade of Na+ current by 
tetrodotoxin has no effect on SAN center tissue, but slows spontaneous activity in periphery 
tissue.101 However, more recent studies showed the NaV1.1 is present throughout the SAN, while 
blockage of TTX-sensitive sodium currents results in significant reduction of spontaneous 
pacemaking.138, 139 It has also been reported that the TTX-sensitive sodium current accounts for 
spontaneous activity in the SAN cells from newborn rabbits.142-144  
1.2.1.1.5 Potassium channels 
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There are several types of K+ channels reported in SAN, such as voltage dependent K+ channel 
(Ito, Isus, IKr, IKs), inward rectifier K
+ channel (IK1), ATP dependent K
+ channel (IKATP), 
acetylcholine-activated K+ channel (IKACh), calcium-activated K
+ channel (IKCa), etc.
6, 16  
IKr and IKs are voltage-gated, and they are also delay rectifier currents which are characterized 
by an increased positive slope at more positive membrane potential and slow deactivation kinetics.6, 
7 For instance, IKr reaches full activation at membrane potential of -10mV and displays strong 
inward rectification.145 The activation of IKr is counterbalanced by inactivation at positive voltage, 
and causing the negative slope conductance.145 When the membrane potential reaches back to 
negative, IKr de-activates slowly and generates tail currents.
145 IKr is a “rapidly activating” delay 
rectifier K+ current, activated by depolarized membrane potentials from -50mV.146 Compared with 
IKr, IKs has slower activation and faster deactivation kinetics.
147 IKr and IKs are encoded by ERG1 
gene and KCNQ1 gene, respectively. IKr is sensitive to class III methanesulfonanilide compounds, 
such as E-4031 at micromolar concentration, while IKs is not sensitive to these agents.
6, 148 Species 
dependent differences in IKr and IKs distribution exist. In porcine SAN cells, E4031 hardly affected 
IK, while blockage of IKs inhibited IK, indicating IKs is the predominant component of IK in pig.
149 
Satoh et al. supported this view and suggested the only IKs current (without IKr) contributes to the 
porcine SAN.43 Only IKr is recorded in mouse SAN, while both IKr and IKs account for the rabbit and 
guinea pig SAN.6, 43, 149 Besides, blockage of IKr by micromolar E-4031 causes a cession of SAN 
pacemacking in isolated SAN cells of rabbit and guinea pig.150, 151 E-4031 can also slow pacemaker 
activity in isolated mouse hearts and in rabbit right atrial preparations.145, 152 Thus, the presence of 
IKs rather than IKr in pig can be a form of adaption to slower heart rate in large mammals than in 
rodents.6, 43, 149 Lei et al. also suggested that in rabbit SAN, the contribution of IKs to beating rate is 
small under control condition, but significant during -adrenergic stimulation.153 
The transient outward current (Ito) is characterized by rapid activation and inactivation kinetics, 
and sensitivity to 4-AP.154, 155 KV1.4 (Ito,fast), KV4.3 and KV4.2 (Ito,slow) conduct the fast and slow 
components of the outward K+ current. The sustained outward K+ current (Isus) is the sustained part 
of initially discovered Ito or I4-AP.
154  
Inward rectifier current (IK1) presents in ventricle and is responsible for the maintenance of 
resting membrane potential. However, the density of IK1 is generally low in pacemaker cells. It has 
been reported that IK1 is absent in guinea pig, rabbit and pig SAN, but present in mouse, rat and 
monkey SAN.43 Consist with that, a much lower density of IK1 was found in mouse and rat SAN 
than in ventricle.44, 156  
The acetylcholine-activated K+ current (IKACh) has been described in SAN, atria and AVN.
157-159 
Two genes Kir3.1 and 3.4 are responsible for IKACh in the heart.
160 IKACh is activated by muscarinic 
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and adenosine receptors via binding of G protein  subunits to the channel.6, 11, 160, 161 A recent 
study showed that genetic or pharmacological inhibition of IKACh abolishes sick sinus syndrome in 
CaV1.3 knock-out mice, via allowing net inward current to flow during the DD during cholinergic 
activation.162 Thus, IKACh could be a potential therapeutic target for treatment of sick sinus 
syndrome. Interestingly, acetylcholine slows the cardiac pacemaking not only through activation of 
IKACh, and also through negative regulation of cAMP and concomitant activity of If. Furthermore, 
low concentration (nanomolar) of acetylcholine is sufficient to inhibit If, whereas higher 
concentration (micromolar) is required to activate IKACh.
157 This view is supported by Yamada who 
found that heart rate reduction induced by low ACh doses (<100 nM) was insensitive to IKACh 
inhibition.163 These data indicate the existence of multiple effects by ACh stimulation, and the less 
important role of IKACh in response to nanomolar ACh. The ATP-dependent K
+ current (IKATP) is 
identified in rabbit and rat SAN.164, 165 It is activated by stretch or by low levels of intracellular 
ATP.164, 165 Activation of IKATP in rabbit SAN cells hyperpolarizes the membrane, and slows or 
abolishes the pacemaker activity.165  
The calcium-activated K+ channels are activated by elevation of cytosolic calcium and accounts 
for the membrane hyperpolarization.11, 166 According to the channel conductance, calcium-activated 
K+ channels is divided into three subfamilies: BK, SK and IK, which exhibit “big”, “small” and 
“intermediate” conductance, respectively.11, 166 Big conductance calcium-activated potassium (BK, 
KCa1.1) channels are expressed in central nervous system, smooth muscle, and the SAN.
11, 167, 168 It 
has been recently demonstrated that the BK channels are involved in the regulation of cardiac 
automaticity. Pharmacological inhibition of BK channels significantly reduces the automaticity of 
conscious mice heart and isolated rat heart in a dose-dependent manner.169 Besides, the automaticity 
of SAN cells is reduced by application of BK channel inhibitors, and isolated SAN cells from mice 
with genetic deletion of BK exhibit slower firing rate, both associated with the lengthening of the 
diastolic depolarization phase of SAN cell action potential.170 Small conductance calcium-activated 
potassium (SK1-4) channels also play a fundamental role in heart.11 SK channels in mitochondrial 
inner membrane of guinea pig ventricular myocytes contribute to mitochondrial K+ uptake and 
protect hearts against infarction.171 SK1 (KCa2.1), SK2 (KCa2.2) and SK3 (KCa2.3) are identified in 
human and mouse atria and ventricles.172, 173 Genetic knock-out of SK2 channels results in 
prolongation of action potential duration especially in repolarization in atrial myocytes, and 
inducible atrial fibrillation in null mutant mice.174 Qi et al. further confirmed the participation of 
SK2 in atrial fibrillation maintenance.175 SK4 (KCa3.1) channel also play an important role in 
cardiac pacemaker derived from human embryonic stem cells.176  
1.2.1.1.6 Other channels 
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The sustained inward current (Ist) was identified in SAN of mouse, rabbit, rat, guinea pig, and 
also in rabbit AVN, but absent in quiescent cells.6, 44, 156, 177-180 It is activated at membrane potential 
of about -70mV, reaches the peak at about -50mV, and shows little inactivation during 
depolarization.177, 180 The distinct expression pattern and activation of Ist indicate its role for the 
membrane depolarization and SAN automaticity generation.180 This current is carried mainly by 
Na+, but it is distinct from INa, as this current is TTX-insensitive, can be blocked by DHP 
antagonists, facilitated by BAY K 8644 and inhibited by divalent cations.6, 177 These characteristics 
of Ist also suggest that Ist might be mediated by a novel subtype of LTCC.
177  
Two kinds of transient receptor potential (TRP) channels were found in SAN, TRPC (C stands 
for canonical) and TRPM (M stands for melastatin). TRPC channels are nonselective cation 
channels that regulate ion homeostasis and intracellular Ca2+ signaling in numerous cell types, as 
well as store-operated calcium entry (SOCE).181 The TRPC subfamily contains seven isoforms 
(TRPC1-7), which could be divided into three groups based on the sequence alignments and 
functional comparisons: TRPC1/4/5, TRPC3/6/7 and TRPC2. TRPC2 is not expressed in human.182 
TRPC3/6/7 are activated by diacylglycerol (DAG), produced by PLC-mediated hydrolysis of 
phosphatidylinositol 4, 5-bisphosphate (PIP2). TRPC1, 4 and 5 are activated by SR Ca2+ depletion 
or by stretch.183, 184 The stromal interaction molecule 1 (STIM1) is located in the SR acting as a 
Ca2+ sensor and oligomerized when SR Ca2+ is depleted, which in turn activates Orai1 and 
TRPC1/4/5 via directly binding.185, 186 STIM1 also indirectly activate TRPC3/6, but not TRPC7.187 
Besides, it has also been suggested that Orai and TRPC form complexes that participate in 
SOCE.187 And in support of that, Pani et al. observed that TRPCs are colocalized with STIM1 and 
Orai in lipid raft domains.188 However, other investigators have not observed a role for TRPC 
channels in the Orai/STIM1 complex.189, 190 Activation of TRPCs promotes cardiac hypertrophy by 
Ca2+ influx and subsequent calcineurin activation.191-194 In SAN, TRPC1-4, 6 and 7 are detected, but 
not TRPC5.195, 196 TRPCs related SOCE is probably involved in modulation of heart rate rhythm.196-
199 Mice lacking the TRPC3 gene demonstrated the involvement of TRPC3 in sinoatrial 
arrhythmias.197, 198 Orai1 is also expressed in SAN and plays a potentially important role in SOCE 
in SAN pacemaking.200, 201 Certainly, STIM1 also influences SAN function by reducing SR Ca2+ 
content and regulating ionic fluxes in SAN cells.200 
TRPM4 and TRPM7 were detected in SAN, and both of them participate in SAN automaticity 
generation. TRPM4 is a Ca2+-activated nonselective cation channel driving sodium and potassium 
inward current.202-204 Pharmacological inhibition of TRPM4 reduces the automaticity associated 
with a reduction in diastolic depolarization slope in mouse or rat heart.203 TRPM7 is a divalent-
permeant channel.205 Mice with global or SAN restricted TRPM7 deletion show sinus pauses and 
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AVN block with slower diastolic depolarization and reduced HCN4 mRNA, indicating TRPM7 
influences SAN automaticity via regulation of HCN4 expression.205  
Other electrogenic molecules (such as Na+- K+ pump, etc) also exist on sarcolemmal membrane 
of SAN cells and influence the maintenance of the ionic homeostasis and the normal SAN 
automaticity.6 The Na+- K+ pump excludes three Na+ for two K+ uptake resulting in the generation 
of an outward current, which also influences the pacemaker activity of SAN cells.6, 206  
1.2.1.2 Membrane clock 
The ensemble of sarcolemmal electrogenic molecules forms a voltage membrane oscillator, 
known as voltage clock or membrane clock. According to membrane clock, the SAN action 
potential is predominantly generated by the funny current (If), which is activated by membrane 
hyperpolaryzation. It depolarizes the membrane, and then activates multiple voltage-gated ion 
channels, such as TTCC, LTCC, etc.207, 208 The multiple ion channels lead to diastolic 
depolarization as well as upstroke of the action potential via LTCC. Then, the membrane potential 
is repolarized to the maximum diastolic potential by K+ channel.  
1.2.2 Ca2+ clock theory  
1.2.2.1 Sodium-calcium exchanger (NCX)  
Sodium-calcium exchanger (NCX) is a high-capacity, voltage-dependent, Ca2+-dependent and 
time-independent electrogenic protein. It is located on the sarcolemmal membrane, and colocalized 
with cardiac RyR (Figure 6).209 It is one of the major electrogenic molecules that maintain Ca2+ 
homeostasis in SAN cells, and also contributes to diastolic depolarization in SAN cells.16 NCX 
activity is enhanced by the localized SR Ca2+ release during diastolic depolarization.131, 210 It 
extrudes Ca2+ from the cell and brings in Na+. As one Ca2+ ion is extruded for exchanging of three 
Na+ ions, NCX produces an inward current (INCX) and further depolarizes the membrane (Figure 
3).6, 211 Many studies suggest the RyR-NCX-SERCA crosstalk ensure the SAN cell function 
(coupled clock).16, 212 Indeed, acute blockade of the NCX via inhibitor (KB-R7943), via rapid 
substitution of Na+ by Li+, application of ryanodine (RyR2 inhibitor), or chelation of intracellular 
[Ca2+]i abolishes SAN cells beating.
213-215 These data indicate that INCX is attributed to elevated 
[Ca2+]i, and via RyR-NCX-SERCA crosstalk contributing to SAN pacemaking. 
The NCX protein contains ten helical transmembrane domains, and a large intracellular loop 
between the fifth and sixth domains.216-219 The intracellular loop contains two calcium binding 
domains (CBD1 and CBD2) that are required for intracellular ion sensing and binding, and a XIP 
domain which confers sodium inactivation properties.216 Crystal structure shows that NCX from 
19 
 
Methanococcus jannaschii has four ion binding sites at the center of the protein, while one of them 
is specific for Ca2+ and the other three are likely for Na+ to perform the ion exchange.217  
Three NCX isoforms (NCX1-3) have been found to date. NCX1 is expressed widely in 
mammalian tissues, and considered as cardiac isoform.220-222 NCX2 is predominantly expressed in 
smooth muscles and brain, and NCX3 is mainly expressed in skeletal muscle.220, 221 Their levels 
vary considerably during postnatal development.221  
 
B 
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Figure 6 The distribution of NCX and RyR in rabbit SAN cells. A. Confocal image of SAN cell imunolabeled for both 
NCX and RyR. B. Pixel-by-pixel fluorescence intensities of labeling along the arbitrary line in panel A. And the 
horizontal dashed lines report the average pixel intensity. C. Topographical profiles of the pixel intensity levels of each 
antibody labeling and overlay of the small SAN cells in panel A. The maximum height represents the brightest possible 
pixel in the source image (using an 8-bit image intensity scale). Less bright pixels are accordingly scaled to a smaller 
height. (Adapted from Lyashkov et al., 2007209) 
Genetically modified mice are used to understand the contribution of NCX1 to SAN 
automaticity. A total suppression of NCX1 results in lack of spontaneously beating heart and 
embryonic lethality.223 To overcome this problem, Gao et al. generated incomplete NCX1 knockout 
mice and suggested that NCX1 is critical for fight or flight reaction of SAN, but is not required for 
resting heart rate.224 However, this mice model was challenged by Maltsev et al. (2013), who 
indicated that the lower expression of NCX1 could be compensated by the local cross-talk between 
Ca2+ cycling proteins and NCX, i.e. lower NCX1 expression encourages CICR and in turn stabilize 
the density of INCX. Therefore, they suggested that NCX1 is critical for both SAN “fight or flight” 
reaction and maintainence of basal automaticity. Indeed, mice, selectively lacking NCX1in cardiac 
pacemaking and conduction system, show slower heart rate accompanied by severe arrhythmias.225 
Furthermore, complete atrial-specific NCX knockout mice lack P waves, and the isolated SAN cells 
are quiescent with consequently impaired Ca2+ efflux.226, 227  
1.2.2.2 RyR2 in Ca
2+ clock 
C 
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The involvement of RyR2 Ca
2+ release in SAN automaticity was first carried out by the 
observation that application of ryanodine slowed pacemaker activity in cat right atrium.228 Later 
studies further illustrated that both ryanodine (RyR blocker) and cyclopiazonic acid (SERCA 
blocker) reduced pacemaker activity in guinea-pig SAN tissue.229, 230 A concentration of γ0μM of 
ryanodine abolish activity in 83% of isolated-rabbit SAN cells, although in another study the same 
concentration of ryanodine only inhibited rabbit SAN cell firing rate by ~20%.209, 231 Inducible, 
cardiac-specific knockout of RyR2 with acute ~50% loss of RyR2 protein was sufficient to cause 
bradycardia and arrhythmias.232 These studies point to the idea that the SR Ca2+ release through 
RyR2 plays an important role in pacemaking.  
1.2.2.3 Ca2+ clock  
 
Figure 7: Schematic illustration of interactions of key molecules comprising the system. The common regulatory factors 
are lettered in purple, which govern the function of both the Ca2+-clock (gray intracellular area) and the M-clock (light-
blue cell membrane area with blue labels depicting electrogenic proteins).  The green arrows illustrate signaling driving 
action potential (AP) firing, while the red lines suppress the AP firing and balance the system. G protein-coupled 
receptors (green and red shapes within the membrane) modulate both the Ca2+-clock and M-clock function via those 
same crucial signaling nodes of the system. (Adapted from Maltsev et al., 201416) 
According to the Ca2+ clock, the SR generates rhythmic Ca2+ release (local Ca2+ release, LCR) 
via RyR2. The LCRs activate NCX, which generates depolarizing current and causes the slow 
increase in membrane potential toward an excitation threshold for action potential firing, resulting 
in pacemaking (Figure 3).14, 16, 233 The cytosolic Ca2+ is extruded by NCX, or pumped back into SR 
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by SERCA (sarcoplasmic/endoplasmic reticulum Ca2+-ATPase) to complete the Ca2+ cycle. The 
Ca2+ extruded by NCX should quantitatively match the Ca2+ entry through sarcolemmal, and the 
Ca2+ transferred by SERCA needs to match the Ca2+ released by RyR2.
6 The involvement of Ca2+ 
release from RyR2 in SAN pacemaker activity was introduced previously. Subsequent work showed 
the involvement of following NCX current in pacemaking, and in response to -adrenergic 
stimulation.131, 210, 213-215 Besides, calcium sparks were found during the depolarization under normal 
Ca2+ condition, in absence of Ca2+ overload (Figure 3).131, 214 It is likely that the LCRs depolarize 
the cell through activation of NCX that initiate the pacemaking.131, 214 Moreover, in support of Ca2+ 
clock theory, Vinogradova et al. found periodic Ca2+ oscillations during voltage clamp or in 
detergent-permeabilized SAN cells in the absence of sarcolemmal function, and independent of 
diastolic membrane depolarization.234, 235 For instance, in Figure 8, when the voltage clamp at 
potentials that prevent SAN cells from Ca2+ loss via NCX, the SR Ca2+ clock becomes ‘free 
running’ in spite of surface membrane.83 Furthermore, in physiologic intracellular [Ca2+]i (150 nM), 
the free running Ca2+ clock generates roughly periodic LCRs with frequency 2-4 Hz.83 Similarly, in 
detergent-permeabilized SAN cells, the LCRs were observed in 100nM bathing [Ca2+].234 As shown 
in Figure 8 (right) rhythmic LCRs generate rhythmic current fluctuations in voltage-clamped SAN 
cell, and the frequency of current fluctuation is as the same as the frequency of LCRs.83 These 
evidences indicate existence of LCRs and the independent Ca2+ clock.  
1.2.3 Coupled clock theory 
Some studies suggested that membrane clock is not the only mechanism of SAN automaticity, 
as the membrane clock failed to understand some experimental results, such as the reduction or 
cessation of SAN automaticity produced by specific inhibition of Ca2+ cycling, and CaMKII or 
PKA-dependent phosphorylation.209, 228, 229, 235 Thus, the coupled clock was proposed, which 
suggests the SAN pacemaker activity is generated by two coupled oscillators, membrane clock and 
Ca2+ clock.233  
In the coupled clock, the membrane clock and Ca2+ clock are coupled via NCX, which 
generates an inward current and depolarizes the membrane to reach the threshold of activation of 
other ion channels, e.g. LTCC, and further regulate the Ca2+ clock. The Ca2+ clock is implicated 
directly by LTCC, NCX, etc, and also indirectly by K+ channels, HCN channels, etc, via respective 
membrane potential changes and regulating Ca2+ fluxes. For instance, K+ channels repolarize the 
membrane and activate HCN and other channels, while HCN limits the hyperpolaryzation. The 
accumulation of cytosolic Ca2+ in turn implicates membrane clock. The two clocks work together 
through numerous interactions modulated directly by membrane voltage, subsarcolemmal Ca2+, and 
indirectly by PKA and CaMKII-dependent protein phosphorylation (Figure 7).14, 16, 233 The cytosolic 
Ca2+ binds to calmodulin, and CaMKII and to Ca2+ dependent adenylyl cyclase (AC) resulting in 
23 
 
the production of high basal cAMP (Figure 7). The contributions of the interactions are discussed 
below. Based on the mutual entrainment of the interactions, the two clocks form a robust, stable, 
coupled-clock system that ensure the normal SAN automaticity.14, 16, 233  
 
Figure 8 LCRs and current fluctuations in SAN cell during voltage clamp. The left part of panel A shows 
simultaneous recordings of membrane potential or current (top), confocal line-scan image (middle), and normalized 
fluo-3 fluorescence (bottom) averaged over the line-scan image, in a representative spontaneously beating rabbit SAN 
cell; and the right part shows Fast Fourier transform (FFT) of Ca (red) and membrane current fluctuations (green). B. 
PKA inhibition with PKI shifts FFT of both Ca2+ and membrane current fluctuations to lower frequencies during 
voltage clamp. And -adrenergic receptor stimulation (panel C) with isoproterenol shifts FFT of both Ca and membrane 
current fluctuations to higher frequencies during voltage clamp. (Adapted from Vinogradova and Lakatta, 200983) 
Neutral theories also exist. For instance, Capel and Terrar claimed that the “Ca2+ clock” plays a 
modulatory rather than essential role that cooperates with membrane clock, and this is also reffered 
as “coupled clock”.236 However, more studies are needed in this area. 
1.2.4 Autonomic regulation of cardiac automaticity 
Autonomic nervous system is the major extracardiac determinant of the heart rate. The cardiac 
sympathovagal is a complex phenomenon, containing multiple interactions between sympathetic 
and parasympathetic centers in the central nervous system.2, 6, 237 In the adult heart, the sympathetic 
branch of the autonomic nervous system accelerates heart rate, while the parasympathetic branch 
slows it. It is also worth to note that sympathetic and vagal activations induce shifts in the leading 
pacemaker site, which could be explained by the regional densities of adrenergic and muscarinic 
receptors of SAN.238, 239  
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As a terminal part of the cardiac autonomic nervous system, the intrinsic cardiac neuronal 
plexus (ICNP) plays a pivotal role in regulating heart rate, conduction, myocardial contractile force 
and coronary blood flow.240 The canine SAN is densely innervated by nerve fibers of ICNP, which 
forms ~400 ganglia around the junction between the right atrium and the superior vena cava.241 The 
canine atrium, including the SAN, was estimated to be innervated by more than 54,000 intracardiac 
neurons.241 A similar organization of SAN innervation by the ICNP was found in human, while the 
human heart contains on average ~800 epicardiac ganglia (ranged from ~700 up to ~1500) and 
estimated ~43,000 intrinsic neurons (in adult heart, 94,000 in young heart).242 In rat epicardium, 
intrinsic nerves clustered into six routes by which they are selectively projected to different atrial 
and/or ventricular region.243 For instance, the rat AVN and AV bundle are innervated by a dense 
network of thin endocardial nerves projecting from a neuronal cluster adjacent to the interatrial 
septum and the right pulmonary sinus.243 As seen in human, the number of intrinsic cardiac neurons 
in rats is also age-depedent, ~6500 in old rats and ~5000 in juvenile rats.243 In general, small nerves 
in the SAN contain 5-15 axons, through what the neurotransmitter (such as catecholamine) is 
released, while gaps between varicosities and nodal cells are 20-100 μm depending on the species.2 
Adrenergic and nonadrenergic release sites are found in close vicinity to each other.2  
Sympathetic and parasympathetic limbs combine and act as autonomic control regulating the 
pacemaker activity. However, the ratio between vagal and sympathetic input differs among 
species.2, 6 This different ratio of vagal and sympathetic input is one explanation of the different 
basal heart rates in mammals, which are inversely correlated with the body weight, although the 
intrinsic properties of pacemaker cells in different species also account.2, 6 The two branches of the 
autonomic nervous system interact to generate an adaptable equilibrium, thus SAN automaticity can 
be under dominance of the sympathetic or parasympathetic limb.6 In mice, it seems like sympathetic 
tone is dominant, as the isolated SAN beats significantly slower than the heart rate in vivo, although 
a vagal tone is nevertheless present.6 In contrast, dogs and humans show vagal predominance as 
combined muscarinic plus -adrenoceptor blockage accelerates the heart rate.2, 6 When the SAN is 
under sympathetic tone, the effect of parasympathetic input is greater, and this phenomenon is 
named “accentuated antagonism”.237 The ratio between vagal and sympathetic input could also be 
influenced. For instance, long-term endurance training increases parasympathetic activity and 
decreases sympathetic activity in human heart at rest, termed cardiovascular adaptation.244 This 
enhanced vagal tone could also explain the bradycardia observed in the trained athlete, although the 
local factors should also be considered, such as downregulation of HCN4 channel.245, 246  
Besides the autonomic balance, cardiac automaticity is also modulated on a beat-by-beat basis, 
which results in quickly adapted pacemaking to physiological state of the organism.6 Thus the high-
frequency and low-frequency spectra of the heart rate variability could be used to evaluate the 
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dynamic regulation of pacemaking.6, 247-249 However, intrinsic factors might also involve in the beat-
by-beat regulation of heart rate.  
1.2.4.1 Sympathetic regulation of cardiac automaticity 
Sympathetic control of pacemaker activity is carried out through -adrenergic receptor ( -AR) 
activation by catecholamines (Figure 7). -ARs belong to the superfamily of G-protein-coupled 
receptors, of which the conformational change could induce activation of associated G protein and 
in turn activate ACs and ACs/cAMP pathway (Figure 7).250 AC5 and AC6 are the major isoforms in 
heart activated by -AR stimulation, while AC1 and AC8 are Ca2+ activated.250 ACs activation 
results in a higher level of basal cAMP. Thereby, catecholamines activate -ARs/ACs/cAMP 
signaling which regulates SAN automaticity through interaction with both membrane and Ca2+ 
clock (Figure 7), and the modification of the coupled-clock causes the positive chronotropic effects. 
The resultant enhanced [Ca2+]i contributes a negative feedback effect that inhibits AC5 and AC6, 
but a positive feedback effect on Ca2+-activated ACs (AC1 and AC8).251  
AC1- and AC8- induced cAMP-PKA pathway in basal pacemaker activity 
Basal cAMP and cAMP-mediated PKA-dependent phosphorylation forms an essential role in 
basal SAN pacemaker activity via both Ca2+ clock and membrane clock. Early studies have 
demonstrated that superfusion of rabbit SAN with cAMP containing solution increases the 
spontaneous beating rate, with a marked increase in the DD slope.252-254 In support of that, addition 
of adenylate cyclase (AC, cAMP producer) inhibitors suppressed the spontaneous activity of rabbit 
SAN, while the effect could be restored after addition of dibutyryl cAMP.255 The basal cAMP level 
is ~10-fold higher in rabbit SAN cells than in atrial or ventricular myocytes.234 
Further researches found a link between Ca2+ and cAMP (Figure 7), followed by the discovery 
of Ca2+-activated ACs (AC1 and AC8) in SAN.256, 257 Mammalian ACs consists of nine isoforms.258 
AC5 and AC6 are the major isoforms in the heart activated by -AR stimulation, while AC5 is 
predominantly expressed in mature adult ventricle and AC6 is mainly in fetal ventricle.250 In 
contrast, AC1 and AC8 are activated by Ca2+/CaM. They are primary found in neuronal tissue and 
later found in rabbit and guinea-pig SAN within membrane lipid microdomains.257, 258 The 
activation of basal AC within physiologic intracellular Ca2+ range (0.2-1μM) is Ca2+ dependent, 
indicating that basal Ca2+ cycling regulates Ca2+-activated AC-cAMP pathway resulting in rhythmic 
LCRs and driving the generation of rhythmic action potential.257 Besides, -AR stimulation induced 
cAMP is not reduced by Ca2+ chelation, suggesting that this -AR stimulation related AC activation 
is distinct from Ca2+ activated ACs which regulates basal cAMP.83  
The cAMP also mediates PKA-dependent protein phosphorylation (Figure 7). The high basal 
cAMP level is attendant with high level of basal PKA-dependent phosphorylation, which is 
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obligatory for basal pacemaker activity.235 Gradations in PKA activity, which is represented by 
targeted PLB phosphorylation and indexed by specific PKA inhibitor peptide (PKI), are highly 
correlated with gradations in LCR spatiotemporal synchronization and phase, as well as in beating 
rate (Figure 8).83, 235 A higher level of PKA inhibition abolishes LCRs and spontaneous beating.235 
It has been shown that PKA phosphorylates many cellular proteins involved in SAN pacemaking, 
such as LTCC, PLB, RyR2, etc.
235, 259 For instance, PKA could phosphorylate PLB (Ser16), and 
thus the phosphorylated PLB releases the SERCA, which increases SERCA Ca2+ affinity and 
enhances the Ca2+ recovery.260 However, PLB mutation on PKA target site (S16A) did not affect 
HR in vivo or firing rate in SAN cells, indicating multiple regulation of PKA on SAN beating 
activity.261 
The production of cAMP is balanced by high basal phoshpodiedterases (PDE) activity induced 
hydrolysis, which degrades cAMP into 5’-AMP.48 This fail safe system controls the basal cAMP 
level, limits the cAMP-mediated phosphorylation and restricts the spontaneous SAN beating rate. 
Mammalian PDEs are encoded by 21 genes. They are categorized into 11 families based on 
sequence homology, enzymatic property and sensitivity to inhibitors. PDE families contain many 
splice variants that mostly show unique characteristics, such as tissue-expression pattern, enzymatic 
regulation by phosphorylation and regulatory proteins, subcellular localization, and interaction with 
association proteins.262 PDE1, 2, 3, 10 and 11 regulate both cAMP and cGMP, while PDE 4, 7 and 
8 regulate cAMP only, and PDE 5, 6 and 9 regulate cGMP only.262 PDE1-5 and 7 are detected in 
heart, and PDE3 and PDE4 provide the major cAMP hydrolyzing activity.262 In human, bovine, dog 
and rabbit myocardium, the main membrane-bound subtype is PDE3, whereas in mouse and frog 
ventricle microsomal PDE activity is markedly represented by PDE4.263 In dog and rabbit 
ventricular tissue, PDE3 accounts for 70-85% of total cAMP hydrolyzing activity in microsomal 
fraction and about 30-40% in cytosol.263 PDE4 represents 13% of the total cAMP hydrolyzing 
activity in microsomal fraction and 7-8% in cytosole in dog ventricle.263 However, in murine heart, 
PDE4 is the dominant PDE subtype accounting for 60% of total cAMP hydrolyzing activity.263 In 
rat ventricle, PDE3 and PDE4 activity are in equal level leading to ~90% of the total cAMP 
hydrolyzing activity.263 It was also proposed that the localization of PDE3 differs from PDE4. 
PDE4 targets to sarcolemma in canine and human cardiac microsomal fractions, while PDE3 is 
mainly associated with T tubule and SR.263 However, in rat cardiac myocytes, the localizations of 
PDE3 and PDE4 are mainly associated with sarcolemma.263 PDE3 and PDE4 equally contribute to 
cAMP hydrolyzing activity in nuclear fraction of sheep cardiac myocyte in which they are mostly 
localized within nuclear envelope.263 In SAN cells, several studies reported that suppression of PDE 
activity accelerates the spontaneous firing rate, with increased cAMP level and augmented DD 
slope.264-266 A recent study inhibited PDE by 100μM IBMX, a broad-spectrum PDE inhibitor, leads 
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to 9-fold increase in cAMP level and ~55% increase in spontaneous beating rate.48 Besides, PDE 
inhibition increased PKA-dependent PLB Ser16 phosphorylation, suggesting that PKA is involved 
in PDE-dependent regulation of spontaneous SAN firing.48 Vinogradova et al. also compared the 
contribution of PDE1-5 to SAN firing rate with specific inhibitors in rabbit SAN,48 where it was 
known that PDE3 is the most abundant subtype.267 PDE3 inhibitor (milrinone) accelerated 
spontaneous firing (~47%) and increased ampligude of ICa,L (~46%), while the effects of other PDE 
inhibitors are minor, indicating that PDE3 is the major constitutively active PDE in basal state.48  
RyR2 function is critical for cAMP/PKA-induced acceleration of SAN spontaneous firing. 
Gradations in PKA activity affected by specific PKA inhibitor peptide (PKI) are related with 
gradations in LCRs spatiotemporal synchronization, as well as beating rate.235  Higher level of PKA 
inhibition abolishes LCRs, as well as spontaneous beating.235 Ryanodine limites the increase of 
SAN beating rate by CPT-cAMP (a membrane-permeable cAMP analog) from ~36% to ~13%.235 
Besides, the PDE inhibition-dependent acceleration also results in increased LCR amplitude and 
size and decreased LCR period, causing earlier and augemented LCR Ca2+ release, and increased 
NCX.48 Addition of ryanodine prevents the IBMX and milrinone induced increase in LCRs, INCX, 
and SAN firing rate, despite the preserved augmentation of ICa,L amplitude.
48 These results 
confirmed that RyR2 function is critical for cAMP/PKA-induced acceleration of SAN spontaneous 
firing. Basal constitutive PDE activation provides a powerful mechanism to decrease cAMP, thus 
via RyR2 to restrict the spontaneous SAN firing rate.
48 Wu et al. reported that RyR2 knock-in 
mutation on PKA target site (S2808A) failed to affect spontaneous firing rate and isoproterenol 
response in vivo and in SAN cells, indicating multiple PKA targets in SAN cells.261 
The cAMP has a direct effect on If. DiFrancesco and Tortora showed that cAMP shifted If 
activation curve to more positive voltages.268 Besides, several studies demonstrated that PDE 
inhibition by IBMX or amrinone (PDE3 inhibitor, 0.1 mM) increases If activation by shifting the 
current activation range to more positive voltage in rabbit SAN cells.269, 270 This effect was 
confirmed by Mattick et al., who demonstrated that AC inhibition shifted If activation in the 
hyperpolarizing direction, as well as Ca2+ chelation, while PDEs inhibition shifted If activation in 
the depolarizing direction in guinea-pig SAN cells.256 Although, Vinogradova et al. also showed 
that in rabbit SAN cells when If is blocked by Cs
+ (β mM), IBMX (100 μM) or milrinone (50 μM) 
still produces a similar increase in spontaneous beating rate as without Cs+ pretreatment, suggesting 
If only plays a minor role in PDE inhibition induced acceleration of spontaneous SAN firing.
48 
However, this idea is challenged by the limitation of Cs+. In particular, Cs+ does not block If fully, 
the block is voltage dependent and Cs+ is also a K+ channel blocker which could indirectly affect 
If.
271 Thus, the partially unblocked If by Cs
+ block would still be able to drive the automaticity.271 
HCN4 mutation (HCN4-573X) was observed in a patient with SAN dysfunction, caused by a 
28 
 
heterozygous 1-bp deletion (1631delC) in exon 5 of the human HCN4 gene.93 HCN4-573X protein 
had a truncated C-terminus and lacked the cyclic nucleotide–binding domain.93 COS-7 cells 
transfected with HCN4-573X cDNA showed that the mutant channel is insensitive to cAMP and 
exhibits altered deactivation kinetics, providing a likely explanation for the patient’s sinus 
bradycardia and the chronotropic incompetence.93 Another mutation (S672R) is located near the 
cAMP-binding site.272 HEK293 cells expressed this mutant HCN4 channel showed that mutation 
S672R shifts the channel activation to more negative voltages, which is responsible for the familial 
bradycardia.272 
LTCCs are regulated by cAMP/PKA pathway. In ventricular myocytes, addition of membrane-
permeable cAMP resulting in several fold increase in ICa,L.
273 In addition, inhibition of PDE by 
IBMX (100 μM) increased ICa,L by 120% and [cAMP]i by 70% in rat ventricular myocytes.274 
Specific inhibitors of PDE1-4 regulate ICa,L with rank order of potency PDE4> PDE3> PDE2> 
PDE1.274 In rabbit SAN, flash photolysis of caged cAMP (50 μM) increased both pacemaking rate 
and ICa,L.
254 PDE3 inhibitor (amrinone, 0.1 mM) increased ICa,L by ~25% in rabbit SAN cells.
270 
Similar data was got by using another PDE3 inhibitor (milrinone, 50 μM), which increased ICa,L 
amplitude by ~46% in rabbit SAN cells.48 Tanaka et al. also showed Rp-cAMP, a specific 
competitive antagonist of cAMP-induced activation of PKA, abolished the effect of ICa,L by cAMP 
in rabbit SAN cells.254 It seems that the cAMP induced increase in ICa,L is through the cAMP/PKA-
dependent phosphorylation. Indeed, further studies showed both α1C subunit (Ser-19β8) and β 
subunit (Ser-478 and Ser-479) of LTCC are PKA substrates, and rapid dephosphorylation of the 
channel could be provided by the Ser/Thr phosphatases 1 and 2A (PP1 and PP2A).275-277 
It is demonstrated that cAMP regulate delay rectifier K+ current (IK) in ventricular myocytes. It 
increases delay rectifier K+ current (IK) amplitude, slows IK deactivation kinetics, and shifts IK 
activation curve to more negative potentials, mainly via cAMP-mediated PKA-dependent 
phosphorylation.278, 279 In rabbit SAN cells, PDE activity also controls the delay rectifier K+ current 
(IK), as IBMX (100 μM) markedly increases the amplitude of IK,tail (12%) and shifts IK activation to 
more negative potentials, implicating the effect of cAMP.48 On the other hand, another PDE3 
inhibitor amrinone (0.1 mM) increases delayed rectifier K+ current (IK) tail by ~22% in rabbit SAN 
cells.270 
NCX has been proposed as a substrate for CaMKII or PKA-dependent phosphorylation, as it 
contains several phosphorylation sites.83, 280 However, the functional significance of NCX 
phosphorylation is still a matter of debate.83, 281, 282  
It has been shown that sex-related difference in SR Ca2+ release exists in ventricular myocytes. 
Female myocytes had smaller [Ca2+]i transients, Ca
2+ sparks and EC coupling gain in comparison to 
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males.283 Further research found lower cAMP levels in female due, at least in part, to the higher 
expression of PDE4B, probably resulting in lower phosphorylation levels of Ca2+ handling proteins 
and the different Ca2+ behavior in females than in males.283 These findings could also explain the 
sex-related differences in EC coupling, i.e. smaller and slower contraction and underlying [Ca2+]i 
transient in females.284 Whether or not sex steroid hormones are involved in the sex-related 
differences is not yet understood. However, testosterone has been shown to inhibit PDE activity in 
the ventricles of male rats, which could explain the higher levels of cAMP in male cells.285 Thus, 
testosterone may induce a chronic and sex-related effect on SAN pacemaking, although it has no 
acute effect on beating rate of isolated rat right atria.285 Besides, ovariectomy increases PKA 
activity in female rats, which supports the view that cAMP is suppressed in female.286 Besides, the 
lower cAMP level may also limit the positive inotropic responses to -AR agonists.283 However, the 
sex-related effect in SAN cells is not yet investigated.  
The basal spontaneous pacemaker activity is controlled by high level of cAMP, producted by 
Ca2+-activated AC and balanced by high level of PDE activity. Moreover, cAMP is also a potential 
regulator of excitation-transcription coupling (ET coupling).  
AC5- and AC6-induced cAMP-PKA pathway under sympathetic regulation 
Under sympathetic regulation, AC5- and AC6-induced cAMP/PKA pathway is accentuated. 
Besides, kinetics and stoichiometry of increases in PKA activity and protein phosphorylation in 
rabbit SAN cell are linked with changes in the kinetics and stoichiometry of increases in AP firing 
rate in response to physiological ( -AR) stimulation or pharmacological (PDE) inhibition.287 
If has been proposed as an important substrate of heart rate acceleration in response to 
catecholamines, as the activation of If could be facilitated by direct interaction with cAMP. As 
mentioned previously, a small cAMP augmentation increases If open probability, and shifts the 
activation curve positively.6, 50, 63, 83 It has also being illustrated that low does of -AR agonist 
isoproterenol increase the DD slope without affecting the AP waveform, in respect that changes in 
DD slope is a common observation of If modulation.
50 In addition, Stieber et al. also shown that 
cAMP cannot accelerate the heart rate of HCN4-/- embryos.89 All these evidences indicate the 
contribution of If in sympathetic regulation of pacemaker activity, although this idea is questioned 
by the observation that the full range of responses to autonomic agonists is possible in the partial 
absence of If or when If function is deficient.
64, 65  
The involvement of ICa,L in sympathetic regulation of SAN automaticity has also been 
demonstrated in different species.6, 83, 95, 133, 210, 288 In isolated hearts from Cav1.3 knock-out mice, 
the positive chronotropic response to isoproterenol is moderately reduced.6 In addition, -AR 
stimulation still enhanced pacemaking in isolated SAN cells from Cav1.3 knock-out mice, but to a 
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lesser extent than in WT SAN cells.112 These results indicate a moderate contribution of Cav1.3 to 
sympathetic regulation. The -AR stimulation induced ICa,L increase could also be explained by 
increased cAMP/PKA level. In ventricular myocytes the increased ICa,L is linked to PKA-dependent 
phosphorylation of serine 1928 residue of the C-terminal α1C of LTCC.277 -AR stimulation 
increases ICa,L by augmenting the channel open time and the open probability in ventricular 
myocytes.102 The data in ventricular myocytes implicate the potential effect of ICa,L in SAN 
sympathetic response, suggesting that at least part of the positive chronotropic effect of the -AR 
stimulation in SAN automaticity could be explained by the increase of ICa,L. 
The increased IK in SAN by -AR agonist was first observed in rabbit SAN preparations.6, 40, 83 
This observation was confirmed in isolated SAN cells. The -AR agonist increased IK in rabbit 
SAN cells, and IKs in guinea-pig SAN cells, attributed to the increase in cAMP-mediated, PKA-
dependent phosphorylation.289, 290 Lei et al. also suggested that in rabbit SAN, the contribution of IKs 
to beating rate is small under control conditions, but significant during -adrenergic stimulation.153 
An additional study demonstrated that this regulation of IKs is mediated by a macromolecular 
signaling complex including the targeting protein AKAP9 (Yotiao) which regulates channel activity 
by phosphorylation of Ser27 in the N-T of KCNQ1, and of Ser43 in the N-T of Yotiao.291 
Ist is also increased by the -AR agonist, indicating the potential involvement of Ist in SAN 
sympathetic response.83, 177, 179, 292 However, blockage of Ist by 50% produces only ∼10% decrease in 
the isoproterenol induced acceleration in rabbit SAN cells, suggesting that Ist current likely has a 
minor role in SAN -AR response.133 
The cardiac TTX-resistant Scn5A-mediated INa is a potential substrate of SAN sympathetic 
regulation, as it is sensitive to phosphorylation by PKA and PKC.6, 293, 294 In contrast, the TTX-
sensitive INa probably contributes more to the DD in basal condition than under adrenergic 
activation, as in neurons it can be negatively regulated by the sympathetic nervous system.138 More 
studies are needed in this area.  
-AR stimulation regulates the Ca2+ clock, resulting in an significant contribution to the positive 
chronotropic response. -AR stimulation increases the LCRs number, amplitude and size during 
late DD in rabbit SAN cells.133 The synchronization is due, at least in part, to the increase in PLB 
phosphorylation, ICa,L and SR Ca
2+ content.48, 133, 235 Besides, the increased RyR2 Ca
2+ release 
reflects the increased RyR2 phosphorylation, in respect that -AR stimulation induces cAMP-
dependent RyR2 phosphorylation and concomitant Ca
2+ release in ventricular myocytes.295, 296 
Indeed, -AR stimulation increases the cAMP/PKA dependent RyR2 phosphorylation.297 In this 
sense, mice harboring mutant RyR2 channels (RyR2-S2808A+/+) that cannot be PKA 
phosphorylated exhibited blunted cardiac contractile response to catecholamines, and similar results 
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were also found in isolated SAN cells from RyR2-S2808A+/+ mice.
297 In addition, the inhibition of 
RyR2 by ryanodine prevented -adrenergic augmentation of LCRs, DD rate, INCX and SAN cell 
firing rate, even if the augmented -adrenergic effect on ICa,L was preserved.83, 133, 230 Similar effects 
were found in isolated SAN cells or intact SAN tissue.235, 298 In contrast, another study suggested 
that ryanodine (γ0 μM) inhibited basal SAN cell firing rate but failed to block the -adrenergic rate 
increase, as the presence of both ryanodine and -AR agonist still causes ~50% increase in firing 
rate, although this study did not compare the -adrenergic effect with and without ryanodine.231 
Besides, it is also noticeable that in contrast to a lower ryanodine concentration, the high 
concentration used in this study could probably lock the RyR2 in a close state, preventing the SR 
Ca2+ depletion and -AR stimulation effect.83, 299 The majority of studies point to the idea that Ca2+ 
release through RyR2 is increased by -AR stimulation.
133, 230, 235, 298, 300 The augmented and earlier 
Ca2+ releases could cause an augmented and earlier activation INCX, leading to increase of 
membrane DD rate and SAN cell firing rate, considering INCX is dependent to elevated [Ca
2+]i rather 
than changes in the intrinsic properties.213, 299 Indeed, Zhou and Lipsius demonstrated that -AR 
stimulation induced increase in INCX accounts for the concomitant increase of the DD slope.
210  
It has also been demonstrated that the acceleration of heart rate under -AR stimulation requires 
CaMKII activation, considering CaMKII implicates many proteins involved in coupled clock. 
Indeed, CaMKII inhibited mice showed similar basal heart rate as wild type, but significant slower 
acceleration of the heart rate during -AR stimulation.300 Further investigation showed that CaMKII 
inhibition prevents -AR agonist effects on SR Ca2+ uptake and release, i.e. on CaMKII-dependent 
PLB phosphorylation (Thr17) and RyR2 Ca
2+ release, independent of If.
300 Moreover, ryanodine still 
significantly reduced the firing rate of SAN cells from CaMKII-inhibited mice and the wild type 
mice, indicating that the positive chronotropic effect of -AR stimulation requires the RyR2 Ca2+ 
release.300  
Sex differences in -adrenergic response have been demonstrated in rabbit hearts in respect of 
the cardioprotection in female, while the cardioprotection confers a survival benefit in female 
patients with severe cardiac disease, such as heart failure.301-303 It was shown that female hearts had 
a decreased capacity to -adrenergic response, particularly under conditions of increased demand.303 
The reduced -adrenergic response was associated with reduced arrhythmic activity.303 These data 
is consistent with the lower cAMP level in females. 283  
1.2.4.2 Parasympathetic regulation of cardiac automaticity 
Parasympathetic regulation of cardiac automaticity is achieved by the activation of muscarinic 
receptors following release of acetylcholine (ACh) from vagal nerve endings. The cholinergic 
agonists induce a negative chronotropic effect on cardiac automaticity and AV conduction observed 
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in vivo and in isolated heart preparations.6, 304, 305 The type 2 muscarinic (M2) receptor is the 
predominant subtype in the heart. It activates Gi-type G protein in response to ACh, and dissociates 
αi subunit from the  subunit. The αi subunit is negatively coupled to AC activity causing the 
downregulation of cAMP, while the  subunit directly opens KACh channels, resulting in the 
negative chronotropic effects on SAN pacemaking. Indeed, numerous studies have reported that 
vagal stimulation slowed or stoped SAN automaticity. However, the effects were accompanied with 
a decrease in the DD slope (involvement of If) or hyperpolarization of maximum diastolic potential, 
being aware that activation of IKACh requires higher concentration (micromolar) of ACh than 
inhibition of If (nanomolar).
157, 163, 306-309  
As mentioned previously, acetylcholine-activated K+ current (IKACh) is a substrate of muscarinic 
agonist. Hutter and Trautwein observed that vagal stimulation increased membrane K+ conductance 
in the frog sinus venosus, accounting for the inhibition of spontaneous automaticity.310, 311 Further 
investigation found the activation of IKACh channel by micromolar concentration of ACh.
157  
If is negatively regulated by ACh in respect of the downregulation of cAMP. DiFrancesco et al. 
observed the negative shift of If activation curve by nanomolar ACh, which slowed pacemaking, but 
without affecting IKACh.
157 If is also more sensitive to ACh than ICa,L, as If is inhibited at lower doses 
of ACh than that required by ICa,L inhibition.
312  
ICa,L is relatively insensitive to muscarinic regulation, as its inhibition requires high doses of 
ACh.273, 313 However, Petit-Jacques et al. showed that muscarinic regulation of SAN ICa,L is related 
with the previous -adrenergic stimulation and cAMP levels.259 That means if SAN is previously 
stimulated by -adrenergic agonists, the moderate doses of ACh can significantly inhibit ICa,L.259 
Similarly, accentuated effect of ACh after -AR activation has also been observed on If in canine 
Purkinje fibers.314 The depressing effect of ACh on ICa,L was abolished by PKA inhibition or cell 
dialysis with a nonhydrolyzable cAMP analog.259  
It has also been illustrated that muscarinic receptor stimulation modulates Ca2+ handling in 
rabbit SAN cells. When both If and IKACh were inhibited, ACh (1 μM) was still able to reduce 
pacemaker frequency by 72%, as ACh also reduced SR Ca2+ content, decreases [Ca2+]i transient 
amplitude, slows [Ca2+]i transient rise and decay.
315 These effects are probably mediated by the 
downregulated cAMP, and the following reduction of PKA and CaMKII. Furthermore, the 
downregulated cAMP induces the decreased [Ca2+]i and concomitantly a negative feedback loop. It 
is likely that intracellular Ca2+ responds the muscarinic receptor stimulation via cAMP modulation, 
contributing to the negative chronotropic effect.  
Nitric oxide (NO) signaling pathway also underlies muscarinic regulation of SAN automaticity. 
It is known that muscarinic receptor activation is coupled to NO synthesis, which stimulates 
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guanylyl cyclase activity and in turn elevates cGMP production.6 The elevated cGMP production 
promotes phosphodiesterase (PDE) activity that hydrolyzes cAMP, especially PDE2.6, 316 Han et al. 
suggested that NO signaling pathway plays an obligatory role in the muscarinic regulation of rabbit 
SAN, as blockage of NO synthesis prevents the effects of cholinergic agonists.317 However, Sasaki 
et al. showed that NO can partially modulate accentuated antagonism but does not play an essential 
role in the vagal regulation in canine SAN.318 The importance of NO signaling pathway in vagal 
regulation of heart rate is still controversial.6 The mice lack of endothelial nitric oxide synthase 
(eNOS) or Gαo protein failed to exibit the muscarinic response.
316, 319 However, Vandecasteele et al. 
used another eNOS-deficient mouse line, and observed neither the adrenergic nor muscarinic 
regulation.320 In support of that, Mori et al. also reported that NO is not involved in accentuated 
antagonism in isolated mouse atria.321  
1.2.4.3 Additional regulator of cardiac automaticiy 
Calcium 
Over 40 years ago, Seifen et al. discovered that the increase of extracellular [Ca2+]i increases the 
spontaneous beating rate of SAN, while the intracellular [Ca2+]i also increases during the 
extracelluar [Ca2+]i increase.
322 Up to date, numerous studies investigated the effect of Ca2+ on 
pacemaker activity by application of Ca2+ chelators. Zaza et al., who used ruptured patch and 
buffered the intracellular Ca2+ with EGTA (10 mM), found that spontaneous activity became 
unstable and ceased in the majority of cells within several minutes after achiving the whole-cell 
configuration.323 Application of 10 mM BAPTA from the patch pipette solution causes rapid 
cassation of spontaneous activity of guinea-pig SAN cells.324 Some studies exposed the cells to the 
Ca2+ chelator in acetoxy methyl (AM) ester form. The AM ester renders the Ca2+ chelator cell 
permeant. Once in the intracellular espace, cellular esterases release the chelator. For instance, 
Sanders et al. applied EGTA-AM and BAPTA-AM to guinea-pig SAN cells, resulting in cessation 
of spontaneous activity.215 Even the fluorescent indicator (indo-1 AM), which has inherent 
buffering capacity, could reduce the firing rate compared to the non-indo loaded guinea-pig SAN 
cells.230 The calcium-induced SAN firing rate regulation is, at least partially, produced via direct 
interaction or indirect act via activation of CaM/CaMKII and AC/cAMP pathways.  
It has been reported that Ca2+ regulates of many ion channels, such as ICa,L, ICa,T, IK, If. Calcium 
regulates both ICa,L and ICa,T, as an elevation of extracellular [Ca
2+]i increases in the amplitude of 
both ICa,L and ICa,T in rabbit SAN cells.
95 Besides, the inactivation of ICa,L is Ca
2+-dependent, to 
terminate Ca2+ entry. The regulation of delayed rectifier K+ current (IK) by intracellular [Ca
2+] is 
investigated in ventricular myocytes. The concentration-response curve of IK for intracellular [Ca
2+]i 
was meatured by Tohse in guinea-pig ventricular myocytes.325 An elevation of [Ca2+]i from 10 to 
34 
 
100nM increases IK threefold by increased number and open probability of functional IK 
channels.325 BAPTA-AM markedly suppressed the amplitude of rapid component of IK (IKr) in 
guinea-pig ventricular myocytes.326 The density of IKs was also larger during intracellular dialysis 
with a higher Ca2+ concentration (100nM) compared with that of a lower Ca2+ concentration 
(0.1nM).327 Intracellular [Ca2+]-induced increase of If and shift of If activation curve were observed 
in rabbit and rat SAN cells.328, 329 However, further investigations found out that CaM antagonists 
(W-7, Calmidazolium and ophiobolin A) causes reduced amplitude of If and shifted voltage-
dependent activation to more negative potentials, indicating involvement of CaM in If regulation.
66 
These observations could also be explained by the increase of cAMP level on the basis of Ca2+/CaM 
activation of AC activity, as cAMP also activates If. It was also reported that the peak of Ist is 
increased by lowering extracellular [Ca2+].177 Ca2+-activated Cl- current (ICl(Ca)) was identified in 
one third of rabbit SAN cells, although it only has a limited role in pacemaker activity.330 
Many Ca2+-induced effects could control pacemaker activity.83, 324 For instance, intracellular 
Ca2+ induces acceleration of AC/cAMP and CaM/CaMKII pathways that further regulates many 
proteins involved in generation of SAN spontaneous activity.  
Calmodulin (CaM)  
Calmodulin (CaM) is a ubiquitously expressed, highly conserved, small (17-kDa) Ca2+-binding 
protein in eukaryotic cells.331, 332 It has a dumbbell-shape structure with two globular domains, N-
lobe and C-lobe, while each domain contains two EF-hand Ca2+ binding pockets.331 The N- and C-
lobe display different Ca2+ binding affinity. The C-lobe binds Ca2+ with higher affinity but slower 
association and dissociation rate (slow exchange) than N-lobe (fast exchange).333 Upon Ca2+ 
binding, the dumbbell-shaped Ca2+ free calmodulin (Apo-CaM) undergoes a conformational change 
and forms a compact globular structure of Ca2+-bound calmodulin (Ca/CaM). Via this 
conformational changes upon Ca2+ binding, calmodulin translate cytosolic Ca2+ changes to target 
proteins. CaM interacts with RyR2 (session 1.4.3), as well as a vast number of proteins and plays a 
critical role in numerous intracellular processes (Figure 7).  
CaM could bind to CaV1.2 governing both Ca
2+ dependent inactivation (CDI) and Ca2+ 
dependent facilitation (CDF). The interaction between CaM and CaV1.2 is still not fully understood. 
The C-terminal region of CaV1.2 contains an EF hand and three CaM binding sites (A-region, C-
region and IQ motif). Apo-CaM binds to the IQ motif of CaV1.2 channel via C-lobe.
334 This setting 
preassociated CaM and serves the optical position for rapid binding of Ca2+ to the C-lobe of 
CaM.335, 336 Upon Ca2+ binding, the dumbbell-shaped Ca2+ free calmodulin (Apo-CaM) undergoes a 
conformational change and forms a compact globular structure of Ca2+-bound calmodulin (CaCaM). 
CaCaM C-lobe interacts with the IQ motif of CaV1.2 resulting in CDI, meanwhile the N-lobe has a 
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role in CDF.337 Besides IQ motif, CaCaM also interacts with the C-region and A-region via C-lobe. 
The binding of C-lobe with C-region has a lower affinity (Kd ~400nM) than with IQ motif (Kd 
~2.5nM), and the binding with A-region is even weaker than the CaCaM N-lobe-A-region 
interaction (Kd >10μM).9, 338 The binding between ApoCaM and A-C region remains controversial, 
and may depend on Ca2+ binding to EF-hand of CaV1.2.
9, 339, 340 Disruption of CaCaM and C-region 
interaction has no effect on CDI, but a reduction on CDF.338 It is proposed that two CaM molecules 
bind to the C-terminus of CaV1.2 channel.
338, 341 Sone mutations on calmodulin are associated with 
severe disease, such as CPVT, early-onset long-QT syndrome (CQTS), etc. Limpitikul et al. showed 
that overexpression of mutant CaM (D96V, D130G and F142L) in adult guinea-pig ventricular 
myocytes induces prolonged action potential duration (APD), enhanced [Ca2+]i transient and 
proarrhythmic behavior.342 Further investigation showed deficient CDI of LTCCs, indicating that 
LTCC is a key contributor of CQTS induced by CaM mutation.342 However, other proteins 
interacting with CaM should also be considered.  
CaM regulates several types of voltage-gated K+ channels, such as Ito, IKs, etc. CaM modulates 
KV1.1 and KV1.4 via KV 1.1 subunits to decelerate the response to the rise in intracellular Ca
2+ 
concentration, providing a negative feedback to limit neuronal overexcitation, while KV1.4 also 
conduct the Ito,slow in heart.
343 Pharmacological inhibition of Ca2+-occupied CaM (with W-7) leads 
to reduction of KV4.3 (Ito,fast) current.
344 IKs could be enhanced by increase in cytosolic [Ca
2+]i via 
allosteric interaction with CaM, rather than phosphorylation.345, 346 Further investigation confirmed 
that CaM is responsible for both IKs channel assembly and gating.
347 However, a recent research 
illustrated that CaMKII participates in the enhancement of IKs by CaM.
327 CaM regulates KV10.1 
channel (ether à go-go channel, EAG1) via direct binding to the cytosolic N- and C- termini.348 Ca2+ 
activated K+ channels (SK1-4) can also be regulated by calmodulin via direct binding.327, 349-351 
Calmodulin also regulates ion conductance of Na+ channel via allosteric interaction at two sites: 
an IQ motif in the C-terminal domain, and a CaM binding domain (CaMBD) within the DIII-IV 
linker.352, 353 At low cytosolic Ca2+ concentration, apoCaM binds to the IQ motif via C-lobe. 
However, at higher cytosolic Ca2+ concentration, the CaCaM C-lobe binds to both the IQ motif and 
the CaMBD, while the N-lobe also binds to the IQ motif with a greater affinity than the C-lobe.354 
CaM interacts with the DIII-IV linker causing reduced gate inactivation ability, which increases the 
duration of the INa.
9  
CaM is also involved in other protein regulations, such as RyR2, If. CaM decreases the RyR2 
opening probability (session 1.4.3). CaM antagonists (W-7, Calmidazolium and ophiobolin A) 
causes reduced amplitude of If and shifts voltage-dependent activation to more negative potentials, 
indicating the role of CaM in If regulation.
66 These results could also be explained by the increase of 
cAMP level on the basis of Ca2+/CaM activation of AC activity, as cAMP activates If. Besides 
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AC/cAMP pathway, CaM also activates CaMKII, and thus regulates numerous proteins via 
CaMKII phosphorylation.  
In ventricular myocytes, CaM is involved in the two signaling pathways of Ca2+-dependent 
excitation-transcription (ET) coupling (Figure 11). Ca/CaM activates calcineurin (Cn), which 
dephosphorylates NFAT (nuclear factor of activated T cells); NFAT is then imported into nucleus 
and interacts with hypertrophic transcription factor GATA4 to drive hypertrophic gene 
transcription.355-357 GATA transcription factors are characterized by their ability of bind to the DNA 
sequence ‘GATA’. Calcineurin (Cn) has two subunits, CnA and CnB. CnA contains the CaM-
binding and phosphatase domains but requires CnB for activity.358 Cardiac overexpression of 
activated Cn or NFAT results in massive cardiac hypertrophy and heart failure.358, 359 In contrast, Cn 
inhibition could prevent hypertrophy, as cardiac expression of dominant negative Cn or CnA  
knock-out impairs hypertrophic responses to pressure overload, angiotensin II, and isoproterenol 
infusion.358-362 Moreover, knock-out of NFATc3, but not NFATc4, induced a significant inhibition 
in Cn overexpression-, pressure overload- and angiotensin II-induced cardiac hypertrophy.363 
Indeed, transgenic mice overexpressing CaM develop cardiac hypertrophy.364 However, the CaM 
effect on ET coupling in SAN is still unclear. The other Ca-dependent ET coupling pathway 
involves activation of CaMKII by CaM. 
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Figure 11 Ca2+-dependent ET coupling in cardiac myocytes. In addition to the Ca2+ regulation in EC coupling (top left), 
and potential role of IP3R in triggered arrhythmias (top right), Ca
2+-dependent signaling to the nucleus can modulate 
transcription. G protein-coupled receptors (GPCR) such as those for endothelin-1 (ET-1) or α-adrenergic agonists 
[phenylephrine (Phe)] and tyrosine kinase receptors (TKR) such as those activated by insulin-like growth factor (IGF) 
and fibroblast growth factor (FGF) can activate phospholipase C (PLC) to produce diacylglycerol (DAG) (which can 
activate PKC) and InsP3 (IP3). IP3R in the nuclear envelope release Ca
2+, which activates calcium-calmodulin-
dependent kinase IIδ (CaMKIIδ), resulting in histone deacetylase (HDAC) phosphorylation (which also occurs by PKD) 
and nuclear export. This nuclear export relieves HDAC-dependent suppression of myocyte enhancer factor 2 (MEF2)-
driven transcription. On the other side, Calcineurin (CaN) is activated by Ca/CaM and dephosphorylates NFAT (nuclear 
factor of activated T cells). NFAT is then translocated to the nucleus, where, along with the transcription factor GATA, 
it can stimulate the transcription of genes contributing to hypertrophy. The orange clouds indicate where local [Ca] 
elevation is critical for signaling near RyR and InsPγR. P indicates phosphorylation, MF denotes myofilaments, and Gα 
and  are subunits of the G protein Gq. (Adapted from Bers, 2008358) 
In summary, CaM could not only affect SAN pacemaking via direct or indirect interaction with 
numerous proteins that are important for pacemaker activity, but also potentially modifying the 
expression of some proteins involved in SAN pacemaking via ET coupling. Although, the Ca2+-
dependent ET coupling in SAN has not been proven yet. 
Ca2+/CaM activates Ca2+/calmodulin-dependent protein kinase II (CaMKII) 
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CaMKII modulates many proteins that are important in SAN pacemaking within both 
membrane clock and Ca2+ clock (Figure 7), such as LTCC, K+ channels, RyR2 and SERCA (directly 
and indirectly via phospholamban), etc.365  
The four main CaMKII isoforms are produced by four different genes (α, , δ, and ).366 The 
predominant CaMKII isoform in heart is delta (CaMKIIδB mainly in nucleus and CaMKIIδc mainly 
in cytosol), while the secondary isoform is gamma (CaMKII ) and CaMKII  is also expressed at a 
low level.367-371 The CaMKII monomer consists of three domains: an N-terminal catalytic domain, a 
regulatory domain and a C-terminal association domain. The regulatory domain is responsible for 
Ca2+/CaM binding and numerous regulations, such as autophosphorylation (Thr287 in CaMKIIδ), 
oxidation (Met281/282), O-linked glycosylation (Ser280).366, 372, 373 The catalytic domain is in 
charge of the enzymatic activity of CaMKII, and is regulated by the regulatory domain.366 Figure 12 
shows the intracellular distribution of total and autophosphorylated (active) CaMKII in rabbit SA 
node cells. The autophosphorylated CaMKII is localized beneath the cell membrane, while the total 
CaMKII is uniformly distribbuted in the cell.374 
It was reported that CaMKII could regulate ICa,L, as inhibition of CaMKII (with KN-93) 
depressed the amplitude of ICa,L without altering the shape of the current-voltage relationship, and 
depressed SAN firing rate.374 CaMKII facilities ICa,L via LTCC phosphorylation, termed slow ICa 
facilitation, whereas the fast facilitation depends on Ca2+ released from RyR2.
97, 375-378 ICa,L 
facilitation drives the possibility to induce pro-arrhythmic consequences.379 Hudmon et al. 
suggested that CaMKII phosphorylate the pore-forming α1C subunit of LTCC.380 Some studies 
supported this view, and proposed possible phosphorylation sites. Erxleben et al. suggested that 
Ser439 and Ser1517 are involved in CaMKII phosphorylation in rabbit Cav1.2 channel.
381 Wang et 
al. demonstrated that CaMKII phosphorylates the Thr1603 residue (Thr1604 in rabbit) in the C-
terminal tail of the Cav1.2 channel of guinea-pig, and regulates the CaM binding to the channel.
382 
Ser1512 and Ser1517 sites were proposed following experiments in knock-in mice showing 
decreased voltage-dependent facilitation.383, 384 Some studies also proposed that CaMKII 
phosphorylates regulatory βa subunits (Thr498) of LTCC, via Leu493 facilitating the binding.385-
387  
CaMKII regulates several types of K+ channels, such as Ito, IK1, IKs.
388 CaMKII slows Ito 
inactivation in human atrial myocytes.389 This point was further confirmed in rat ventricular 
myocytes and showed different CaMKII modulation of KV4.2 and KV4.3.
390 CaMKII modulation of 
KV4.3 is through direct effect at S550, thus slowing the inactivation and accelerating the rate of 
recovery from the inactivation of the channel.391 It is also reported that CaMKII influences the 
expression pattern of K+ channels, including KV1.4 (Ito,slow), KV4.2 and KV4.3 (Ito,fast) , and Kir2.1 
and Kir2.2 (IK1).
392-394 IKs is enhanced by increase in cytosolic [Ca
2+]i via allosteric interaction with 
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CaM rather than phosphorylation.345 However, a recent research illustrated that CaMKII 
participates in the enhancement of IKs by CaM.
327  
CaMKII regulates cardiac sodium channels by phosphorylation predominantly on I-II linker and 
to a lesser extent in the C-terminal region.395 Until now, multiple phosphorylation sites, such as 
S516, T594, S571 and S516 are proposed.396-398 S516 phosphorylation is reduced in human heart 
failure.398 The general effect of CaMKII phosphorylation seems like increasing INa, which leads to a 
higher cytosolic Na+ concentration and AP prolongation. Wagner et al. investigated the effect of 
CaMKIIδC overexpression in rabbit ventricular myocytes via adenovirus infection and transgenic 
CaMKIIδC mice.399 Besides persistent increase in inward INa and intracellular Na+ concentration, 
they also found that CaMKIIδC over-expression shift the voltage dependence of Na+ channel 
availability to more negative membrane potential, enhanced intermediate inactivation and slowed 
recovery from inactivation.399 In this sense, Ashpole et al. confirmed that CaMKII shifted INa 
activation to a more negative membrane potential. 396 However, another study found that CaMKII 
shifted the voltage dependence of Na+ channel availability to more positive membrane potential, 
hastened recovery from inactivation, as well as increased late current in guinea-pig ventricular 
myocytes. 395 This work used whole-cell voltage-clamp to investigate INa in absence or presence of 
CaMKII in pipette solution.395 Thus, regulation of CaMKII to Na+ channel is important for 
maintaining Na+ channel function and membrane excitability under physiological conditions.397, 400 
CaMKII regulates SERCA via two pathways, direct SERCA phosphorylation and 
phospholamban (PLB) phosphorylation.379, 401 SERCA is a 110 kDa, membrane-embedded ATP-
driven calcium pump, which pumps Ca2+ back into SR. Dephosphorylated phospholamban (PLB) 
acts as a reversible inhibitor of SERCA. CaMKII binds to SERCA resulting in collapse of Ca2+ 
binding sites and stabilization of divalent cation-free conformation of SERCA.402 When CaMKII 
phosphorylates PLB, the phosphorylated PLB (Thr17) releases the SERCA, increasing SERCA 
Ca2+ affinity and enhancing Ca2+ reuptake.260, 379 Indeed, CaMKII inhibition slows SAN cells 
responses to isoproterenol associated with decreased SR Ca2+ content, and PLB deficiency rescues 
SR Ca2+ content and SAN cells isoproterenol responses.261 These data indicate that normal PLB 
function and concomitant minimum SR Ca2+ content are essential in CaMKII-related regulation.261 
However, this work also demonstrated that PLB deficiency or PLB mutation on CaMKII target site 
(T17A) did not affect basal HR in vivo or firing rate in SAN cells.261  
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Figure 12. Intracellular distribution of total and autophosphorylated (active) CaMKII in rabbit SA node cells. A, 
Uniform distribution of the total CaMKII. B, Localization of autophosphorylated (active) CaMKII to the sarcolemmal 
membrane. C, Negative control, ie, in the absence of the primary antibodies. (Adapted from Vinogradova et al., 2000374) 
The phosphorylation of RyR2 by CaMKII is mainly at Ser2808 and Ser2814, while additional 
phosphorylation sites might also exist, such as Ser2011 (session 1.4.2.8).403 A significant number of 
researches illustrated that RyR2 phosphorylation by CaMKII caused prolonged openings of RyR2 
and excessive SR Ca2+ leak in ventricular myocytes.368, 404-406 For instance, Li et al. found that 
inhibition of CaMKII by KN93 reduces RyR2 activity (via Ca
2+ spark) in ferret ventricular 
myocytes,404 which is confirmed by Currie et al. in rabbit.405 Guo et al. reported more SR Ca2+ 
release (more Ca2+ sparks in frequency, and longer in duration) after CaMKII activation in mouse 
ventricular myocytes, and this effect was abolished by CaMKII inhibitor peptides.406 It has also 
been reported that CaMKII δC over-expression in mice increased diastolic SR Ca2+ leak (via sparks) 
and reduced SR Ca2+ load, which contributes to the following heart failure.368, 407 However, Yang et 
al. expressed constitutively active CaMKII δC via adenoviral gene transfer in cultured rat ventricular 
myocytes and found depressed SR Ca2+ release, whereas a dominant negative CaMKII enhanced 
it.408 Some single channel recordings of RyR2 channels reconstituted in lipid bilayers also showed 
CaMKII either increase 409-411 or decrease 412 RyR open probabilities. The controversial results may 
indicate multiple CaMKII effects on RyR2, probably via different target sites on RyR2 or auxiliary 
proteins.388 In general, most works point to an activatory effect of CaMKII on RyR2. In SAN, 
pharmacological inhibition of CaMKII (with KN93 or AIP) reduced LCR number and size in both 
nomal and permeabilized rabbit SAN cells, which decreased the pacemaker activity. However, Wu 
et al. investigated mice with RyR2 knock-in mutation that replaced CaMKII target site (S2814) with 
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alanine and disabled CaMKII phosphorylation at this site.261 They found that S2814A mutation 
failed to affect spontaneous firing rate and isoproterenol response in vivo and in SAN cells, 
indicating multiple CaMKII targets in SAN cells.261 Further investigations are needed to clarify this 
issue.  
The CaMKII substrates probably lead to a positive feedback via Ca2+ release, and further 
enhance CaMKII activity during normal EC coupling and -adrenergic stimulation.413 Even though 
CaMKII targets many proteins within the membrane and Ca2+ clock in SAN, If is not directly 
affected.66 
The contribution of CaMKII in regulating SAN basal pacemaker activity is under debate. 
Pharmacological inhibition of CaMKII (with KN93 or AIP) decreases the pacemaker activity in 
rabbit SAN cells.60, 374 The reduced pacemaker activity by CaMKII inhibition was also confirmed 
by Rigg et al. in guinea-pig SAN cells.66 However, these results were questioned because of the 
documented off-target actions of the inhibitors.414 Besides, in myocardial targeted transgenic mice 
with expression of a highly selective CaMKII inhibitory peptide, inhibition of CaMKII did not 
affect baseline SAN pacemaker activity, but reduced heart rate increases in response to 
physiological stress associated with decreased SR Ca2+ content.261, 300, 414-416 Yet, species dependent 
differences should be considered. 
CaMKII is required for SAN response to -adrenergic stimulation.300, 415, 417 Curran et al. found 
that -adrenergic receptor agonists increases SR Ca2+ leak via a CaMKII dependent manner, not 
PKA dependent.418 Besides, transgenic mice with CaMKII inhibition have slower heart rates than 
controls under stress or -adrenergic stimulation.300 Isolated SAN cells from CaMKII inhibited 
mice presented reduced positive chronotropic response to isoprenaline, and related reduced SR Ca2+ 
content and Ca2+ sparks frequency.300 
In spite of the essential role of CaMKII in coupled clock and -adrenergic response, CaMKII 
also regulates SAN bioenergetics.60 As in contrast with graded reductions in ATP demand by 
CaMKII inhibition, SAN cells become depleted of ATP, indicating the reduction in mitochondria 
ATP generation.60  
Besides, CaMKII is involved in promoting SAN dysfunction. Conditions that favor SAN 
dysfunction, such as heart failure, hypertension, atrial fibrillation, atrial apoptosis, etc, are 
associated with elevated ROS and angiotensin II.414 Interestingly, CaMKII could be activated by 
pro-oxidant conditions.372 This redox-dependent CaMKII activation is carried out by oxidative 
modification of the Met-281/282 site in the regulatory domain, which prevents CaMKII from 
inactivation after Ca2+/CaM removal.356, 372, 414 Thus, it is reasonable that infusion of angiotensin II 
in mice increased oxidized CaMKII, and caused SAN cell apoptosis and SAN dysfunction, while 
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transgenic mice with CaMKII inhibition were protective from angiotensin II induced fibrosis.419 
These results suggest the contribution of CaMKII to SAN and right atrial apoptosis and fibrosis 
induced by angiotensin II, in respect that activation of CaMKII through oxidation may be in volved 
in SAN dysfunction through any of the channels detailed previously. In addition, increased oxidized 
CaMKII is also linked with atrial fibrillation and raised mortality in diabetic patients after 
myocardial infarction.356, 420, 421  
CaMKII expression and activity are increased in numerous heart diseases, such as hypertrophy, 
atrial fibrillation, heart failure, etc, making CaMKII as a potential target for clinical therapy.365, 389, 
416, 422-425  
In ventricular myocytes, CaMKII is involved in one of the two signaling pathways of Ca2+-
dependent ET coupling (Figure 11). CaMKII or PKD (protein kinase D) phosphorylates class II 
histone deacetylases (HDACs, types 4 and 5), relieves HDACs from repression of hypertrophic 
transcription factor MEF2 (myocyte enhancer factor 2) and increases MEF2 transcription 
activity.355, 356, 426, 427 CaMKII binds to a unique docking site of HDAC4 near the key 
phosphorylation sites, and results in phosphorylation and nuclear export.426 As a result, CaMKII 
phosphorylation of HDAC4 could cause hypertrophic growth, which is blocked by a signal-resistant 
HDAC4 mutant.426 HDAC5 lacks the CaMKII docking site and a third phosphorylation site. It 
seems that HDAC5 alone is unresponsive to CaMKII and becomes responsive by oligomerization 
with HDAC4.427 Certainly, a parallel Ca-dependent ET coupling pathway involves activation of Cn 
by Ca2+/CaM. As the nuclear lumen and SR lumen are continuous but insulated from the cytosol, 
the CaMKII affect EC coupling and ET coupling by targeting distinct proteins via distinct isoforms 
(CaMKIIδB in nucleus and CaMKIIδc in cytosol).355, 356, 428 However, the Ca2+-dependent ET 
coupling in SAN has not been proven yet.  
CaMKII directly or indirectly targets proteins accounting for the normal cardiac function and 
SAN automaticity. Besides, the diverse expression pattern of channels in different region of the 
heart, including the cardiac disease changed expression pattern of the channels, also makes CaMKII 
an important regulator for electrical activity in diseased and healthy heart.388 Moreover, CaMKII 
level varies in numerous cardiac diseases. All these evidences indicate the critical role of CaMKII 
in heart function, as well as SAN automaticity.  
Others 
The existence of leptin receptors on SAN cells is recently demonstrated. It is known that leptin 
plays an important role in cardiac contractility, development of hypertrophy and apoptosis.429-433 
Initial studies uncovered that the effects of leptin are indirect via adrenergic receptors stimulation, 
and later studies indicated the presence of direct interaction via leptin receptors.434-436 The two 
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distinct pathways could probably explain the both increased and unchanged/decreased heart rate 
associated with increased metabolic demands.437-439  Indeed, a recent research demonstrated the 
existence of leptin receptor in SAN cells.440 This study also investigated the effect of low does (0.1-
γ0 μg/kg) and high does (150-γ00 μg/kg) of leptin: low doses of leptin decreased resting heart rate, 
and high doses of leptin induced a biphasic effect (decrease and then increase) on heart rate. 
Besides, in the presence of beta-blocker (propranolol), high-dose leptin only reduced heart rate and 
sometimes caused sinus pauses and ventricular tachycardia. Furthermore, leptin antagonist reversed 
the leptin-induced inhibition of resting heart rate. These data indicate that in addition to indirect 
pathway via sympathetic tone, leptin can directly decrease heart rate via its receptor independently 
of -adrenergic receptor stimulation. 
Cardiac automaticity is also regulated by other factors, such as neuropeptides, adenosine, 
hormones, mechanical load and atrial stretch, electrolytes and temperature.6  
1.3 CPVT and CPVT related sinus dysfunction 
 Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a lethal heritable disease 
discovered in 1975441. It is characterized by exercise/emotion triggered syncope or sudden cardiac 
death in children or young adults with structurally normal hearts.442 Recent reports suggest that 
mutations in genes encoding RyR2 (sarcoplasmic reticulum Ca
2+ release channel), cardiac 
calsequestrin (CASQ2), triadin, and calmodulin are related to CPVT.443-447 Other mutations in gene 
KCNJ2 (encoding potassium channel) have also been identified with a CPVT-like phenotype, 
although further and much more research is needed.448 A large number CPVT families with RyR2 
mutations has been reported in literature, accounted for approximately 60% to 70% of patients.449-
453  
CPVT mutated channels are not only limited to the ventricular myocardium, but also in other 
regions of the heart (including SAN and atria). Indeed, patients with CPVT are frequently 
associated with supraventricular arrhythmia and SAN dysfunction, such as sinus bradycardia, which 
is observed in both RyR2 and CASQ2 related CPVT patients.
444, 454, 455  
According to Van der Werf et al. sinus bradycardia is observed in 19% of relatives in RyR2 
related CPVT families in their study, while other supraventricular dysrhythmias were present in 
16%.456 Postma et al. investigated heart rate in a series of RyR2 mutation carriers, and found out 
heart rate in CPVT patient is significantly lower regardless of the site of the mutation.454 Domingo 
et al. also reported a new mutation, RyR2
R420Q, found from a Spanish family with several sudden 
deaths.457 Electrocardiogram studies, associated with exercise text or epinephrine challenge, 
confirmed that it is a CPVT related mutation.457 Besides, this mutation is also associated with sinus 
dysfunction, such as sinus bradycardia.457 So far, only one research from our team studied SAN 
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activity in a RyR2 linked CPVT model, which carries the Carboxyl-terminal region (C-terminal 
region) mutation R4496C.458 The heart rate of RyR2
R4496C mice have no difference in basal 
condition compared to their wild-type littermates, but get significant lower under -adrenergic 
stimulation.458 This impaired -adrenergic response, which indicates SAN dysfunction, is due to 
increased activity of mutated RyR2.
458  
 Sinus dysfunction and inducible atrial tachyarrhythmias were also reported in CASQ2 
mutation-induced CPVT patients.455 SAN dysfunction was further confirmed by CASQ2 null 
mice.459 Together with sinus bradycardia, CASQ2 null mice also exhibited enhanced atrial ectopic 
activity, SAN conduction abnormalities, and slower heart rhythm during -adrenergic/cholinergic 
stimulation.   
Some studies show gender difference in hearts, such as sex difference in excitation-contraction 
coupling, or in -adrenergic responsiveness of action potentials.283, 284, 303 Cardioprotection in 
female has also been reported, conferring a survival benefit in female patients with severe cardiac 
disease, such as heart failure.301, 302 A study shows sex difference in RyR2 related CPVT patients: 
male CPVT patients have a higher risk of cardiac events, while 118 family members including 30 
probands were evaluated.442 Interestingly, there is also a noteworthy difference between genders in 
heart rates in RyR2 mutation related CPVT patients. Male patients have a lower heart rate than 
female patients.454 But is the severe syndrome in male related with low heart rate? What’s their 
underlying mechanism? What’s the difference and mechanism in heart rate between male and 
female in RyR2-CPVT animal model? These questions remain unknown. 
RyR2 related CPVT mutations 
CPVT or arrhythmogenic right ventricular dysplasia type 2 (ARVD2) mutations are clustered 
primarily in three discrete domains of the human RyR2 polypeptide (Figure 13): the N-terminal 
(residues 44-466), the central (residues 2246-2534) and the C-terminal domain (residues 3778-
4959).460-463 Mutations on RyR2 could result in protein gain-of-function or loss-of-function effect 
that increase or decrease channel activity respectively. 
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Figure 13 Structure and mutational clusters of RyR2. A. Clusters with frequent mutations are depicted with their 
location along the protein. Clusters are represented by numbered red lines. Individual mutations outside the canonical 
clusters are depicted as yellow dots. N-terminal region, cluster1. Central domain, cluster2. C-terminal domain, cluster 3 
and 4. B. Clusters are represented by boxes, with the amino acid (AA) range of the clusters and the percentage of 
published mutations for each cluster (AA numbering refers to the human RyR2 protein sequence). The numbers in A 
correspond to the clusters shown in B. SR indicates sarcoplasmic reticulum. (Adapted from Connie et al., 2015463) 
Mutations in C-terminus of RyR2 could induce either gain-of-function or loss-of-function effect. 
For instance, RyR2
R4496C is a gain-of-function mutation, but RyR2
A4860G is a loss-of-function 
mutation. RyR2
R4496C mice displayed bidirectional ventricular tachycardia after administration of 
epinephrine and caffeine, and hearts from RyR2
A4860G mice also presented malignant arrhythmias 
with sympathetic stimulation.464, 465 Mutation R4496C attributed to the leaky RyR2 triggering 
arrhythmogenic disorders in ventricular myocytes.466 The leaky RyR2
R4496C also lowered the SR 
Ca2+ content and the threshold for waves, while -AR stimulation produced Ca2+ waves via 
increasing the SR Ca2+ content.466 However, isolated ventricular myocytes from RyR2
A4860G mouse 
had decreased the peak of Ca2+ release during systole, gradually overloading the SR with Ca2+.464 
The resultant Ca2+overload then randomly caused bursts of prolonged Ca2+ release, activating 
electrogenic NCX activity and triggering early afterdepolarizations.464 Interestingly, RyR2
R4496C 
mice also displayed decreased heart rate after isoproterenol injection, indicating a RyR2 C-terminal 
mutation induced SAN dysfunction.458 Our team investigated the RyR2
R4496C behavior in SAN cells 
and its contribution to SAN automaticity. We found that Ca2+ spark frequency was increased by 2-
fold in RyR2
R4496C SAN cells, associated with prolonged cycle length and impaired isoproterenol 
response.458 Besides, RyR2
R4860G mutant mice also exhibited sinus bradycardia, although the 
46 
 
underlying mechanism remains unknown.464 Nevertheless, if mutations in N-terminus or central 
region also attributes to SAN dysfunction, and their mechanisms are unclear.  
Central region (zipping domains) interacts with N-terminal region stabilizing the RyR in the 
closed state. Mutation-resultant reduction in the interaction affinity causes separation of the regions 
(unzipping), which increases RyR2 open probability and thereby induces greater Ca
2+ release. For 
instance, genetic modified mice with CPVT-associated RyR2 mutation (R2474S) exhibited exercise 
or drug administration induced ventricular tachycardia. Isolated RyR2
R2474S cardiomyocytes have 
more Ca2+ spark release both before and after isoproterenol stimulation, associated with decreased 
threshold of SR Ca2+ content. Further investigation found defective interaction (unzipping) between 
N-terminal and central region in mutant RyR2
R2474S. 
Some N-terminal mutations were also proposed through zipping/unzipping hypothesis 
modifying RyR2 Ca
2+ release behavior.467 Indeed, N-terminal mutation R176Q resulted in gain-of-
function. R176Q KI mice exhibited decreased right ventricular end-diastolic volume.468 Ventricular 
tachycardia was observed after either caffeine and epinephrine challenge or intracardiac stimulation 
in R176Q KI mice, but not in WT mice.468 Isolated cardiomyocytes from R176Q KI mice presented 
increased Ca2+ release events, which increase susceptibility to catecholamine-induced VT.468 
However, this mutation was found in patients with ARVD2, which is not pure CPVT. The 
mechanism underlying RyR2 N-terminal mutation related CPVT is still unknown. Besides, this 
mutation is located in A-domain of N-terminus, but mutations in other domains are unclear. Lack of 
animal model limits the further investigation. When this thesis was studied, no N-terminal C-
domain mutation related animal model or N-terminal mutation related CPVT model was reported. 
1.4 Ryanodine receptors (RyRs)  
Ryanodine receptors (RyRs) are Ca2+ release channels located on intracellular calcium storage 
and release organelle, endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR). In physiological 
condition, there is a 104-fold Ca2+ gradient across the SR/ER membrane between the SR matrix (~ 1 
mM) and the cytosol (~ 100 nM). A similar gradient also exists between extracellular space and the 
cytosol. The cytosol [Ca2+]i is maintained at the low level by plasmalemmal Na
+/ Ca2+ exchanger 
(NCX) and Ca2+-ATPase (PMCA), the ER/SR Ca2+-ATPase (SERCA), by the mitochondrial Ca2+ 
uniporter, and by Ca2+ buffering molecules of differing capacity and kinetics.469 This low resting 
cytosolic [Ca2+]i avoids the toxicity of sustained high [Ca
2+]i, and also bestows on the Ca
2+ 
signaling system a wide dynamic range and a high signal-to-background ratio.469 Many Ca2+ 
signaling cascades are initiated by rapid mobilization of Ca2+ among membrane-bound 
compartments, usually down its electrochemical gradient across the membrane. Ca2+ enters the cell 
via diverse Ca2+-permeant channels and their gating mechanisms, and NCX acting in the reverse 
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mode. Ca2+ release from the ER/SR is mediated by two families of Ca2+ channels, the RyRs and 
inositol 1,4,5-triphosphate receptors (IP3Rs), and pumped back into SR/ER by SERCA.  
Mutations in RyR channel could influence channel function through modification in ion 
permeation, gating, and sensitivity to regulators and accessory proteins that resulting in the 
pathogenic consequences. Thus, in this session we are going to introduce RyRs, including their 
isoforms, tissue distribution, structures, regulation, and accessory proteins. We will focus on the 
cardiac isoform (ryanodine receptor type 2, RyR2), which plays an essential role in CICR, SAN 
automaticity generation, arrhythmia, among others.  
1.4.1 RyR isoforms and tissue distribution 
RyR are termed like that because they irreversibly bound the alkaloid ryanodine, which blocks 
the channel in open state.470 There are two types of major Ca2+ release channels localized in SR/ER 
membrane, ryanodine receptors (RyRs) and inositol 1.2.5-triphosphate receptors (IP3Rs).
471, 472 
RyRs are the largest ion channels to date (~2.2MDa).473, 474 Each RyR is consisted of four 
homologous subunits, and each subunit contains approximately 5000 amino acids (a molecuclar 
weight of ~560kDa).474, 475 RyRs are crucial for many cellular events, for instance, EC coupling. In 
skeletal (RyR1) and cardiac muscle (RyR2), the membrane (including transverse tubules, t-tubules) 
depolarization during the action potential activates LTCC inducing SR Ca2+ release by either 
mechanical coupling to RyR1in skeletal muscle or by activating the RyR2 through Ca
2+ elevation in 
its vicinity (Ca2+ induced Ca2+ release) in cardiac muscle, and the increased cytosolic Ca2+ initiates 
cell contraction, termed EC coupling.211 Depending on species, 70 to 90% of cytosolic Ca2+ release 
during EC coupling is from the SR.476  
In mammals, there are three RyR isoforms (RyR 1-3) exhibiting tissue-specific expression 
patterns.475, 477 RyR1 was the first one to be cloned.
478, 479) It is highly expressed in mammalian 
skeletal muscle, and also found in cardiac muscle, smooth muscle, kidney, thymus, cerebellum, 
Purkinje cells, adrenal glands, ovaries, testis, and B-lymphocytes.477 Because of its high expression 
in skeletal muscle and ease of purification, RyR1 is the most thoroughly examined isoform. The 
gene encoding RyR1 is located on chromosome 19q13.2 and spans 104 exons in human, and on 
chromosome 7A3 in mice.480 
RyR2 is the predominant isoform in cardiac myocytes.
471, 481-483 It is also expressed at high 
levels in Purkinje cells of cerebellum and cerebral cortex and in low levels in stomach, kidney, 
adrenal glands, ovaries, thymus, and lungs.477 Lacking of RyR2 is embryonically lethal in mice.
484 
The gene encoding RyR2 is located on chromosome 1q43 and spans 102 exons in human, and on 
chromosome 13A2 in mice.480 It is responsible for EC coupling in cardiac myocytes and 
spontaneous electrical impulse generation in SAN.  
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RyR3 is expressed at low levels in various cell types, including hippocampal neurons, thalamus, 
Purkinje cells, corpus striatum, skeletal muscles (highest expression in the diaphragm), the smooth 
muscle cells of the coronary vasculature, lung, kidney, ileum, jejunum, spleen, stomach of mouse 
and aorta, uterus, ureter, urinary bladder, and esophagus of rabbit.477, 483 The gene encoding RyR3 is 
located on chromosome 15q13.3-14 and spans 103 exons in human, and on chromosome 2E4 in 
mice.480 
 
Figure 14. Three-dimensional structure of RyR. The projection view of RyR from the cytosol to sarcoplasmic 
reticulum (SR) lumen (left panel), from SR lumen to cytosol (middle panel) and side view (right panel). The numerals 
on the cytosolic cap refer to distinguishable globular domains. TA, transmembrane assembly. The colorful symbols 
indicate divergent regions D1 (yellow), D2 (orange), D3 (purple), N-terminal regions (red), central domains (light 
green), FK506-binding protein 12 (FKBP12) (brown) and calmodulin (CaM) (green). Clamp, handle and central rim are 
shown in right panel. (Modified from Zissimopoulos et al., 2007331) 
The three mammalian isoforms share 65% sequence identity with three divergent regions, 
known as D1 (residues 4254-4631 in RyR1, residues 4210-4562 in RyR2), D2 (residues 1342-1403 
in RyR1, residues 1353-1397 in RyR2), and D3 (residues 1872-1923 in RyR1, residues 1852-1890 in 
RyR2) as shown in Figure 14 indicated by yellow, orange and purple symbols respectively.
485 D1 is 
the largest and most variable region, and D2 is completely absent in RyR3.
331 For RyR1, mutations 
in D1 region alter its Ca2+ and caffeine sensitivity, whereas D2 region contains critical determinants 
for maintaining interaction with Cav1.1, and D3 region contain Ca2+ dependent inactivation 
sites.486-488  
Non-mammalian vertebrate (birds, amphibians, reptiles and fish) also expresses three RyR 
isoforms (RyRα, RyR  and cardiac type), whereas one single RyR isoform was found in lower 
organisms, including nematodes, fruit flies and lobster.331, 475, 477 RyRα and RyR  are homologous 
to mammalian RyR1 and RyR3 sequence, respectively.
331  
1.4.2 RyR structure 
1.4.2.1 Overall mammalian RyR structure 
Clamp 
Handle 
Central 
rim 
49 
 
Subnanometer-resolution electron cryomicroscopy (Cryo-EM) studies indicate that the overall 
shapes for all mammalian RyR isoforms are similar.489-492 Their overall structure can be described 
as a mushroom shown in Figure 14, with a cap (also called foot) located in the cytosol, and a stalk 
protruded from cap and crossing the membrane into the SR/ER lumen.493-496 The transmembrane 
region is rotated by approximately 40 with respect to cytosolic region.493, 497 Figure 14 displays 
RyR architecture as a projection view from the cytosol to sarcoplasmic reticulum (SR) lumen (left 
panel), from SR lumen to cytosol (middle panel) and side view (right panel). RyR structure has a 4-
fold cyclic symmetry around an axis perpendicular to the membrane consistent with the tetrameric 
nature of the channel.  
Each subunit of the RyR homotetramer consists of two main parts: a cytosolic part and a 
transmembrane part. The cytosolic part contains four-fifths of RyR protein and as an overall square 
prism shape (dimension of 29nm  29nm  12nm, or around 270Å  270Å  100Å using cryo-EM 
at resolution near 10Å).493-496 It is composed of several portions, named clamps, handles, central rim 
and columns as seen in Figure 14 and 15, while the left panel of Figure 14 also labels the 
subdomains in one subunit of RyR1 with numerals. The clamps, defined by the corners of the 
cytosolic caps (Figure 14, subdomains 5-10), are connected through the handles (subdomains 3-4) 
that surround the central cavity (central rim, subdomains 1-2).475, 477 Each clamp contains seven α-
helices and three -sheets, while one -sheet is localized on handle region and two more -sheets 
are found in central rim (Figure 15).498 The clamps undergo major conformational changes during 
the opening and closing of the channel.495, 498, 499  
The cytosolic part regulates RyR gating via interaction with a variety of intracellular 
messengers, including FKBP12, calmodulin, ATP, Ca2+, and Mg2+ ions (Figure 14). The four 
homologous sequences of the tetrameric RyR structure suggest a similar arrangement. 
Four columns are between cytosolic cap and transmembrane, holding a height of ~14Å of RyR1 
detected by cryo-EM at resolution around 10Å (Figure 15).494, 495, 498 Each column consists of one -
sheet ( 7 in Figure 15) and eight α-helices, to maintain the connection of cytosolic cap and 
transmembrane region.498 Thus, in each RyR1 subunit cytosolic region, γ6 α-helices with various 
rotations and 7 -sheets are identified (Figure 15).498 
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Figure 15 Secondary structure elements of two opposing RyR1 subunits from the tetramer are shown in a side view. 
α-Helices are annotated as cylinders colored according to their locations in the map: red, TM region; green, central part 
of the CY region; purple, clamps; cyan, column region. -Sheets are shown as orange symbols. A dashed line indicates 
-sheets in the column region. (Adapted from Serysheva et al. 2008498). 
The transmembrane region/assembly, which contains the other one-fifth of RyR protein, is 
consisted of membrane spanning and luminal domain (Figure 14, right panel). This square-shaped 
region has an edge length of 12nm at the attachment side of the cap and approximately 6nm at the 
luminal side, while 7nm perpendicularly across the ER/SR membrane (RyR1 dimension of 
approximately 120Å  120Å  60Å using cryo-EM at resolution near 10Å).493-496 The number of 
transmembrane helices on each subunit is still under debate. Recent cryo-EM studies at 8-10Å 
suggest five496, 498 or six α-helices494, 495, 500 with different orientation in the transmembrane region. 
Two kinds of transmembrane helices, the inner helices and outer helices (the four S5 and S6), 
together with the pore loops (each contain a pore helix) form the pore-forming region (Figure 15 
and 17). The transmembrane part is critical for undergoing large structural changes of RyRs and 
releasing Ca2+ during gating.  
1.4.2.2 RyR2 structure 
The three-dimensional structure of RyR2 is detected by cryo-EM at a low resolution of ~30Å 
and by bioinformatic mapping.332, 489 The overall shape of RyR2 structure is similar as RyR1 in 
respect of their high degree of sequence conservation.332, 489, 491 However, some conformational 
differences are found in the size or shape of certain domains (indicated by arrows in Figure 16). In 
particular, domains 8, 9, and 10 in the clamp regions of the cytosolic cap are larger, whereas 
domain 7 is somewhat smaller in RyR2 relative to RyR1. Domains 5 and 6 connected by a bridge in 
RyR1 is absent, or weaker, in RyR2 (left panels of Figure 16, A and B). This bridging density has 
been found to vary among reconstructions of RyR1, and thus the significance of this difference is 
unclear.489, 493 
 
Cytoplasmic cap 
Transmembrane region 
Columns 
Cytoplasmic region 
51 
 
 
Figure 16. Three-dimensional reconstruction of RyR2 (A) and RyR1 (B). Leftmost vertical structures of A and B 
show the view of RyR2 and RyR1 from cytosol. The middle structures show the view from sarcoplasmic reticulum, 
while the rightmost structures show the side view. Arrows point to obvious differences between RyR2 and RyR1. The 
putative structural domains are labeled with numerals 1–10 as Figure 14. TA, transmembrane assembly. Scale bar, 100 
Å. (Adapted from Sharma et al., 1998489) 
1.4.2.3 Membrane topology and pore region 
The number of transmembrane helices is still under debate. Hydropathy profiles indicate 4 to 12 
helices per subunit, while two topology models of 4TM and 10TM segments have been proposed, 
although four segments of the 4TM model corresponding to M5, M6, M8 and M10 of the 10TM 
model.331 Current three-dimensional reconstructions at ~10Å resolution suggest five or six α-helices 
are identified.494-496, 498 A recent advanced cryo-EM study at 4.8 Å resolution further confirm that 
RyR1 is a six transmembrane ion channel.
500  
The currently favoured RyR1 membrane topology is depicted in Figure 17. Each subunit has six 
transmembrane helices (S1-S6) per subunit surrounding the central pore (Figure 17).494-496, 500 The 
transmembrane region could be separated into two domains: the pore domain, formed by two 
transmembrane helices (S5, S6) and the extended peptide (P-segment); and the interfacing domain 
formed by S1-S4 that is connected with the pore domain (Figure 17).500  
The primary sequence of pore forming region is highly conserved (90% identity) among RyR 
isoforms. The P-segment contains a pore helix, an amino acid motif (GGGIGD) forming the 
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selectivity filter, and many negatively charged amino acid residues contributing to the high cation 
conductance.500, 501  
More recently, cryo-EM study at ~4.8Å resolution found that the S6 helix extends ~30 Å into 
the cytosol (Figure 17).500 This study also found that the S6 helix has a 24° kink (centered on 
G4934) in the middle near the cytosolic face of the membrane, which orients the cytosolic extension 
of S6 roughly parallel to the channel axis.500 This glycine residues is conserved in the pore-lining 
helices of other 6TM ion channels, that may operate as ‘glycine-hinges’ facilitating reorientation of 
the pore-lining helix and consequent alteration in the cytosolic aperture of the channel.500, 502 G4934 
is also conserved in all RyR isoforms and in a closely related channel, the inositol 1,4,5-
trisphosphate receptor. Seven negatively charged residues are also found along the cytosolic 
extension of S6 and presumably serving the high cation conductance as the ones on P-segment.500 
The S2-S3 helical bundle lies in close proximity to the putative Ca2+ binding domain and the 
Carboxyl-terminal region (Figure 17) suggesting this domain may be involved in transmitting 
conformational changes in the cytosolic assembly to the pore.500  
JM1 region form a cytosolic leaflet on the SR membrane (Figure 17),331 while a recent study 
further demonstrates that the transmembrane region contains  three apparently amphipathic helices 
(JM1, the first helix of the S2-S3 insertion and the S4-S5 linker helix) that are expected to lie in the 
plane of the cytosolic surface of the SR membrane. 
 
Figure 17 Membrane topology of RyR1. Colored as follows: dark blue, N-terminal region, including NTD A and B 
(N-terminal beta-trefoil domain A and B), and N-Sol (N-terminal solenoid); cyan, SPRY1, SPRY2 and SPRY3 (named 
from SPla and the ryanodine receptor); salmon, clamp region (RY12 repeats), and phosphorylation domain (RY34 
repeats); yellow, calstabin; green, the bridge solenoid scaffold; red, the core solenoid; and orange, transmembrane and 
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Carboxyl-terminal domains (CTD); purple, putative Ca2+ binding domain (EF). Dashed lines represent major disordered 
segments. (Modified from Zalk et al., 2015500) 
The negative residues on both sides of the pore forming region are depicted in the study of 
Welch et al.501 and Zalk et al..500 Besides the high conductance, they also contribute to the relative 
permeabilities of divalent and monovalent cations in RyR. In support of this proposal, neutralization 
of acidic residues at the luminal entrance to the selectivity filter (ED4832AA) results in non-
discrimination between divalent and monovalent cations, and cation conductance is significantly 
altered.503 Further more, the regulatory proteins triadin and junctin also interact with the pore 
forming region through negatively charged residues.504-506 Junctin binds two different domains of 
RyR2: luminal residues 47-77 of junctin specifically bind to RyR2 luminal M5-M6 linker (residues 
4520-4553), and luminal residues 78-210 bind to the RyR2 pore loop (residues 4789-4846).
504 
However, triadin is more likely to band single sites: three acidic residues (D4878, D4907 and 
E4908) are critical for triadin binding to the RyR1.
506  
Some studies depicted P-segment as a structurally analogue to the selectivity filter of potassium 
and sodium channels,494-496 although a more recent study indicates that it’s more similar to the 
equivalent region of the TRPV1 cation channel.500 Indeed, the luminal aperture is also comparable 
to that of the highly Ca2+-permeable TRPV1.500  
1.4.2.4 Ion permeation 
The permeation properties of the different RyR channel isoforms are similar, including the ion 
selectivity and unitary conductance.507-509 
The physiological role of RyR is to be permeable to Ca2+ ion to release it from the lumen of the 
SR to the cytosol. Besides Ca2+, RyR channel is also permeable to variously divalent and 
monovalent cations, but nearly impermeable to anions.510, 511 The relative permeability of the RyR 
channel to different monovalent and divalent cations has been defined by single channel recording 
in planar lipid bilayer.510, 511 The RyR channel shows very little selectivity among different 
monovalent cations, or divalent cations. However, the RyR channel is modestly selective between 
monovalent and divalent cations (permeability ratio PCa/PK ~6). In comparison to other Ca2+ 
channels like the L-type Ca2+ channel, which displays a much higher degree of discrimination 
between monovalent and divalent cations (permeability ratio PCa/PK >25), RyR channel is not a 
highly selective Ca2+ channel.512-514  
The unitary conductance of the RyR channel with both divalent and monovalent cations is 
extremely high, approximately 10 times higher than L-type Ca2+ channel.331, 510, 511, 514 Channel 
conductance with divalent (e.g. 135-150 pS for Ca2+) is generally lower than monovalent cations 
(e.g. 720-800 pS for K+), in spite of that divalent cations are six to seven times more permeable than 
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K+. The conductance sequence of sheep RyR2 channel for monovalent cations is K
+ > Rb+ = NH4+ 
> Na+ = Cs+ > Li+ >> Tris+ in symmetrical ionic solutions, while for divalent cations is Ba2+ > Sr2+ 
> Ca2+ > Mg2+.508, 510 The high conductance of RyR channel determines less time to perform the 
steps needed to discriminate between ions. In this respect, the apparent deficiency in Ca2+ 
selectivity may be related to its high conductance.512  
Between the cytosol and SR lumen, there is a great free [Ca2+]i gradient. The diastolic free 
[Ca2+]i is only ~100 nM in the cytosol but ~1 mM in the SR lumen, while cytosolic concentrations 
of other ions are much larger (~150 mM K+) or comparable (~1 mM Mg2+) on both sides of the SR 
membrane.515, 516 Ca2+ is the only cation with this significant concentration gradient across the SR 
membrane, which makes Ca2+ essentially the only ion released through RyR. The concentration 
gradient is the major driving force, regardless of the moderate selectivity or lower but still high 
conductance between divalent and monovalent cations.331, 513 During the EC coupling, the Ca2+ ions 
are released from the SR in several milliseconds, accounting for >70% total cytosolic Ca2+ 
uptake.476  
1.4.2.5 Gating 
During opening, RyR channel performs substantial structural rearrangements while most of the 
domains appear to move.337, 475, 496 The main idea of the swiveling movement is to make the 4-fold 
axis less crowded, to increase the ion gate diameter.495 
The largest-magnitude conformational change occurs in the cytosolic region.495, 499 The clamp 
region (subdomains 9 and 10) together with the structure formed by subdomain 7, 8 and 8a move 
downwards the ER/SR up to 8 Å (Figure 14 and 18). Concomitantly, the subdomain 2 of central rim 
move approximately 4 Å upwards and outwards away from the the ER/SR membrane and 4-fold 
axis, respectively. Subdomain 6 moves approximately 5 Å outwards.495  
The movement in the cytosolic region is conveyed to the inner branches of columns.495 The four 
inner branches are located on the cytosolic side, shaped as thin bent rods.494, 495, 498 They connected 
each other and merge into a ring of high density inside the transmembrane assembly above the pore 
in closed state. In the open state, they rotate 5 and move approximately 6 Å further away from 
each other, which is directly related to the diameter of the ion gate (Figure 18).495  By directly 
linking the cytosolic region, the inner branches are proposed to transmit the conformational changes 
from the transmembrane region to cytosolic region.495  
In the transmembrane region, the inner helices form a right-handed helical bundle constricting 
towards the cytosol in closed state.494, 495 From closed to open state, changes in angle and the 
outwards bending of inner helices are seen in a recent research, generating a relaxation of the 
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helical bundle and the wider ion gate.495 The pore helices also protrude into the central cavity, and 
provide a narrow passage. 
 
 
Figure 18 Allosteric changes during opening and closing. (a) View of RyR1 from cytosol in presumed mass of 
closed (gray) and open (red) states. The red portion in the central rim indicates that this region moves upward during 
opening, whereas the gray portions in the clamps indicate that this area moves downward toward the ER/SR membrane. 
(b) Side view. Arrows indicate relative movements during opening, which can be generally described as a tilting 
motion. (c) Side view, cut along the center to show movements within the central rim. (d) Top view, cut along the 
surface plane of inner branches, showing their outward movement. Arrows indicate the relative movement during 
opening. (Adapted from Van Petegem, 2015517) 
RyR channel’s cytosolic region interacts with proteins or small molecules, such as FKBP1β, 
CaM, L-type Ca2+ channel, etc (Figure 14).331, 475 In all cases, the binding sites are situated at least 
130 Å away from the ion gate. It is likely that the upward and outwards movement of the cytosolic 
region pulls the inner branches at the same direction.495 As the inner branches are directly connected 
to the ion gate, it is straightforward to see how their being pulled apart and increases the diameter of 
the ion gate.495 
1.4.2.6 N-terminal region and R420 site 
As the mutation studied in this thesis (RyR2
R420Q) is located on the C-domain of the RyR2 N-
terminus, this session specifically introduces RyR2 N-terminus mutations. Addition of a peptide 
corresponding to amino acids 163-195 of RyR2 markedly increased diastolic calcium release of 
RyR2, which means N-terminal region allosterically regulates channel activity.
518 Indeed, 
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CPVT/ARVD2 related mutations are found in N-terminal region as shown in Figure 19. All these 
evidences indicate the importance of N-terminal region to RyR2 channel function.  
The human N-terminal region consists of three domains: A (residues 10–223), B (224–408) and 
C (409–544) as shown in Figure 19 panel C.462 Domain A and B correspond to Pfam domain 
Ins145_P3_rec and MIR domain respectively, which are presented in green and red color in panel A 
of Figure 19 and the amino acids involved are exhibited with the same color in panel B. Domain C 
contains five α-helices including the RIH domain (residues 451–655).332, 462 The first α -helix of 
domain C (central helix, residues 410–4γ7) doesn’t belong to RIH domain as shown in panel B of 
Figure 3, where the purple bar between residues 373-434 is labeled. This helix is located in the 
centre of the structure, forming contacts with all three domains and plays a prominent stabilizing 
role.462  
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Figure 19 N-terminal fragment (amino acid residues 1-759) of the cardiac human RyR2 receptor. (A) Schema of 
domains in the RyR2 N-terminal fragment. Pfam analysis indicates that it consists of an Ins145_P3_rec, MIR, RIH and 
part of a SPRY domain. Some mutations of specific residues believed to be involved in ARVD2 and CPVT1 are shown. 
LIZ (residues 554-585) indicates the leucine-isoleucine zipper area, while SPI and PP1 represent spinophilin and 
protein phosphatase 1, respectively. (B) Alignment of the RyR2 N-terminal fragment. Amino acids involved in 
Ins145_P3_Rec, MIR, RIH and SPRY domains according Pfam are in green, red, yellow and magenta colors as shown 
in A. Interdomain amino acids are in black. Purple bars and blue arrows illustrate α-helices and -strands, whereas the 
asterisks represent areas rich in leucines and isoleucines. The trypsin cleavage sites are labeled with black triangles, and 
residure of R420 is masked with red point. (C) Top view of RyR2 indicate the structure of N-terminal region and 
interaction between domain A (blue), domain B (green) and domain C (red). (Panel A and B adapted from Bauerova-
Hlinkova et al. 2010,519 panel C adapted from Xiao et al., 2015461) 
In RyR1 N-terminal region, four residues located in all three domains (Asp61, Arg283, Arg 402 
and Glu40) form an ionic pair network and stabilize the RyR1ABC structure.
520 However, in mice 
RyR2, the ionic pair network is replaced by a chloride ion, which interacts with three residues 
(Arg420, Arg298 and Arg276) from domain B and C.520 The human RyR2 N-terminal structure is 
substantially different from other N-terminal RyR structures known so far. For instance, the the 
anion binding site in mice RyR2 is absent.
462 The domain A, B and C of human RyR2 are held 
together by a unique network of interactions, while the central helix (amino acids 410-437) is 
prominent.462  
Arg420 is crucial for maintaining a stable A/B/C domain arrangement.462, 520 It is not conserved 
between RyRs, but well conserved among RyRs from different organisms.462 Arg420 is a target for 
two CPVT mutations, R420Q and R420W. All these evidences indicate the potentially important 
role of Arg420. R420W mutation structural alteration is well studied. This mutation may cause 
changes on side chain size, charge and polarity.462 But it is likely that the tryptophan side chain in 
the R420W mutation adopts a conformation pointing to the solvent and avoids significant structural 
changes.462 This is further conformed by the unchanged thermal stability of R420W with respect to 
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that of WT and the R420Q mutation.462, 520 Tang et al. also proposed that R420W mutation 
contribute to reduced threshold for Ca2+ release termination and increased fractional release.521 
Recently, some studies suggested that R420Q mutation may induce changes on side chain size and 
charge, although the thermal stability is not influenced.462, 520 However, lack of animal model limits 
the further investigation. When this thesis was studied, no N-terminal C-domain mutation related 
animal model was reported. 
1.4.2.7 RyR2 Ca
2+ release events 
Ca2+ signals were first observed in the late 1960s as intracellular [Ca2+]i transients during single 
twitches in barnacle muscle fibers522 and first imaged in the late 1970s as Ca2+ waves in fertilizing 
Medaka fish eggs.469, 523, 524 Shortly after, [Ca2+]i transients during cardiac EC coupling were 
observed in frog cardiac muscle525 and in canine Purkinje fibers526. With the development of Ca2+ 
detectors, Ca2+ sparks, the brief and fast Ca2+ releases, were visualized in mouse SAN cells from 
intact tissue (Figure 20).527  
 
Figure 20 Ca2+ sparks and transients. A. Two-dimensional confocal images of [Ca2+]i transients in mouse SAN cells 
from intact tissue. B. Line scan confocal images of an action potential (AP)-elicited [Ca2+]i transient (top) and two 
spontaneous spark (bottom) in one SAN cell, while the bottom image corresponds the 250ms depicting in the upper 
image. Time and space ordinates are displayed in the horizontal or vertical directions. (Adapted from Cheng and 
Lederer, 2008469) 
Ca2+ spark is an intracellular Ca2+ release event. Its fluorescent recording of Ca2+ release is from 
a single Ca2+ release unit (CRU), which refers to a cluster of Ca2+ release channels (RyRs) in the SR 
membrane.469 In cardiac myocytes, Ca2+ sparks could occur when the L-type Ca2+ channels are 
opened, when local [Ca2+]i is elevated by some other mechanisms, and when RyRs open 
spontaneously.106, 469, 528 In rat heart cells, the rate of spontaneous Ca2+ spark is about 100 per cell 
per second. Ca2+ sparks have a variable amplitude (ΔF/F0 up to 4), a short duration (half time of 
decay of ~20-30 ms), and a small diameter (full width at half-maximum of ~2-β.5μm).528 In atrial 
myocytes, which largely lack T-tubules (TTs) and contain both peripheral junctional and central 
nonjunctional CRUs, spontaneous Ca2+ sparks are larger and longer lasting than their ventricular 
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counterparts (300,000 Ca2+ in 12 ms versus 100,000 Ca2+ in 7 ms), with a high prevalence at the 
periphery.529-531 
Within a sarcomere, Ca2+ sparks tend to center on the TTs at the Z-disk of a sarcomere, where 
discrete CRUs are spreaded on a plane that is perpendicular to the long axis of the cell.469 In some 
conditions, Ca2+ sparks activate nearby CRUs inducing Ca2+ waves.469 Ca2+ sparks also constitute 
the elementary events of cardiac EC coupling, i.e. a [Ca2+]i transient is composed of temporal and 
spatial summation of thousands of Ca2+ sparks.469 
1.4.2.8 RyR regulation by endogenous effectors 
RyRs are regulated by endogenous effectors (such as Ca2+, Mg2+ and adenine nucleotides), 
cellular processes (such as phosphorylation), exogenous compounds (such as ryanodine, tetracaine, 
caffeine) that can be used for experimental studies. The regulations of the major endogenous 
effectors are briefly reviewed.  
1.4.2.8.1 Cytosolic calcium 
Ca2+ ion is the most important regulator of RyR activity.532 Open of all three RyR isoforms can 
be triggered by Ca2+. In cardiac cells RyR2 are activated by calcium ions that flow into the dyadic 
space through L-type Ca2+ channel,532 while in skeletal muscle, RyR1 could be activated even 
without Ca2+ flow by conformational changes in the L-type Ca2+ channel when opens.533, 534  
Steady-state single RyR channel activity is a bell-shaped curve depending on the cytosolic 
[Ca2+].512, 535-539 The RyR channel is activated by low [Ca2+] (1-10 μM) and inhibited by high [Ca2+] 
(1-10 mM).512 Studies found out RyR2/3 have some marked differences from RyR1. RyR1 cannot be 
fully activated by Ca2+ along, but RyR2/3 can achieve almost-full/full activation by Ca
2+ along at 
100 μM. Furthermore, RyR2/3 is less sensitive to Ca2+ inhibition by high [Ca2+]. A higher [Ca2+] 
(range from 2 to > 10 mM) is required for half-maximal inhibition for RyR2/3 (because of the low-
affinity of inhibition sites, I1-sites, see below), while 1 mM Ca2+ is enough to achieve entire 
inhibition for RyR1. The physiological role of this very high Ca
2+ inhibition for RyR2 is not yet 
clear, as such high cytosolic [Ca2+] is difficult to reach in cells. It is also reported that all RyR1 
don’t respond in the same way (functional heterogeneity) with respect to Ca2+ regulation. But 
RyR2/3 responds much more homogeneously, which maybe due to their difference in the redox 
state.331, 512  
For RyR2 channel, both activation and inactivation are rapid, while activation rate is also 
dependent on [Ca2+] but the inactivation is not.540-542 The rapid activation and inactivation kinetics 
allow RyRs to respond to physiological calcium signals that last only a few milliseconds.332 The 
rapid response and biphasic behavior of RyR2 reveal that RyR may have several Ca
2+ binding sites.  
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It has been proposed that there are four Ca2+ binding sites for RyR2, while three are in cytosol 
and one in lumen (Figure 21).543, 544 The three cytosolic sites are: a high-affinity activation site (A-
site, 1 μM affinity), a low-affinity inhibition site (I1-site, 10 mM) and a high-affinity inactivation 
site (I2-site, 1.β μM affinity).543 Binding of Ca2+ at the A-site has a strong positively conformational 
effect.545 At diastolic calcium concentrations, almost full of the A-sites are occupied by competitive 
Mg2+.332, 545 It is generally recognized that the cytosolic Ca2+ induced activation and inactivation is 
mediated by A-sites and I1 sites.543 Concomitantly, because of the high [Ca2+] required for I1-sites, 
the [Ca2+] required for RyR2 inhibition is very high, even higher than physiological cytosolic [Ca
2+]. 
The A site properties are strongly affected by ATP and caffeine, which do not trigger channel open 
on their own but enhance RyR2 response to cytosolic Ca
2+.543 Unlike A site, the divalent cation 
affinity of I1-site is unaffected by ATP or caffeine. I2-site is identified more recently, which causes 
brief (1 ms) channel closures.546 The precise locations for these binding sites are still unknown.544  
 
Figure 21 Ca2+/ Mg2+ regulatory sites on the RyR2. The hypothetical locations of four Ca
2+/Mg2+ sites of RyR2 are 
shown. The names given to these sites are indicated on the left and the corresponding Ca2+-Mg2+ affinities of the sites 
are shown on the right (the Mg2+ affinity of the I2-site is unknown (?)).The arrows indicate the ability of Ca2+ on the 
luminal and cytosolic sides of the membrane to access Ca2+ sites on the cytosolic domains of the channel (Adapted from 
Laver, 2009544) 
A more recently study indicates that a cytosolic Ca2+ binding site of RyR1 is located on the EF-
hand pair (Figure 17).500 It is adjacent to the S2-S3 insertion from a neighboring subunit the C-
terminal domain (CTD) of the originating subunit, suggesting a mechanism for Ca2+ mediated 
gating. Thereby, Ca2+-dependent changes in the conformation of the Ca2+ binding domain are 
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transmitted to the pore via contacts with the S2-S3 loop and/or the CTD, inducing a conformational 
change that alters the cytosolic aperture of the channel.500 
Diastolic free [Ca2+] is ~100 nM in the cytosol, and can be changed in pathological conditions, 
which also change RyR channel activity.515 
1.4.2.8.2 Luminal calcium  
Single RyR2 channel studies have confirmed the existence of luminal Ca
2+ regulation. The 
luminal Ca2+ could affect RyR2 activity by binding to the cytosolic Ca
2+ binding sites (Figure 
21).543, 544, 547, 548 At low cytosolic [Ca2+], when RyR2 activity is low, the presence of luminal Ca
2+ 
could increase RyR2 activity by passing through the open channel and binding to the A-site.
547 
Cytosolic Ca2+ inactivation site (I2-site) is also involved, which cause brief channel closures.  
Luminal Ca2+ also affects RyR2 activity by binding to luminal binding site, which may be 
located either on the luminal activation site (L-site, 60 μM affinity) or/and on an associated protein 
(Figure 21).332, 543, 544, 548 Some studies show that binding of Ca2+ to the L-site triggers brief 
openings, albeit much weaker than A-site, which produces a 30-fold prolongation of opening.543 
Once the pore is open, luminal Ca2+ again accesses to the A-site and to the I2-site.543 The negatively 
charged residues make the L-site possible, while the concomitant Ca2+ binding could alter the 
channel conformation and increase its open probability.500, 549 Another possibility is that luminal 
Ca2+ modulate RyR2 via associated protein, such as calsequestrin, triadin and junctin.
550-552  
[Ca2+] changes in the SR lumen in the pathological condition (diastolic free [Ca2+]i ~1 mM in 
physiological condition) could also influence RyR channel activity.516 
1.4.2.8.3 Magnesium 
Mg2+ is a potent RyR channel inhibitor.331, 553 The cytosolic free [Mg2+] in cardiomyocytes is 
~1mM.546, 554 The effect of Mg2+ on RyR2 is less than RyR1.
332, 555 Mg2+ inhibits RyR2 by 
competitively binding at the A-site and L-site, but Mg2+ fails to open the channel (Figure 21).556  
Mg2+ competitively binds to A-site (60 μM affinity), but unlike Ca2+, Mg2+ causes a weak 
negatively conformational effect and closure of RyR2 (Figure 21).
544, 545 At diastolic Ca2+ 
concentrations, the cytosolic activation sites are almost fully occupied by Mg2+.545 Since Mg2+ 
dissociation from this site is relatively slow, it limits the response rate of RyR2 to Ca
2+ elevations, 
which might have an important role in the physiological regulation of RyR2.
331, 545, 557 
Mg2+ inhibits the luminal effect of Ca2+ at RyR2 also by competing with it at the luminal 
activation site.544 Mg2+ has the same affinity (40 μM) as Ca2+ at the L-site, but its binding does not 
cause channel opening.544, 556  
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I1-site of RyR2 does not identify My
2+ with Ca2+, both of them cause channel closure.544, 558 Its 
physiological role is not clear. As for cytosolic Ca2+, I1-site inhibition of RyR2 also requires a 
higher [Mg2+] than the physiological intracellular [Mg2+].543 Mg2+ effect at the I2-site is still 
unclear.556  
Luminal and cytosolic Mg2+ inhibitions are alleviated by increasing luminal [Ca2+] or cytosolic 
[Ca2+].556 
1.4.2.8.4 Adenine nucleotides 
Adenine nucleotides ATP, ADP, AMP, cyclic-AMP, adenosine and adenine are RyRs 
activators, while ATP is the most effective one.331, 332, 477  
The effect of ATP on RyR2 is more modest than on RyR1.
331, 332, 559 Besides, ATP can trigger 
RyR1 in the absence of Ca
2+, although Ca2+ is needed to reach the maximal activation.560, 561 But 
RyR2 cannot be activated by ATP only, it only increases the sensitivity of the channel to cytosolic 
Ca2+ activation, and concomitantly increases open probability of the channel (EC50= ~100 μM).562-
564 Most ATP in the cell exist as Mg·ATP complex, although the activating species seems to be free 
ATP2-.332, 553  
The other adenine nucleotides also activate RyR channel activity, but are much less effective 
than ATP.332 Chan et al. suggested ATP is more effective than other adenine nucleotides because it 
can convert the greatest amount of binding energy into conformational changes and stabilize the 
open channel state.565 ADP is a partial agonist with a lower affinity (EC50 = ~1 mM).563 Adenosine 
and adenine also have low effects, while CTP, GTP, ITP and UTP do not activate the channel at 
all.566, 567 
Thereby intracellular adenine nucleotides level changes (e.g., heart failure) affect not only 
energy source, but also RyR channel activity.568, 569  
In the extracellular milieu, ATP also plays critical roles as neurotransmitter, such as inhibitory 
neurotransmitter released from enteric nerves and cotransmitter coreleased from postganglionic 
sympathetic or parasympathetic nerves.570 Both ATP and adenosine could activate sarcolemmal 
adenosine A1 receptor in rat right atria, and cause cardiac arrest.
571  
1.4.2.8.5 Phosphorylation status 
RyR contains several conserved phosphorylation/dephosphorylation sites, which can be 
phosphorylated by serine/threonine protein kinases (e.g. cAMP-dependent protein kinase, PKA; 
Ca2+/calmodulin-dependent protein kinase II, CaMKII; cGMP-dependent protein kinase, PKG; etc) 
or dephosphorylated by protein phosphatases 1 (PP1) and 2A (PP2A).331, 332, 572, 573  
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The first discovered RyR2 phosphorylation site was S2808 (S2843 on RyR1) in human and 
rodents (S2809 in rabbit).409, 573 It is phosphorylated by CaMKII, while later studies shown that 
PKA and PKG also phosphorylate this site.574, 575 The second CaMKII phosphorylation site, S2814 
(S2815 in rabbit), was found later only for RyR2. Addition to S2808, S2030 (S2031 in rabbit) is 
recently identified as a second and specific PKA phosphorylation site on RyR2.
576, 577  
Contradictory results have been reported for the effect of RyR2 S2808 site phosphorylation. It 
has been reported that in heart failure patients, S2808 is hyperphosphorylated and in turn enhanced 
the activity of RyR2 channel.
296, 573, 575, 578 But the fact that S2808 is already substantially 
phosphorylated (~50-75%) in normal hearts raising the doubts of the effect of S2808 
phosphorylation.573, 574, 576, 578, 579 Indeed, some studies reveal that mice with genetic ablation of the 
S2808 phosphorylation site (RyR2-Sβ808A) have normal -adrenergic response, have unchanged 
cardiomyocyte function, and lack of protection against heart failure.580-582 Nevertheless, it has been 
also suggested that S2808 phosphorylation lead to dissociation of FKBP 12.6, which concomitantly 
destabilized the closed state of the channel and increased RyR2 Ca
2+ release.296, 297, 577 However, the 
other studies found no effect of RyR2 phosphorylation in its affinity to FKBP12.6, and some studies 
even reported FKBP12.6 does not affect RyR2 activity at all.
403, 583-587 
Unlike S2808, S2814 is barely phosphorylated in quiescent cardiomyocytes.573 To investigate 
the contribution of Sβ814 to inotropic effects induced by -adrenergic stimulation, mice with 
genetic ablation (S2814A) or constitutively activation (S2814D) are tested. RyR2-S2814A mice 
were protected from pacing-induced tachyarrhythmias after TAC (transverse aortic constriction) 
surgery.423 Consist with that, Respress et al. also reported that S2814A mice are protected from 
heart failure following TAC surgery, although the protective effects are not observed from MI- 
(myocardial infarction) induced heart failure.588 Several researches indicated the protective role of 
inhibition of S2814 phosphorylation with this same mouse line, which averts the functional and 
structural damage to the heart induced by heart failure, atrial fibrillation, and other insults.420, 572, 589, 
590 Further more, RyR2-S2814D increased RyR2 channel open probability, while RyR2-S2814D 
mice develop sustained ventricular tachycardia and sudden cardiac death upon catecholaminergic 
provocation by caffeine/epinephrine or programmed electrical stimulation.423 However, it is also 
notable that 2814D mice still have structurally and functionally normal hearts without 
arrhythmias.423  
S2030 is highly conserved PKA phosphorylation site in RyR2.
576 Xiao et al. reported that the 
phosphorylation of Ser-2030 responded to isoproterenol stimulation in rat cardiac myocytes in a 
concentration- and time dependent manner, but not in unstimulated cells.575, 576 In addition, the 
extent of the increase in S2030 phosphorylation after isoproterenol stimulation was much more than 
that for S2808 in both normal and failing hearts.576 Isoproterenol induced phosphorylation of 
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S2030, not of S2808, is markedly inhibited by PKI, which is a specific inhibitor of PKA.575 In 
summary, it is likely that Sβ0γ0 is the major PKA activation site responding to acute -adrnergic 
stimulation in both normal and failing hearts, but nearly unphosphorylated in normal or failing 
hearts.573, 575, 576, 591 
S2811 is another serine residue between S2808 and S2814, and proposed to be phosphorylated 
by both PKA and CaMKII in vitro, but its contribution is still unclear.403, 572  
In spite of RyRs, CaMKII and PKA can also phosphorylate other proteins (such as L-type Ca2+ 
channel, phospholamban, etc) and thus influence RyR Ca2+ release.592-594  
In SAN, Wu et al. used the mice with RyR2 knock-in mutation that replaced CaMKII target site 
(S2814) or PKA target site (S2808) with alanine and disabled the phosphorylation at these sites.261 
They found that unique S2814A or S2808A mutation failed to affect spontaneous firing rate and 
isoproterenol response in vivo and in SAN cells.261 However, multiple target sites were not 
investigated, as both CaMKII and PKA have multiple phosphorylation sites, which could explain 
the unchanged responses. PKA and CaMKII could also regulate SAN activity via interactions with 
numerous Ca2+ handling proteins or other pacemaking-related proteins.83, 327, 365, 414 More 
information about CaMKII phosphorylation on RyR2 and other proteins are given in point 1.2.3.3.  
1.4.3 RyR accessory proteins 
RyRs interact with endogenous proteins which together ensure RyRs to sense the environment 
changes and properly regulate Ca2+ release, such as FKBP (FK506-binding proteins), calmodulin 
(CaM), and calsequestrin (CASQ). In this session, we will briefly review the accessory proteins.  
1.4.3.1 FK506-binding proteins (FKBP) 
FKBP (FK506-binding proteins) is named according to their molecular mass, FKBP12 and 
12.6.477 It belongs to the immunophilins, which are a family of highly conserved proteins that bind 
immunosuppressive drugs such as FK506 and rapamycin.331, 332 FKBP12 and FKBP12.6 are 108 
amino-acid proteins that share approximately 85% sequence homology. Both FKBP isoforms 
physically interact with RyR1 and RyR2, but have different expression levels and binding affinities 
in different tissues.477, 595, 596 RyR1 has similar affinities with both FKBP12.6 and FKBP12, but the 
much higher tissue expression level of FKBP12 makes it the predominant isoform bounding to 
RyR1. However, FKBP12.6 is the predominant isoform for RyR2 in cardiac tissue because of the 
higher binding affinity, in spite of the higher expression level of FKBP12 than FKBP12.6.587, 595 
Each RyR tetramer contains four FKBPs binding sites, one for each subunit (Figure 14).332 The 
binding site is localized on the amino-terminus (residues 307–1855) or the carboxyl-terminus 
(residues 3788–4967).331, 597, 598 
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Some studies reported that the interaction of FKBP with RyR stabilizes the closed state of the 
channel. Removal of FKBP12.6, by application of FK506 or rapamycin or by genetic FKBP12/12.6 
deficiency in mice, leads to greater open probability of the RyR2 and longer open duration.
599-601 Li 
et al. demonstrated that FKBP12.6 null mice exhibit spontaneous atrial tachyarrhythmia.602 Our 
team overexpressed FKBP12.6 in rat cardiac myocytes and found decreased spontaneous Ca2+ 
sparks but increased [Ca2+]i transients, in relation with enhanced SR Ca
2+ load, therefore improving 
excitation-contraction coupling.603 Conditional FKBP12.6 overexpression mouse model further 
indicated that increased FKBP12.6 binding to RyR2 prevent triggered VT in normal hearts in stress 
conditions, probably by reducing diastolic SR Ca2+ leak.604 However, some studies found that 
removal or addition of FKBP12.6 does not alter RyR2 channel behavior or only has modest 
effects.585, 587, 600, 605 FKBP12 was also reported to play a critical role in mammalian cardiac 
development and heart rhythm via trans-sarcolemmal ionic currents (predominately INa) 
regulation.599, 606  
1.4.3.2 Calmodulin (CaM) 
As mentioned in session 1.2.4, CaM is an intracellular Ca2+ sensor in eukaryotic cells. It 
interacts with a vast number of proteins, including RyR2, and plays a critical role in numerous 
intracellular processes.  
CaM binds all three mammalian RyRs in both Ca2+-free (apoCaM) and Ca2+-bound (CaCaM) 
states, although the effects are different.539, 607-609 Apo-CaM (at nanomolar Ca2+ concentration) is an 
agonist of RyR1 and RyR3, but has no effect on RyR2.
539, 609, 610 However, CaCaM (at micromolar 
Ca2+ concentration) inhibits all RyR isoforms. Each RyR subunit contains one CaM binding site 
(four per tetramer, amino acids 3583–3603 in RyR2, Figure 14), which are conserved in all RyR 
isoforms.331, 611 
In cardiac muscle, CaM negatively shifts the Ca2+-dependent RyR2 activity curve while a higher 
Ca2+ concentration is needed to maintain the same RyR2 activity, and therefore decreases the RyR2 
opening probability.477, 607 It is also reported that Calmodulin mutations can cause severe cardiac 
diease, such as CPVT, sudden cardiac death, etc.447 For instance, heterozygous CaM mutations 
(N53I, N97S) are linked to CPVT.447 Further investigation found that these two mutations confer 
opposite changes on CaM N- and C-lobes.612 CaM mutation F90L is related to idiopathic 
ventricular fibrillation manifested in childhood and adolescence.613 Søndergaard et al. expressed 
CaM mutations (N53I, D95V, D129G, N97S) in HEK293 cells, and found that mutations increased 
RyR2 sensitivity to SR Ca
2+ content and thus increased Ca2+ release.614 Thereby, they proposed that 
aberrant regulation of RyR2 is a mechanism underlying CPVT and LQTS (long QT syndrome) 
caused by CaM mutations. On the other hand, mutations on RyR2 are associated with interaction of 
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CaM. Fukuda et al. demonstrated that ventricular myocytes from knock-in mice with RyR2 
mutation (R2474) exhibit increased spontaneous Ca2+ leak, delayed after depolarization, triggered 
activity, and Ca2+ spark frequency, which can be explained by the decreased affinity of CaM 
binding and could be corrected by increased CaM binding affinity.615  
CaM could also impact RyR2 activity by acting on other proteins including the L-type Ca
2+ 
channel. When bound to Ca2+, it activates both CaMKII and calcineurin (Cn), a CaM-activated 
protein phosphatase, etc.331, 616  
In SAN, CaM influences SAN automaticity via direct and/or indirect interaction with numerous 
proteins (LTCC, RyR2, If, etc) involved in pacemaking in both Ca
2+ clock and membrane clock.  
1.4.3.3 Calsequestrin (CASQ) 
Calsequestrin (CASQ) is the major Ca2+ binding protein in the SR with a molecular mass of 
~40kDa.331, 617 It is a low-affinity and high-capacity Ca2+ buffering protein (~ 40 Ca2+ per 
protein).331, 618 It maintains the free [Ca2+] in SR at ~1mM while the total [Ca2+] could reach up to 
20mM.617 CASQ is rich in negative residues (~30%), most of which are involved in Ca2+ binding, 
while Ca2+ binding also induces CASQ conformational changes: it polymerises when Ca2+ 
concentrations approach 1mM.617, 618 These conformational changes concomitantly resulted in the 
high Ca2+ binding capacity, as the condensed CASQ has a higher Ca2+ binding capacity, at least 
twice the CASQ monomer.618   
In addition to Ca2+ buffering effect, it also modulates the activity of RyR channel in a Ca2+ 
dependent manner. It has been reported that CASQ polymer can be anchored to RyR either by 
binding directly to the RyR or via triadin and junctin, which are two RyR anchoring proteins 
embedded in the SR membrane.332, 617 The interactions between CASQ, junctin, triadin, and RyR 
are important for Ca2+ release from the SR, contraction and Ca2+ homeostasis.617  
There are two CASQ isoforms (CASQ1 and CASQ2), sharing 86% identity homology and 
exhibiting tissue-specific expression patterns.331 CASQ1 expresses in skeletal muscle, while 
CASQ2 expresses in cardiac and at low level also in slow-twitch skeletal muscle.477 Functionally, 
CASQ1 reduces RyR1 activity, but CASQ2 increase RyR1 and RyR2 open probability.
619  
CASQ2 mutations are associated with autosomal recessive CPVT and accounts for 3-5% of the 
CPVT patients.453 Some of the human mutation carriers of a single CASQ2 mutation are healthy, 
while some patients carry one or two CASQ2 mutation(s) produce severe forms of CPVT.444, 620  
CASQ2 mutant mouse models have been used to further investigate human CASQ2 
mutations.621-624 CASQ2-null mice display polymorphic ventricular arrhythmias after exercise 
challenge, and isolated ventricular myocytes exhibit decreased Ca2+ content and increased SR Ca2+ 
67 
 
leak.622 Likewise, human homozygous CASQ2 mutations, which cause a complete absence of 
CASQ2, also show CPVT.444 Compensatory responses were also seen in homozygous CASQ2-null 
mice, like increased SR volume and near absence of CASQ2-binding proteins triadin-1 and 
junctin,622 but not seen in heterozygous CASQ2-null mice.621 It may explain why heterozygous 
carriers of CASQ2 mutations are either asymptomatic or significantly less symptomatic compared 
to homozygous patients.444, 625 Heterozygous CASQ2-null mice only had a modest reduction 
(~25%) in functional protein, but still resulted in increased arrhythmia risk and more SR Ca2+ leak 
with similar SR Ca2+ load in isolated ventricular myocytes, which also suggest that the CASQ2 acts 
not only as a buffer but also as a direct regulator of Ca2+ release process.621, 626 Other CASQ2 
knock-in mutations also lead to either a severe reduction or complete loss of CASQ2 protein.623, 624  
SAN dysfunction was seen in both CASQ2 mutations induced CPVT patients and CASQ2 null 
mice.444, 455, 459 CASQ2-related CPVT patients frequently have sinus dysfunction and inducible 
atrial tachyarrhythmias, while CASQ2 null mice also exhibit enhanced atrial ectopic activity, SAN 
conduction abnormalities, and slower heart rhythm during -adrenergic/cholinergic stimulation.444, 
455, 459 
1.4.4 Clinical characterization of RyR2R420Q mutation 
RyR2 mutation R420Q was found from a CPVT family. This CPVT family was noticed after a 
sudden death, which is the fourth sudden death in this family (Figure 22).457 The proband (Figure 
ββ, ІІІ: 8), a 14-year-old male with previous history of unexplained exertion syncopes, suffered a 
sports-related sudden death with an unremarkable postmortem. The other three relatives had also 
died suddenly and young. But unfortunately, no autopsy was performed in these three cases.  
Then, clinical and genetic evaluations were preformed in this family, following a protocol 
conforming to the Declaration of Helsinki and previously approved by the local research ethics 
committee. Informed consent was obtained from each individual. The clinical evaluation was first 
performed in individual III: 10, including electrocardiogram, echocardiography and maximal 
exercise testing (Bruce protocol). The CPVT phenotype was unmasked during exercise testing. 
Then the relatives were tested who are offspring of an affected individual. CPVT phenotype was 
diagnosed in this family (Figure 22), which presents sudden cardiac death, polymorphic ventricular 
arrhythmias or frequent premature ventricular contractions (> 10/min) during exercise testing. 
Sinus, atrial, junctional, and ventricular arrhythmia were evaluated in CPVT phenotype carriers in 
both resting and exercise electrocardiograms. Sinus bradycardia was defined as a heart rate < 60 
bpm over 14 years of age or lower than percentile 2 adjusted to age in younger children. 
Meanwhile, the genetic evaluation was also running, firstly on individual III: 10. Gene RyR2, 
and gene KCNJ2 which is also related with polymorphic exercise-induced ventricular arrhythmias, 
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are considered and analyzed with ABI Prism 3100 sequencer (Applied Biosystems). In RyR2 gene, 
exons 3, 8, 14, 15, 37, 44-50, 83, 87-105, and adjacent intronic regions (GenBank accession number 
NM_001035) are tested. Later, RyR2 mutation (1259 G>A, R420Q) was identified in exon 14 in 
individual III: 10. No KCNJ2 mutations were found. Then exon 14 was tested in the relatives, and 
the ones carrying mutation R420Q were uncovered as Figure 22. DNA was obtained from whole 
blood (relatives) or from paraffin-embedded myocardium (proband).  
Eventually, 25 proband relatives were evaluated, and 11 mutation carriers were found including 
the proband (III: 8). Among these 11 genotype carriers, 10 were CPVT phenotype carriers 
(including the proband), only one two-year-old girl (IV: 4) was an unknown phenotype. 
Notably, a higher incidence of sinus bradycardia was observed in genotype-positive patients 
when compared with genotype-negative individuals (78% vs. 25%, P = 0.030). Atrial and/or 
junctional tachyarrhythmias were detected in 7/9 genotype carriers, but none of the non-genotype 
carriers. These results indicate that RyR2R420Q mutation may induce sinoatrial node (SAN) 
dysfunction.  
 
 
Figure 22 Family pedigree. Square: male. Circle: female. Crossed symbol: deceased individual. Blue symbol: 
CPVT phenotype carrier (with sudden cardiac death or ventricular effort-related arrhythmias). Plus sign (+): genotype 
carrier. The arrow points to the proband. Plus and minus signs depict mutation-positive and mutation-negative 
individuals, respectively. SCD: sudden cardiac death with postmortem without structural heart disease; SD: sudden 
death, no autopsy. (Adapted from Domingo et al., 2015457) 
HEK293 cells expressing mutant RyR2
R420Q showed decreased amplitude of caffeine induced 
Ca2+ release, and released more Ca2+ at diastolic cytosolic Ca2+ concentration.457 Additionally, sinus 
bradycardia, atrial and junctional arrhythmias, and/or post-effort U-waves were also identified, 
which was the first time that supraventricular arrhythmia and SAN dysfunction were reported in 
RyR2 N-terminal mutation. Further researches are needed to understand the functional and vivo 
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contribution, but lack of animal model limits the investigation. Hence, our team generated 
RyR2
R420Q mice model. In this article, we are going to investigate the mechanism of SAN 
dysfunction of RyR2
R420Q mice found in CPVT-related patients.  
1.5 Objectives  
SAN is the physiological pacemaker in mammalian heart, and is predominantly responsible for 
spontaneous heart rhythm generation. Ca2+ release via RyR2 plays a critical role in maintenance of 
normal SAN automaticity. That is why SAN dysfunction is commonly observed in RyR2 mutation 
induced CPVT patients in respect that mutant RyR2 is expressed in the entire heart. Our 
collaborators identified a mutation located in the N-terminus of RyR2 (R420Q) in a Spanish family 
with severe CPVT and SAN dysfunction.457 It is known that N-terminal residue Arg420 (R420) 
plays an important role in RyR2 conformation.
462, 520 But the mechanisms about RyR2 N-terminal 
mutation related SAN dysfunction is never investigated before. Based of these knowledge and the 
background presented in the introduction, this thesis seeks to improve the knowledge of the cellular 
alterations that lead to the SAN dysfunction. In particular, we investigated the mechanism 
underlying the RyR2 mutation R420Q contributed SAN dysfunction.  
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Chapter 2 Materials and methods 
2.1 Generation of RyR2 (R420Q) mutation mice (Performed by Institut Clinique de la 
Souris) and etics statement 
In order to determine the mechanisms involved in this CPVT mutation, we ordered the 
generation of RyR2R420Q KI mice.  
Based on C57bl/6 mice line, RyR2R420Q mice strain was generated by homologous 
recombination. It included genetic modification of embryonic stem cells genome, Cre/loxP system, 
and various strategies. Firstly, targeting vector was constructed. Targeting vector is usually a 
plasmid or virus, which transfers a specific gene into a target cell and allows the cell to synthetize 
the protein encoded by the specific gene. For the construction of targeting vector, a genomic 
sequence containing the mutant exon 14 of RyR2 gene was cloned. Then the genomic region was 
recombined into a plasmid backbone, flanked by LoxP-NeoR-LoxP cassette (Figure 23 and 24). 
The NeoR (neomycin resistant gene) is a drug resistant gene used to screen the homologous 
recombinants, while the LoxP-NeoR-LoxP cassette is a typical floxing and deleting gene-targeting 
strategy. Secondly, the targeting vectors were electroporated into embryonic stem (ES) cells. After 
isolation of the drug resistant ES cell clones, the homologous recombinants were further screened 
by PCR analysis. The homologous recombinant ES clones were then established. After, the 
homologous recombinant ES cell clones were used to produce the germline-transmitted chimeric 
mice. The chimeric mice with highest contribution of ES cells were identified, and mated with wild-
type mice to produce the heterozygous mice (L2, Figure 24). Finally, after in vivo Cre deletion, the 
mutant mouse line was established (Figure 24).  
As a consequence of gene modification, the DNA sequence in mutant mice was longer than in 
wild-type. For the primer designed in this article, the PCR detected sequences were 300 bp (wild-
type RyR) and 400 bp (knock-in RyR) (see session 2.2.1 for genotyping). 
In this thesis, both male and female heterozygous mice were used, and compared to their wild-
type littermates (age 4-6 months). 
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Figure 23 Map of targeting vector plasmid. Ex14: exon 14. Ex15: exon 15. Neomycin resistant gene: NeoR. The 
mutation is shown in purple.  
 
Figure 24 Overview targeting strategy.  
Ethics statement 
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All animal experiments are in accordance to the European Community guiding principles, the 
local ethics committee guide lines, and the French decree in the care and use of animals. 
Authorizations manipulated according to the decree obtained from the French Ministry of 
Agriculture, Fisheries and Food. 
2.2 Genotyping 
The animals were genotyped using tail tips that were collected on weaning. The first step was to 
extract DNA, and then the specific DNA sequence was replicated by PCR, which was followed by 
electrophoresis for identification. The principles and specific techniques are explained below. 
To extract DNA, we used heating to lyse the tissue, and sodium chloride (NaOH) solution to 
dissolve DNA. Each tissue sample (about 0.5cm tail tips) was heated at 95°C for 45 min with γ00 μl 
50 mM NaOH (in water). After, the samples were transferred on ice for 10 min. Then, TRIS HCl 
(β5 μl for each sample, 1M pH 8) was added into it to stop the reaction. The mixtures were 
centrifuged at 14000 rpm and 4°C for 15 min. Then, DNA was extracted to the supernatant. The 
DNA samples can be used immediately for PCR or stored at 4°C for later measurements. 
To replicate the specific DNA sequence, we used polymerase chain reaction (PCR) technology. 
It is a technique to produce copies of a specific DNA sequence, i.e. generate a large amount of 
copies from a small amount of initial sample. PCR is based on thermal cycle, and the fact that DNA 
can be denatured. The DNA double helix is composed of two linear strands (DNA sequence) 
stabilized by hydrogen bonds between adenine·guanine (A·T) and thymine·cytosine (G·C) base 
pairs, which can be disrupted by heating (85-95 °C). This step is named denaturation. At a lower 
temperature (50-65 °C) the primers, which are short nucleic acid sequences that could precisely 
recognize the specific DNA sequence, specifically hybridize with the strand. Then a bit higher 
temperature (75-80 °C) allows DNA polymerase to synthesize a new DNA strand complementary to 
the DNA template strand along the primers. With more than 20 cycles, the specific DNA sequence 
is replicated exponentially.  
To perform the PCR, each DNA sample (1 μl for each sample) was mixed with PCR buffer (2 
μl), Taq polymerase (0.β μl), dNTPs (0.4 μl), forward primer (0.4 μl), reverse primer (0.4 μl) and 
H2O (15.6 μl). Taq polymerase (Thermo Scentific) was used to synthesize the new DNA strand. 
Deoxynucleoside triphosphates (dNTPs, Thermo Scentific) were substrates for DNA polymerase to 
synthesize the new DNA strand. The PCR buffer (contains Tris-HCl, BSA, Tween-20) was used to 
maintain a suitable chemical environment for optimum activity and stability of the DNA 
polymerase. The PCR buffer used in this work (DreamTaq Green Buffer, Thermo Scentific) also 
contains 20mM magnesium ions to optimize the activity of DAN polymerase, and two tracking 
dyes (a blue dye migrates with 3 to 5 kb DNA fragments and a yellow dye migrates faster than 10 
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bp DNA fragments in 1% agarose gel) to visually track the DNA during electrophoresis. The two 
primers were complementary to the γ’ end of each strand of the DNA target. The primers are 
normally 15-30bp, can not be complementary, and each primer can not contain complementary 
sequences or secondary structure. To avoid unspecific binding, the primers can not share more than 
70% homology with unspecific region. In this case, the forward primer was 
ACGCTTTGCTAGGCTCACAGAATAGAA (Ef, Figure 2.1) and the reverse primer was 
GATGGCTCAGGGGTTAAGAAGAACATT (Er, Figure 2.1).  
PCR consists of 6 steps (initialization step, denaturation step, annealing step, extension step, 
final elongation and final hold). It begins with an initialization step, followed by a series of 20-40 
repeated cycles (including denaturation step, annealing step and extension step), and ends with a 
final elongation and a final hold step. It repetitively amplifies the specific DNA sequence 
exponentially. In our case, the cycle was repeated 34 times. The basic steps are explained below: 
1) Initialization step. This step is required for activation of DNA polymerase. Normally it is 94-
96 °C for 1-9 minutes. The temperature and duration depend on the DNA polymerase used. In our 
case, the mixtures were heated at 95°C for 240s to activate DNA polymerases.  
2) Denaturation step (Figure 25). This is the first step in each cycle. It separates DNA double 
helix into two DNA strands. The temperature in this step lies in a range of 85-95 °C. It depends on 
the proportion of G·C base pairs. As each G·C base pair has three hydrogen bonds, it is more stable 
than an A·T base pair, which has only two hydrogen bonds. As a result, the more G·C base pair the 
DAN contains, the greater energy it needs to be separated into two strands. When the G·C content 
increases 1%, the reaction temperature increases ~0.4 °C. In our case, mixtures were heated at 94°C 
for 40s to melt the DNA.  
3) Annealing step (Figure 25). This step decreases the reaction temperature to 50-65 °C, 
allowing the hybridization of the primer and the DNA strand. The temperature affects the binding. 
If it’s too low, the possibility of unspecific binding is increased. If it’s too high, the primer may not 
bind. In our case, the mixtures were heated at 64°C for 30s to let the primer and the strand 
hybridize. 
4) Extension step (Figure 25). This step allows DNA polymerase to synthesize the new DAN 
strand according to the DAN template strand, using dNTPs. It is the last step of each cycle. Its 
reaction temperature is in a range of 75-80 °C, and depends on the DNA polymerase used. In our 
case, the mixtures were heated at 72°C for 40s to let let polymerase extend the strand. 
5) Final elongation. This step is to ensure all the new DNA strands are fully extended, and all 
the single strands renature to double helix based on complementarity. It is performed at 70-74 °C. 
In our case, a 420s, 72°C incubation was used. 
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6) Final hold. This is the last step of PCR, normally at 5-15 °C for an indefinite time. It is seen 
as a short-term storage. In our case, the reactions were short-term stored at 7°C. 
 
Figure 25 PCR reaction. The cycle of denaturation step, annealing step and extension step is shown. (Adapted 
from: www.assl.net/Forensic/DNATestingpdf.pdf ) 
After PCR, samples were used immediately for DNA electrophoresis to separate DNA 
sequences by size. As DNA sequence is formed by nucleotides, and the nucleotide consists of 
nucleoside and phosphate, this sugar-phosphate backbone determines the negative charge of DNA. 
With an electric field, DNA migrates toward the anode. The size and charge of DNA sequence 
determine its mobility. The longer the DNA sequence has the bigger resistance, and the slower it 
migrates. Therefore the smaller DNA fragments travel faster. The DNA sequences are visualized by 
fluorescent DNA stain, such as ethidium bromide (EB), GelRed, GelGreen, etc. GelRed and 
GelGreen belong to a newer generation designed to replace the highly toxic EB. In this work, we 
used GelRed (Biotium).  
Two common types of gel for DNA electrophoresis are agarose (for longer DNA sequence) and 
polyacrylamide (for shorter DNA sequence) gels. Agarose gel is formed of helical agarose 
molecules, which are aggregated into a sieving three-dimensional matrix for electrophoresis. It 
separate molecules based on molecular weight, as small molecules are more easily fit and pass 
through the pores in the gel. Therefore, smaller molecules pass at faster speed and migrate further 
than larger molecules. As the pores are too big for protein, it is not suitable for protein 
electrophoresis, or only for very large proteins. Agarose is conditioned as powder, and is melted in 
water (or electrophoretic buffer, see next paragraph) at high temperature (>50°C depending on the 
type of agarose) and then gelled when temperature decreases (<40°C depending on the type of 
agarose). Different agarose percentages have relatively different size of pores, and are used for 
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separation of molecules with different sizes. A higher agarose percentage has smaller pore size, 
hence enhances resolution of smaller bands. Polyacrylamide gel is introduced in session 2.5.  
Electrophoretic buffers are used to reduce pH changes induced by the electric field, and provide 
electrical conductivity. The most common electrophoretic buffers for DNA electrophoresis are TAE 
and TBE. TAE buffer (Euromedex) was used in this work as running buffer, and also for agarose 
gel preparation. In agarose gel, TAE buffer allows the DNA run smoothly through the gel by 
optimizing the pH and ion concentration of the gel. TAE buffer contains Tris base, acetic acid and 
EDTA, at pH 8.0. The Tris-acetate is used to maintain a consistent pH. The EDTA chelates divalent 
cations (mainly Mg2+), as Mg2+ can activate nucleases for DNA degradation and binds DNA 
resulting in precipitation. TBE buffer uses boric acid in place of acetic acid. DNA sequences move 
faster in TBE buffer, but it can be easily exhausted. 
In this case, we used 1.5 % agarose (Euromedex) gel with 1× GelRed, and melted with 1× TAE 
buffer. The mixture was heated up with microwave oven until the solution was transparent (agarose 
was melted), and then cooled down to around 50°C. Then the mixture was poured into the gel 
casting apparatus (with combs) kept in flat position, without bubbles. After 10-15 minutes when the 
gel solidifies, the combs and the end-pieces were removed. The gel was then placed into the 
electrophoresis bath chamber and submerged in 1× TAE buffer. The PCR samples were loaded into 
the gel, including at least one 100bp DNA ladder (Thermo Scientific) for the wells on the same 
plane. The electrophoresis was run at 160V for 1-1:30 hours. In the end, the bands were visualized 
by UV transmission on a reader. The band at ~300 bp is the wild-type RyR, and at ~400 bp is 
knock-in RyR. If there are 2 bands, the mouse has both alleles and is heterozygote. 
2.3 Telemetry  
In order to analyze the basal electrocardiogram (ECG) and arrhythmia we used a telemetry 
method, which allows us to record ECG in awake animals and avoids the effects of anesthesia. 
2.3.1 ECG and telemetry 
The electrocardiogram (ECG) is a graphical, accurate and composite record of the electrical 
activity generated by the heart (see Introduction), recorded through the electrodes on the body 
surface. ECG is used to depict the electrical function of the heart.  
While it is possible to measure ECG in humans in awake conditions, for animal recordings, 
mostly rodents, it needs anesthesia to immobilize the animal. This may perturb the ECG. Thus we 
have used a telemetry system, which implant the transmitter (7 ETA-F10) subcutaneously in the 
animal during surgery. After one week recovery, the ECG can be recorded in awake animals. As it 
transmits the data to receiving equipment without contact, the data can be continuous monitored in 
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the cage when mice are placed over the receiver. The telemetry monitoring system normally has 3 
electrodes or 5 electrodes, including one electrical ground. Even through the 2 electrodes telemetry 
like in our case, all the leads still can be positioned by the positive electrode and the negative 
electrode.  
Before the surgery, sterilization of ECG transmitters was needed. The transmitters were soaked 
by Actril® cold sterilant for a minimum of 5.5 hours at room temperature. They were thoroughly 
rinsed in sterile saline at least 3 times until no residues left, detected by detector strips provided by 
Actril manufacturer. The sterile transmitters were then soaked in sterile saline for minimum of 5.5 
hours up to 48 hours. If the transmitters will not be reused after 48 hours, it should be air dried at 
room temperature and stored at dry place. After dry storage, re-sterilization might be necessary. 
During the subcutaneous implantation of ECG transmitter, the mouse (4 to 9 month old) was 
placed in an isoflurane (2.5%) inhalation apparatus for anesthesia induction. Then, the animal was 
placed on a warm pad fitted with a device to provide a continuous flow of 1.5% isoflurane in 0.5 
L/min oxygen for maintenance during surgery. 
On the abdomen (Figure 26) or on the dorsum of the mouse, a midline incision was made in the 
skin to free a subcutaneous pocket for placing the transmitter. The ECG electrodes were positioned 
as the lead ІІ configuration (Figure β6). The electrode with white sheath was placed on the upper 
right chest, and the one with red sheath was placed on the left side of the abdomen below the 
diaphragm. If the transmitter was placed on the abdomen, a blunt scissor was used to detach the 
skin from the muscle from the incision until the final electrode sites. Then, the electrodes were 
anchored to the underlying muscle/peritoneal tissue by suture to make a good electrical contact. 
When the transmitter was placed on the dorsum, two incisions on the position where the electrodes 
should be placed were cut, and two tunnels from the dorsal incision until each electrode incision 
were made. And then, the electrodes were pulled through the tunnels and anchored. The incision 
was closed by suture. During the surgery, tissue was maintained wet by the sterile saline. 
Betadine was applied to the wound. Post-operative analgesia was provided in the drinking water 
(0.5 ml of Ibuprofene syrup for 100 ml of water) for 24 hours. 
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Figure 26 Telemetry implantation on the abdomen of the mouse with proper positive and negative electrode sites. 
(Adpated from McCauley and Wehrens, 2010) 
At least one week after surgery, basal and challenged ECGs were recorded. Basal ECGs were 
recorded during day and night time. The animals were kept in a cycle of 12 hours light (from 8 to 
20h) and 12 hours dark. We analyzed separately day time (rest time for mice, because they are 
nocturnal) and night time (activity period). The first hour of each light change was discarded. 
In order to see if our RyR2R420Q mice carry the CPVT phenotype, animals were injected with 
epinephrine (2mg/kg) plus caffeine (120mg/kg), which is the typical CPVT test for mice, as this 
species is resistant to arrhythmia.465 ECGs were recorded from 5 minutes after i.p. injection (for 
letting even body distribution), until at least two hours after injection for full response. 
We also analyzed ECG response to sympathetic and parasympathetic stimulation. For 
sympathetic challenge we injected isoprenaline (ISO, Sigma, 1 mg/kg i.p., in sterilized saline 
solution, freshly prepared). For parasympathetic challenge, we injected carbachol (CCH, Sigma, 
0.25 mg/kg i.p., in sterilized saline solution, freshly prepared), which is a cholinergic receptor 
agonist, more stable than acetylcholine. Before ISO/CCH injection, a ten to thirty minutes recording 
was necessary as baseline before ISO/CCH injection. The ECGs were recorded at least two hours 
after injection for full response.  
At the end of the experiments, mice were sacrificed and the ECG transmitters were extracted for 
reuse. Upon extraction, all possible attached tissue and sutures were gently removed. Then, the 
transmitters were rinsed with water. Attached tissues rests were dissolved in a 1% (w/v) solution of 
Terg-A-Zyne® for a minimum of 4 and maximum of 72 hours at room temperature. After thorough 
rinse, the transmitters were air dried at room temperature and stored in a dry place.  
2.3.2 ECG analysis 
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Figure 27 A normal human ECG waveform. The PR interval goes from the beginning of the P wave to the beginning of 
the QRS complex, while the QT interval is from the beginning of QRS complex until the end of T wave. The PR 
segment goes from the end of P wave until the beginning of Q wave, and the ST segment is between the end of S wave 
and the beginning of T wave. (Adapted from http://en.wikipedia.org/wiki/Electrocardiography) 
The ECG waveform is shown in Figure 27. The electrical activity is initiated from SAN as 
mentioned previously. It spreads across both right and left atrium, and induces the atria 
depolarization. This process corresponds to P wave on ECG (Figure 27). Then the impulse goes 
through the AV node, which corresponds to PR segment, a flat line following the P wave (Figure 
27). The PR interval represents the duration from the beginning of atrial depolarization until 
ventricular depolarization. After that, the impulse travels to His bundle, bundle branches and 
Purkinje fibers, inducing ventricular depolarization. On the ECG, it is represented by QRS complex 
(Figure β7). Meanwhile, the atrial repolarization occurs, although it’s buried in QRS complex. The 
Q wave depicts the septum depolarization, from left to right. When the depolarization travels 
throughout the ventricles, the R wave and S wave show up. Then another flat line, ST segment 
(Figure 27), indicates no large electrical vector, while ventricle is contracting. The ventricle 
repolarization represented by T wave (Figure 27). As the enpicardial cells repolarize before the 
endocardial cells, the T wave reflects positively.   
For ECG analysis, all the recordings were analyzed firstly with ECGauto (version 3.3.0.5). 
Heart rate (RR, duration of adjacent R waves), PP (duration of adjacent P waves), PR interval and 
QT interval (Figure 27) were quantified. The preliminary data was further statistically analyzed by 
Origin (9.0). QTc (QT interval corrected to heart rate) and heart rate variability (HRV), including 
SDNN, RMSSD and pNN6, were also evaluated.627-630 SDNN stands for standard deviation of all 
consecutive normal R wave intervals.628-630 RMSSD is the square root of the mean of the sum of the 
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squares of differences between adjacent normal R wave intervals.628-630 PNN6 is the percentage of 
normal consecutive R-R intervals differing by greater than 6 ms (%).629 QTc, SDNN and RMSSD 
are shown in the following formulas.  
QTc = QT / [(RR/100)1/2] 
 
 
2.4 Ca2+ handling recording by confocal microscopy 
To evaluate Ca2+ ions dynamics, the SAN tissue was dissected, loaded with fluorescent Ca2+ 
dye and recorded by confocal microscope. Their principles and protocols are introduced below.  
2.4.1 SAN dissection 
The mice were anaesthetized by i.p. injection of around 100 mg/kg Na pentobarbital (Ceva 
Sante Animale) with 50U heparin (Sigma) to avoid blood coagulation. When the mouse lost 
consciousness and failed to respond to leg pinch, we opened its chest extracted the heart into 
oxygenated Tyrode solution (Table 2). Tyrode solution is widely used as a physiological bathing 
medium to reproduce the extracellular environment in vivo. It mimics the ionic composition and pH 
of blood. Its composition is shown in the following table, and the pH is buffered with Hepes. For 
SAN dissection, heparin (50 U/ml) was also added into tyrode solution as anticoagulant. 
Table 2 Tyrode solution. 
Product Concentration (mM) 
NaCl 140 
KCl 5.4 
CaCl2·2H2O 1.8 
MgCl2·6H2O 1 
Hepes 5 
D-glucose 5.5 
pH 7.4 with NaOH 
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The heart was fixed onto a homemade silicon dish in posterior position under binocular lenses. 
Ventricles were discarded and the right atrium was fixed, and SAN was exposed between superior 
vena cava and inferior vena cava. Then the tissue was moved and fixed to the bottom of the 
homemade dish for confocal microscope recording as shown in Figure 28. It was irrigated with 
37C tyrode solution during all the procedures.  
 
Figure 28 Photograph of typical preparation and SAN location on a homemade dish. SAN, sinoatrial node; SCV, 
superior vena cava; RA, right atrium; ICV, inferior vena cava; LA, left atrium.   
2.4.2 Ca2+ handling recording by confocal microscopy 
 
Figure 29 Jablonski energy diagram of fluorescence. (Adapted from https://www.thermofisher.com ) 
To visualize the Ca2+ dynamics in SAN cells, the SAN was loaded with fluorescence Ca2+ dye 
Fluo-4. Fluorescence is the emission of light produced by some molecules which have the property 
to absorb energy and emit energy in the form of photons. During the excitation, the electron of the 
molecule goes into an excited electronic state (Figure 29). It firstly dissipates a bit of energy due to 
molecular vibrations, and then loses the remaining energy and returns to the ground state by 
emitting light (fluorescence, Figure 29). Thereby the emitted light has lower energy than the 
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absorbed energy, and concomitantly longer wavelength. Thus, the emitted fluorescence can be 
distinguished from the excitation light. The excitation and emission of molecule is cyclical, which 
means it can be excited repeatedly until irreversibly damaged.  
 
Figure 30 Fluorescent excitation (blue) and emission (red) spectra of Fluo-4. (Adapted from 
https://www.thermofisher.com/order/catalog/product/F14201 ) 
Fluo-4 AM is a calcium indicator used to analyze the spatial dynamics of Ca2+ ions. It displays 
high sensitivity to Ca2+ and large fluorescence increase upon excitation (Figure 30). Fluo-4 is 
excited at peak 488 nm (Figure 30), and the fluorescence is emitted between 500 and 650nm. The 
Fluo-4 AM (acetomethil esther) is a cell permeable form. The AM ester helps the Fluo-4 pass 
through the lipid membrane and enter the cell. Once inside the cell, esterases in the cytosol cleave 
the AM residue and release the active Fluo-4. Fluo-4 is only fluorescence when bound to Ca2+. 
In this work, we dissolved Fluo-4 AM in DMSO with 20% Pluronic acid.458 Pluronic acid was 
used to prevent aggregation of Fluo-4 AM and help uptake by the cell. Fluo-4 AM was loaded to 
the fixed SAN tissue at concentration of 30μM (diluted by Tyrode solution) for 1h at 37C on a 
shaking device. After Fluo-4 AM incubation, the SAN tissue was loaded with Tyrode solution 
contained Blebbistatin (2.5μM or 5μM, Sigma) or cytocalasin D (50μM) at least 10 mins before 
recording to avoid contraction artifacts. Blebbistatin (2.5μM or 5μM) or cytocalasin D (50μM) were 
used to inhibit contraction by inhibition of myosin and actin, respectively. 
To evaluate Ca2+ dynamics in SAN cells, the SAN tissue was detected under confocal 
microscopy after Fluo-4 AM loading. Confocal microscopy is one of the fluorescence microscopies 
with a pinhole to eliminate out-of-focus light away from the focal plane, which provides possibility 
for high-quality images recording of fixed or living cells and tissues.  
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Figure 31 The diagram of a confocal microscopy. (Adapted from http://www.olympusconfocal.com/theory/ ) 
A confocal microscope contains laser for excitation source, the beam splitter, the detector 
pinhole with variable aperture, and the detector (Figure 31). The laser emitted by the laser 
excitation source passes through the excitation filter, and it is reflected by the beam splitter mirror 
with a scanning head to scan across the specimen. It directs to a point of fluorophore-labeled 
specimen, and scans across the specimen in a defined focal plane. The labeled specimen then emits 
fluorescence, which passes back through the beam splitter mirror and toward the pinhole aperture 
(termed detector pinhole aperture in Figure 31). The mirror is chosen to match the spectral 
excitation and emission characteristics of the fluorophore. The pinhole aperture is positioned in 
front of the detector to select the emitted fluorescence from the focal plane of the specimen, and 
excludes lights emmited from the above and below planes (termed out-of-focus light rays, Figure 
31). Thus the emitted fluorescence becomes confocal through this pinhole aperture, and then 
detected by the detector. Only a small fraction of the out-of-focus fluorescence emission is 
delivered through the pinhole aperture, most of this extraneous light is not detected and does not 
contribute to the resulting image. The confocal microscope equipped with a resonant scanning 
mirror can generate the necessary speed of 8000 Hz for ultrafast time imaging.  
In this work, SAN cells were recorded under a resonant scanning confocal microscope (Leica 
SP5) equipped a white laser that we tuned to 500 nm, and from different regions of the SAN as 
basal condition. To visualize the response of each compound, SAN perfused with the compound 
(such as ISO 20nM, CCH 500nM, etc) for around 10 min. Then the same SAN cells recorded in the 
basal condition were recorded again. Both line-scan images and 2D images are captured, at a 
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scanning speed of 8000 Hz. In order to get better signal to noise, 2 line average were used, thus the 
final speed was 0.25 ms per line. A small window of only one cell was used in the 2 D images to 
optimize the time between 2 consecutives images. All the recordings are performed at 37C. The 
fluorescent emission is collected between 500 and 700nm.  
2.4.3 Confocal microscope recording analysis  
Line-scan images were quantified by IDL (8.2) with homemade programs, and statistically 
analyzed by Origin (9.0). Characteristics of [Ca2+]i transients, including time to peak (ms), 
amplitude (maximum value of F/F0, where F is the fluorescence signal and F0 the fluoredscence on 
diastolic period) and decay time constant (tau, time constant obtained by fitting the descending 
portion of the fluorescence trace to a single exponential function, in ms), were quantified. 
Characteristics of [Ca2+]i sparks during diastolic periods were also quantified (Figure 32), including 
spark frequency (number of sparks/s/100μm), width at half maximum (W50, μm), time to peak (ms), 
duration at half maximum (D50, ms) and peak amplitude (F/F0).  
 
Figure 32 Ca2+ spark characteristics. The up-left image shows a line-scan image recorded by confocal microscope. 
The up-right image corresponds the 250ms depicting in the up-left image, while the linear trace on its right shows the 
spatial profile in the blue bracket indicating the W50 of the spark. The down-right image presents the time profile of two 
sparks, and the peak (black arrow), D50 (green arrow) and time to peak (red arrow) of the upper spark.  
Global calcium transients of 2D images were quantified using a Region of Interest (ROI) 
covering the whole cell and further analyzed by Origin (9.0), while the mean cycle length (duration 
between the peaks of two transients) was measured.  
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2.5 Protein measurement 
To measure the channel expression, we extracted protein from SAN and performed western 
blot.  
Protein extraction is the sample preparation step for western blot. In this step, the protein is 
brought into solution by breaking the tissue or cells, such as homogenization. Lysis and extraction 
buffer is also used to efficiently lyse cells or tissue, increase protein solubilization, and avoid 
protein degradation. In this work, we used RIPA buffer. RIPA buffer (radioimmunoprecipitation 
assay buffer) is a lysis buffer, commonly used for whole cell extracts and membrane-bound 
proteins. RIPA buffer contains Tris HCl pH 8, NaCl, phosphatase inhibitor, protease inhibitor, 
Triton X100, DOC (sodium deoxycholate acid), SDS (Table 3). Tris HCl acts as buffer providing an 
ionic environment similar to that of the cell in vivo and maintaining the protein stability. NaCl 
maintains or increases the strength of the ionic medium and detergents, to dissolve the cell 
membranes and concomitantly facilitates the release of proteins. Phosphatase inhibitor and protease 
inhibitor are used to avoid the protein degradation. DOC, SDS and Triton X-100 are detergents, 
which are used to lyse cells, solubilize proteins and lipids, etc. DOC and SDS could denature and 
solubilize the protein, and Triton X100 facilitates lysis.  
Table 3 RIPA buffer: 
 [stock] [final] 10 ml 5 ml 
Tris HCl pH 8 1 M 50 mM 500 μl β50 μl 
NaCl 3 M 150 mM 500 μl β50 μl 
Phosphatase inhibitor Tablet PhosSTOP, Roche (1 for 5 ml) 
Protease inhibitor Tablet Complete, EDTA free, Roche (1 for 5 ml) 
Triton X100 100% 1% 100 μl 50 μl 
DOC (sodium 
deoxycholate acid) 
10% 0.5% 50 μl β5 μl 
SDS 10% 0.1% 100 μl 50 μl 
H2O   8.75 ml 4.375 ml 
The hearts were dissected on ice, and SAN tissues were cut out. The tissues can be used 
immediately or stored at -80C for later use. To extract protein, the tissue samples were placed into 
Bertin tubes with beads and RIPA buffer (50-75μl for each sample), and homogenized Bertin 
homogenizer (program: 6500rpm x 10sec, 2 cycles). Then the samples were centrifuged at 4°C 
3000 rpm for 1 minute. The lysates can be used immediately, or frozen at -80°C for later use. 
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The concentration of cell/tissue lysate protein could be measured by many methods, such as 
BCA assay, Lowry protein assay, etc. In this work, we used BCA assay. BCA assay is a high-
precision method, which detects the color change of the sample solution from green to purple in 
proportion to protein concentration, and compares to protein standards. The peptide bonds of 
protein reduce the cupric ions (Cu2+) to cuprous ions (Cu+) in an alkaline environment at a higher 
temperature (37 to 60C). Then two BCA molecules chelate one Cu+ forming an intense purple 
complex, which has a strong linear absorbance at 562nm with the increase of protein concentration. 
The protein concentration of the sample is determined by comparing this absorbance with a 
standard curve of absorbance from varying bovine serum albumin (BAS).  
In this work, we used 96-well flat-bottom plate to perform the BCA. Different BSA 
concentrations were used to make absorbance curve (γ0, β5, β0, 15, 10, 5, β.5, 1.β5 μg). Each 
sample (β μl) was mixed with 98 μl H2O and 100 μl smart BCA solution (contains 98 μl solution A 
and β μl solution B, iNtRON Biotechnology). Samples were performed in triplicate. The plate was 
then wrapped with aluminum, incubated at 60°C for 20-30 min, and read by TECAN instrument. 
The protein concentration was calculated by comparing the absorbance with the standard curve, and 
β0 to 40μg of total protein was used for western blot.  
To detect and quantify specific proteins, we used western blot. Western blot uses gel 
electrophoresis to separate proteins by their molecular weight, and then transfers the proteins to a 
membrane, where the specific protein could be stained by targeting antibody.  
Before running the gel, the lysate protein was loaded with loading buffer. Loading buffer 
contains anionic denaturing detergent SDS to denature proteins and make them negatively charged. 
SDS removes the secondary and tertiary structure, which facilitates the protein separation by 
molecular weight and the following binding with antibody. Meanwhile, the proteins are negatively 
charged via attachment to the SDS, with equal charge-densities per unit length as SDS binds to the 
majority of proteins at a constant ratio of 1.4mg SDS/gm protein. -mercaptoethanol and 
dithiothreitol (DTT) are reducing agents used to break disulphide bonds. Glycerol is added to the 
loading buffer to increase the density of the sample, making the sample easier to load and 
maintaining at the bottom of the well. A small anionic dye molecule (e.g. Bromophenol blue) is also 
used to track the migration of protein. Since it is anionic and small, it migrates faster than proteins 
to provide a migration front and monitor the running progress. Loading buffer also contains Tris 
HCl pH 6.8, which is the same as stacking gel buffer. In this thesis, we used the loading buffer 
produced by Sigma.  Boiling/heating is also useful to denature the protein. The temperature and 
heating duration depends on the protein. For NCX, the protein was heated at 37°C for 10 min. For 
HCN4, the protein was heated at 95 °C for 10 min, and for RyR2, the protein was not heated at all.  
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Then, the anionic protein is fractionated on SDS-PAGE (Sodium Dodecyl Sulfate 
PolyAcrylamide Gel Electrophoresis) gel. The gel is a sieving electrophoresis matrix formed by 
three-dimensional networks of long hydrocarbons crosslinked by methylene groups. The gel is 
made of acrylamide, bis-agrylamide, denaturant (such as SDS), a buffer with adjusted pH, and 
TEMED and APS to initiate polymerization. During electrophoresis, proteins move through the 
pores of the gel, and are separated based on the molecular weight. Larger molecules pass through at 
slower speeds and migrate less than smaller molecules. The pore size of a gel is determined by the 
percentages of acrylamide and cross-linker (bis-acrylamide). A lower percentage gel provides 
bigger pore size, and is better for resolving higher molecular weight molecules. Normally, a 
conventional gel is formed by two sections, the running gel on the bottom and the stacking gel on 
the top. The stacking gel has a lower acrylamide concentration to ensure the proteins enter the gel. 
The stacking gel also is prepared with low pH buffer to provide a lower ionic strength, which lines 
the proteins up at the starting line. The running gel has a higher acrylamide concentration and 
higher pH to separate the proteins. In this thesis, the conventional gel was chosen according to the 
size of the targeted protein (Table 4), and prepared as follows: the ingredients of the running gel 
were mixed and added into the gel apparatus reached to around ¾ of total volume, while the rest of 
cast was filled with water (creates level, removes bubbles); When the running gel polymerized, the 
stack gel prepared as Table 4 was added to the cast after removal of water. It can be used ~20 min 
later after polymerization started. This conventional gel was used for separation of NCX1 (8%).  
Gradient and discontinuous gradient running gels are also widely used to separate proteins with 
broader range of molecular weight. In this work, the homemade discontinuous gradient gel was 
prepared as follows: every acrylamide solutions were made as Table 5, and added to the gel 
apparatus from 20% to 4% before polymerization, and the two solutions mixed at the interface as 
the gradient process. The discontinuous gel was used for RyR2 and HCN4 protein separations. 
Table 4 Stacking and running gels: 
 Component volumes (in ml) per indicated amount of gel 
6% (very large proteins) 10 ml 20 ml 30 ml 40 ml 50 ml 
H2O 5.3 10.6 15.9 21.2 26.5 
30% acrylamide mix 2 4 6 8 10 
1.5 M Tris (pH 8.8) 2.5 5 7.5 10 12.5 
10% SDS 0.1 0.2 0.3 0.4 0.5 
10% ammonium persulfate (APS) 0.1 0.2 0.3 0.4 0.5 
TEMED 0.008 0.016 0.024 0.032 0.04 
8% (large proteins) 10 ml 20 ml 30 ml 40 ml 50 ml 
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H2O 4.6 9.2 13.8 18.4 23 
30% acrylamide mix 2.7 5.4 8.1 10.8 13.5 
1.5 M Tris (pH 8.8) 2.5 5 7.5 10 12.5 
10% SDS 0.1 0.2 0.3 0.4 0.5 
10% ammonium persulfate (APS) 0.1 0.2 0.3 0.4 0.5 
TEMED 0.006 0.012 0.018 0.024 0.03 
10% (medium size proteins) 10 ml 20 ml 30 ml 40 ml 50 ml 
H2O 4 8 12 16 20 
30% acrylamide mix 3.3 6.6 9.9 13.2 16.5 
1.5 M Tris (pH 8.8) 2.5 5 7.5 10 12.5 
10% SDS 0.1 0.2 0.3 0.4 0.5 
10% ammonium persulfate (APS) 0.1 0.2 0.3 0.4 0.5 
TEMED 0.004 0.008 0.012 0.016 0.02 
12% (small proteins) 10 ml 20 ml 30 ml 40 ml 50 ml 
H2O 3.3 6.6 9.9 13.2 16.5 
30% acrylamide mix 4 8 12 16 20 
1.5 M Tris (pH 8.8) 2.5 5 7.5 10 12.5 
10% SDS 0.1 0.2 0.3 0.4 0.5 
10% ammonium persulfate (APS) 0.1 0.2 0.3 0.4 0.5 
TEMED 0.004 0.008 0.012 0.016 0.02 
15% (very small proteins) 10 ml 20 ml 30 ml 40 ml 50 ml 
H2O 2.3 4.6 6.9 9.2 11.5 
30% acrylamide mix 5 10 15 20 25 
1.5 M Tris (pH 8.8) 2.5 5 7.5 10 12.5 
10% SDS 0.1 0.2 0.3 0.4 0.5 
10% ammonium persulfate (APS) 0.1 0.2 0.3 0.4 0.5 
TEMED 0.004 0.008 0.012 0.016 0.02 
5% (stacking gel) 3 ml 6 ml 9 ml 12 ml 15 ml 
H2O 2.1 4.2 6.3 8.4 10.5 
30% acrylamide mix 0.5 1 1.5 2 2.5 
1 M Tris (pH 6.8) 0.38 0.76 1.14 1.52 1.9 
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10% SDS 0.03 0.06 0.09 0.12 0.15 
10% ammonium persulfate (APS) 0.03 0.06 0.09 0.12 0.15 
TEMED 0.003 0.006 0.009 0.012 0.015 
Table 5 Discontinuous gradient gel: 
 20%(3ml) 16%(3ml) 12%(3ml) 8%(3ml) 4%(3ml) 
40% acrylamide (ml) 1.5 1.2 0.9 0.6 0.3 
1.5M Tris pH 8.8 (ml) 0.75 0.75 0.75 0.75 ---- 
1M Tris pH 6.8 (ml) ---- ---- ---- ---- 0.38 
10% APS (ml) 0.03 0.03 0.03 0.03 0.03 
TEMED (ml) 0.0012 0.0012 0.0012 0.0012 0.003 
H2O (ml) 0.7 1 1.3 1.6 2.3 
When the gel was polymerized, it was removed to the gel running apparatus which was filled 
with running buffer (Table 6). Protein ladder (5 μl, Euromedex) and samples were loaded in the 
wells. The generator was run at 80 V for 30 min, and then at 120 V for 1:30 h.  
Table 6 10 Running buffer: 
Tris-Base 150 g 
Glycine 720 g 
SDS 50 g 
H2O deionized to 5 liters final volume 
After running the gel, the proteins were transferred from the gel to a nitrocellulose or 
polyvinylidene difluoride (PVDF) membrane. This step uses an electric current to pull proteins 
from the gel into the membrane. When an electric field is applied across the gel, the negative 
charged proteins migrate from the negative electrode and towards the positive electrode, hence from 
the gel to the membrane. The proteins bind to the membrane through the non-specific hydrophobic 
interactions. In this thesis, PVDF membrane was used. The membrane was soaked in methanol for 2 
minutes, followed by 5 min wash in deionized water and at least 5 min in transfer buffer (Table 7) 
at 70 rpm agitation. Whatman (filter) papers were also cut to correct size, 2 pieces per gel. Then in 
the transfer buffer, the transfer apparatus was assembled (black/white board in this case) as follow: 
Black board on bottom, sponge, filter paper, gel, membrane (hydrophobic side away from gel), 
filter paper, sponge and the white board on the top. The transfer apparatus was then inserted into 
transfer box with ice, and transfer in cold room at 110 V for 1.5 hours. Then, the membrane was 
took out and cut to separate targeted protein and housekeeping protein according to the ladder, and 
rinsed separately in TTBS (TBS with 1% Tween, Table 8).  
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Table 7 10 Transfer buffer: 
Tris-Base 150 g 
Glycine 150 g 
H2O deionized to 5 liters final volume 
Table 8 10 TBS: 
Tris-Base 121 g 
NaCl 1461 g 
H2O deionized to 5 liters final volume 
Adjust pH to 7.4 with Tris 
Then, to avoid the hydrophobic binding between the membrane and the antibodies, the 
membrane was blocked by BSA or non-fat dry milk in TBS solution, with a low concentration of 
detergent (such as Tween 20 or Triton X-100) to prevent unspecific protein-protein interaction. In 
this work, the membranes were incubated in 5% milk solution (in TTBS), agitated at 35 rpm for 45-
50 min.  
At last, the membrane was incubated with the primary antibody which binds to the specific 
protein, and then the labeled secondary antibody which binds to the first antibody. Both antibodies 
were diluted in 5% milk TTBS solution. Through the second antibody, the specific protein is 
detected. The second antibody is commonly labeled with horseradish peroxidase (HRP). HRP is an 
enzyme which oxidizes the chromogenic, fluorogenic, and chemiluminescent substrates that 
produces colored, fluorimetric or luminescent derivatives, respectively. In this work, the membrane 
was incubated with the primary antibody overnight at 4°C, 35 rpm. The next morning, the first 
antibody was collected for reuse (it can be used 3 times) and frozen at -20°C. The membrane was 
washed with TTBS (at 70 rpm, 3x 10 min), and incubated with the secondary antibody for 1h at 35 
rpm, and after, washed in TTBS as previously (at 70 rpm, 3x 10 min).  
Antibodies for HCN4 (trial sample from Alomone Labs, APC-052, 200, anti-rabbit), NCX1 
(Swant, R3F1, 1000, anti-mouse), RyR2 (ThermoFisher Scientific, MA3-916, 1000, anti-mouse), 
S2814 phosphorylated RyR2 (Badrilla, A010-31AP, 2000, anti-rabbit), S2808 phosphorylated 
RyR2 (Badrilla, A010-30AP, 2000, anti-rabbit), GAPDH (Abcam, 2000, anti-rabbit) were 
prepared with 5% milk in TTBS. The matched secondary antibodies (Santa Cruz Biotechonology) 
were also diluted from 10000 stock with 5% milk in TTBS. 
To visualize the protein, the membrane was placed on the plastic sheet, and loaded with the 
substrate (Classico, Crescendo, Forte or Femto Luminata Western Substrates, Millipore and Thermo 
Scientific) depending on the quantity of the proteins. Classico was used for high signals, and femto 
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was used for the lowest signals. After 5 minutes incubation at room temperature, the substrate was 
removed by pressing the plastic sheet with paper to clear the substrate. The membrane was exposed 
and visualized by the chemiluminiscence appropriately. After saving the images, the membrane was 
rinsed and washed with TTBS for around 5 minutes, and sealed to clean plastic sheet. Membranes 
can be stored at 4°C, and reused for re-blotting of other proteins. 
To re-blot the protein, we rinsed the membrane with 1 Re-blot Plus Strong solution (Millipore, 
10, in water), followed by blocking, first/second antibody incubation, and so on.  
The western blot images were quantified with Image J, and further statistically analyzed by 
Origin (9.2).  
2.6 SAN cell dissociation and patch clamp (Performed by Pietro Mesirca) 
To identify the properties of the action potential, L-type Ca2+ current, funny current, caffeine-
induced current in single cell, SAN cells were dissociated and performed patch clamp.  
2.6.1 SAN cell dissociation 
In SAN cell dissociation, several solutions are needed. Low Ca2+ solution is used to prevent cell 
contraction and destabilize cell-cell adhesion. Enzymatic solution is used to digeste the tissue and 
break down the extracellular matrix. A Ca2+-free, Na+-free and high-K+ solution, Kraftbrühe (K-B) 
solution, is used to maintain the resting state and wash out the enzyme, and followed by mechanical 
separation to collapse the tissue. At the end, Ca2+ should be recovered by progressively increasing 
the Ca2+ concentration, while another solution (10 μM NaCl and 1.8 μM CaCl2 in water) and BSA 
in Tyrode solution (1mg/mL, Table 2) are used.  
2.6.2 SAN cell patch clamp (Performed by Pietro Mesirca) 
Patch clamp was developed by Erwin Neher and Bert Sakmann (in 1976) as an 
electrophysiological technique for single channel study, through a glass pipette with a small 
opening. The resulting electrical current can be measured through an electronic amplifier connected 
to the pipette, and another electrode placed in the bath as a ground electrode. Today, technical 
modifications have enhanced the patch clamp technique, and several common variations of the 
patch clamp method have been applied (Figure 33), such as cell-attached recording, whole cell 
recording, inside-out recording, outside-out recording, etc.631  
Cell-attached patch uses the pipette to tightly contact with the cell membrane. The pipette is 
sealed onto the membrane after a light suction from the back of the pipette (Figure 33), which 
ensures that no ions flow through the seal. Via the pipette, the single, or a few, ion channels on the 
connected patch of the membrane are monitored, i.e. the currents flowing through the channels are 
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recorded by the electrode in the pipette. This method attaches to the exterior of the cell membrane 
without influencing the interior, recording the channel behavior under physiological conditions.  
In the whole cell recording, the membrane patch within the pipette in the cell attached method is 
disrupted by a briefly applied strong suction (Figure 33). The pipette is then directly connected with 
the cell cytoplasm, and records the electrical potentials and the currents through multiple channels 
over the entire cell membrane. Therefore, whole cell patch could be used to study the electrical 
behavior of the entire cell.  
 
Figure 33 The variations of patch clamp. A shows cell-attached recording, and panel B shows whole cell recording, 
while C and D show outside-out patch and inside-out patch. (Adapted from http://www.bem.fi/book/04/04.htm ) 
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The outside-out patch and the insie-out patch also exist to measure the channel behavior in 
different extracellular/cytoplasmic medium by changing the bathing solution (Figure 33).  
2.7 Statistics 
Values were expressed as mean±s.e.m. Student’s t-test and ANOVA were used to assess 
significant differences. A value of p<0.05 was considered significant. 
2.8 Materials 
Sodium deoxycholate (DOC), sodium dodécyl sulfate (SDS), DMSO, calcium chloride 
dihydrate (CaCl2·2H2O), magnesium choride hexahydrate (MgCl2·6H2O) and hepes were purchased 
from Sigma. TEMED, acrylamide/bisacrylamide 30%, Tris (hydroxymethyl) aminomethane, 
sodium chloride (NaCl), potassium chloride (KCl) and D-glucose were from Euromedex. 
Ammonium Persulfate (APS) was from Carlo Erba. 
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Chapter 3 Results 
During my Ph.D., I have focused on SAN Ca2+ regulation in a mice model bearing the 
RyR2
R420Q mutation found in a CPVT family. The resulting manuscript constitutes the first part of 
this thesis.  Some of the results that I have obtained in this work are not included in the manuscript 
and they are under “Additionnal Data”. During the time spend in the laboratory I have also 
participated in a sutudy of Ca2+ sparks in a mice model of myocardial infarction. This work has 
been recently published, but as my participation was partial, I have added de manuscript in the 
anexe, at the end of the thesis. Because during my thesis work, I was studing Ca2+ handling in mice 
SAN and its response to isoproterenol, I did a work on the modulation of SAN Ca2+ handling by the 
cAMP effector Epac. This manuscript, that is well advanced, and where I will be first co-author 
with Anna Llach, still requires few experiments. As this thesis is focused on CPVT, I choosed not 
to add these data.  
3.1.1 Manuscript 
Mechanisms of bradycardia in RyR2
R420Q Catecholaminergic Polymorphic Ventricular 
Tachycardia mutation 
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Cathecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited disease 
manifested as syncope or sudden death in children and young adults under stress 
conditions. CPVT often presents bradycardia and sinoatrial node (SAN) dysfunction. To 
identify the underlying mechanism, we created a knock-in (KI) mice model carrying a novel 
CPVT- mutation, RyR2
R420Q. ECGs recorded in KI mice showed sustained bidirectional 
ventricular tachycardia after epinephrine/caffeine challenge, validating the model. KI mice 
presented slower heart rhythm, and junctional escape beats after β-adrenergic stimulation, 
denoting alteration in SAN function. Spontaneous [Ca2+]i transients rate was slower in KI 
SAN preparation than in wild type (WT), without any significant alteration in the funny 
current. L-type Ca2+ current (ICa) was depressed in KI SAN cells, dependent on intracellular 
Ca2+. [Ca2+]i transients amplitudes were significantly smaller, consistent with reduced 
sarcoplasmic reticulum (SR) Ca2+ load. This was consistent with higher leak through 
RyR2
R420Q. In fact, the presence of local Ca2+ release was significantly higher in KI SAN cells. 
Ca2+ sparks frequency between spontaneous beats was slightly increased in KI SAN cells, 
and their duration was dramatically prolonged. These data showed that RyR2
R420Q mutation 
increases the diastolic Ca2+ leak by producing prolonged Ca2+ sparks, evidencing a new 
mechanism in CPVT which depresses spontaneous activity.  
 
 
 
 
 
3 
Cathecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited heart 
disease manifested as syncope or sudden cardiac death (SCD) in children and young adults 
under physical or emotional stress1. Although CPVT stands for ventricular arrhythmia, it 
often associates supraventricular (SV) arrhythmias including not only tachyarrythmias (atrial 
fibrillation and atrial flutter) but also bradyarrythmias such as sinus bradycardia caused by 
sinoatrial (SA) node dysfunction 2-4.  These findings may be of paramount importance in 
CPVT patients since severe sinus bradycardia may require that implantable cardioverter 
defibrillator devices (ICD) uses their pacing mode, which consume quicker the ICD battery. 
Moreover SV tachyarrhythmias may trigger inappropriate ICD discharges stressing the 
patients and worsening atrial and ventricular arrhythmias which could lead to SCD 3, 5. In not 
ICD carriers, CPVT patients SV tachyarrhythmias have been also somehow associated to 
ventricular life-threating arrhythmias since they have been registered immediately after 
spontaneous ventricular tachycardia and ventricular fibrillation5. Collectively, these data 
support the idea that non-ventricular arrhythmias are not trivial in CPVT patients. 
Thus, CPVT arrhythmic disorders are not limited to the ventricles, as RyR2 CPVT-related 
mutations are expressed in the entire heart. Indeed, Postma et al2 investigated 13 missense 
mutations in RyR2 in 12 probands, and reported that the RyR2-related CPVT patients exhibit 
bradycardia regardless of the site of the mutation. In keeping with this observation, van der 
Werf et al investigated 160 relatives from 15 families, and observed sinus bradycardia in 
19% of relatives and other supraventricular dysrhythmias in 16%6.  
The heart beat is initiated by the automatic electrical firing of the primary pacemaker, located 
at the sinoatrial node (SAN). SAN cells automatically generate action potentials (AP), which 
are then conducted to the atria and ventricles assuring the coordinated contraction of the 
heart. The mechanism of the automatic AP generation involves several ion currents and 
transporters. While the hyperpolarization activated current, If, plays an important role, 
intracellular Ca2+ is also involved7, 8. Indeed, it has been proposed that rhythmic SR Ca2+ 
release via RyR2 (Ca
2+-clock), together with the sarcolemmal channels such as If and ICa,L 
(membrane-clock), control SAN automaticity. The involvement of RyR2 Ca
2+ release in SAN 
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automaticity has been demonstrated in numerous studies showing that application of 
ryanodine slowed SAN pacemaker activity in different species9-13. In addition, inducible and 
cardiac-specific knockout of RyR2 with acute ~50% loss of RyR2 protein was sufficient to 
cause bradycardia and arrhythmias14.  
 
Mutations in four genes – RyR2, calsequestrin (CASQ2), triadin (TRDN), and calmodulin 
(CALM1) – are known to cause CPVT or related phenotypes of adrenergically induced life-
threatening arrhythmias. Approximately 50 - 65% of CPVT identified mutations are 
autosomal dominant mutations in RyR2. An impaired β-adrenergic SAN response was 
reported by our group in a RyR2-related CPVT mouse model carrying the C-terminal 
RyR2
R4496C mutation, due to an increased Ca2+ sensitivity15. Of note, mutations in other 
regions of the RyR2 protein have not been studied with regard to their SV proarrhythmic 
potential. These CPVT mutations are clustered primarily in three discrete regions of the 
RyR2 protein: the N-terminal (residues 77-466), the central (residues 2246-2534) and the C-
terminal region (residues 3778-4959)16. Thus it is possible that the mechanism underlying 
arrhythmic disorders differs according to the mutation site within the protein. Besides the 
intrinsic defect related to the RyR2 mutation causing SA dysfunction, other mechanisms may 
account for sinus bradycardia, such as a decreased β-adrenergic receptor density and/or a 
reduced presynaptic catecholamine recycling. In the past years, an increased G protein 
coupled receptor kinase type 2 (GRK2) expression in lymphocytes was observed in patients 
with heart failure  mirroring that  what happens at the myocardium; its consequences in the 
failing heart (increased β-adrenergic receptor degradation) directly lead to a loss of β-
adrenergic receptor density and cardiac denervation17. On the other hand, patients with 
arrhythmogenic right ventricular cardiomyopathy, right ventricular outflow tract tachycardia 
and ischemic heart disease have been shown to exhibit left ventricular patchy defects in 
radionuclide distribution which may identify patients at risk of ventricular arrhythmias and 
sudden cardiac death18. Planar or SPECT imaging with  Metaiodobenzylguanidine (MIBG)  
is considered a pharmaceutical suitable for the assessment of the presynaptic portion of the 
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cardiac adrenergic innervation 19 although recently, other techniques have also been used, 
such as PET with11C-labeled norepinephrine analog [11C]-hydroxyephedrine 18. Briefly, 
both β-adrenergic receptor density decrease and heterogeneous sympathetic denervation 
may create a proarrhythmic substrate to contribute to initiating and sustaining arrhythmias 18. 
In this scenario, a given increase in the systemic autonomic tone can trigger a life-threating 
arrhythmia in a denervated hypersensitive myocardium, which may accentuate electric 
heterogeneities of primary arrhythmic conditions 18. 
 
 
We have identified a CPVT mutation in the N-terminal portion, RyR2
R420Q, in a large Spanish 
family, which is associated with bradycardia4. In the present study, we have created and 
characterized the SAN activity of the KI mouse model carrying RyR2 N-terminus mutation 
(RyR2
R420Q). Although CPVT affects both men and women, male CPVT patients have a 
higher risk of cardiac events and lower heart rate2, 20. It is still unclear why the heart rate of 
CPVT men is lower than that in women, and if the severity of this entity (SCD) is related with 
low heart rate. Thus we have separately analysed RyR2
R420Q males and females mice. Those 
parameters without differences stratified by gender were pooled together. Other possible 
mechanisms to explain the presence of sinus bradycardia have been explored in patients 
with the RyR2 mutation and non-affected relatives.  
 
In this study, we generated and analyzed a new mouse model of CPVT, carrying out a RyR2 
mutation in the N-terminus (R420Q) which has been described in different CPVT families 4, 
21. Our data show that this N-terminus mutation alters the Ca2+ homeostasis of SAN cells in 
KI mice. While gender difference may be due to different autonomic tone, we found that the 
mutation affected both sexes similarly, manifesting a slowed heart rhythm in KI SAN. Neither 
a decreased β-receptor density nor a sympathetic denervation could be observed in CPVT 
patients and, thus, did not account for sinus bradycardia associated to the RyR2
R420Q 
mutation. Slow SAN rhythm was associated with an enhanced Ca2+ leak during the diastolic 
period, which unloads the SR of Ca2+ and inactivates the L-type Ca2+ channel, thus affecting 
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both calcium and voltage clocks. The enhanced SR Ca2+ leak in KI cells is produced by 
longer Ca2+ sparks, consisting with abnormally prolonged RyR2
R420Q openings. 
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RESULTS 
We previously identified the RyR2
R420Q mutation in a family of CPVT4. Figure 1A shows an 
ECG presenting burst of bidirectional ventricular tachycardia (BDVT) recorded during 
recovery of an exercise testing in a 57 year old woman, carrier of the RyR2
R420Q   mutation. 
Note a junctional escape beat (JE) and BDVT.  In this family, the presence of sinus 
bradycardia was significantly higher in the RyR2
R420Q carriers than those non carriers4. Here 
we analyzed the averaged heart rate in men and women during rest, before any β-blocker 
therapy. HR was lower in RyR2
R420Q carrier females (Fig.1B). To understand the underlying 
mechanism of the sinoatrial node dysfunction in RyR2
R420Q patients, we created a KI mouse 
model carrying RyR2
R420Q mutation. We analyzed ECGs in free moving KI and littermate WT 
mice by telemetry. After epinephrine/caffeine (2/120 mg/kg) challenge, all KI mice but none 
of the WT presented sustained bidirectional ventricular tachycardia (VT) (Figure 1C, D), 
validating the model. Sinus heart rhythm was analyzed in mice by measuring the PP 
intervals during 24 hours. During night time there were no significant differences between KI 
and WT mice (Males: 103.70 ± 1.58 ms vs. 102.86 ± 2.40 ms, in 10 WT mice and 11 KI 
mice; Females: 97.14 ± 2.62 ms in 10 WT vs. 101.64 ± 1.68 ms in 9 KI). During the day time 
(resting period, where the sympathetic tone is reduced) we found a statistically significant 
prolongation of the PP interval in females KI compared to WT (Figure 1E). Moreover, we 
found that WT females have faster heart rate than males (Figure 1E), reminiscent of human 
data (Figure 1B). We challenged the mice with 2 opposite approaches: either activate the 
sympathetic system by isoproterenol (ISO) (1 mg/kg) injection or inhibit it with 
parasympathetic activation (carbachol, CCH, injection, 0.25 mg/kg). As expected, ISO had a 
positive chronotropic effect (Figure 1F), and CCH had a negative chronotropic effect (Figure 
1G) in all mice. Comparison of WT and KI mice showed higher effect of ISO in female KI and 
of CCH in male KI. Besides this ventricular dysfunction, RyR2
R420Q KI mice presented signs 
of sinus dysfunction after ISO injection, notably evidenced by JEs as shown in the ECG 
example in Figure 1H, and in the pooled data (Figure 1I). As with the presence of 
biventricular tachycardia, no difference was observed between males and females, thus data 
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were pooled together. JEs were also present in RyR2
R420Q humans. Figure 1 J shows 
exercise testing in a 35 year old woman, carrier of the RyR2
R420Q mutation with JEs. 
 
We next explored another trigger, emotional stress, by blowing the mice with warm air from 
a hair-dryer during 15 s followed by 45s rest, and repeated 10 times 22. In Fig. 2A (top) the 
RR intervals of a WT mice are shown during this protocol. Each time the air is blown, the 
heart rate accelerates, and then recovers during the rest periods. With time the animal is 
getting used to the protocol and the positive chronotropic response weakens and even 
disappears. In KI mice the response is different (Fig.2A, bottom). At the end of the protocol 
there is severe sinus dysfunction and a slow ventricular escape rhythm until asystolia is 
established and the mouse died. Unfortunately, resuscitation maneuvers did not work. Most 
of the KI mice (5 of 7) died. Because the ECG was continuously recorded after the 
experiment until next day, we could record some of these deaths. Figure 2B shows the ECG 
of a KI mouse which died during the recovery phase. Strikingly, although the CPVT mouse, 
once stressed, developed VT, they were self-terminated and the final arrhythmia underlying 
the sudden cardiac death one hour later was a severe sinus dysfunction with a progressively 
slower ventricular escape rhythm ending up with asystolia.  
 
R420Q mutation decreased SAN activity in vitro.  
In order to analyze intrinsic SAN activity, we dissected the SAN and analyzed the frequency 
of spontaneous [Ca2+]i transients by confocal microscopy. Figure 3 A shows confocal images 
of Fluo-4 loaded SAN at different times from a WT (upper images) and KI (lower images) 
male mice. The cycle length, measured between 2 consecutives automatic [Ca2+]i transients 
at their upstroke was significantly longer in KI than in WT, showing a lower rhythm in 
RyR2
R420Q SAN. Both male and female KI SAN cells had longer cycle length than WT, 
revealing an intrinsic defect in KI SAN (Figure 3B). We didn’t pool together all data because 
of a gender difference in cycle length, but the presence of RyR2
R420Q mutation affected 
similarly both males and females. 
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Acute ISO treatment decreased the cycle length in all mice, but the response of KI SAN was 
greater than WT (Figure 3C). On the other hand, CCH prolonged the cycle length equally 
regardless the sex and genotype (Figure 3D).  
 
Membrane clock 
Several mechanisms account for the automatism of pacemaker cells, including the 
membrane and calcium clocks. The membrane clock stands for ionic channels in the 
sarcolemma, and the Ca2+ clock by the Ca2+ release channel (RyR2) and the electrogenic 
Na+/Ca2+ exchanger (NCX) 23. Although the difference between KI and WT mice is the 
presence or absence of the RyR2
R420Q mutation, secondary alterations in membrane currents 
could potentially account for the slowing of SAN cell automatism found in KI. In order to test 
this possibility, we isolated SAN cells to measure ionic currents by patch-clamp. No 
differences in current densities in cells isolated from males compared to females were 
observed, thus all data were pooled together. Figure 4 A shows representative recordings 
and current - density relationships of If, the main ionic current involved in SAN automatism. 
As it is shown in the averaged data, no significant differences were found between groups. 
Likewise, no significant difference was found in ICa between KI and WT (Figure 4B) in 
presence of a Ca2+ chelator in the pipette solution (BAPTA). However we observed a 
reduction in the ICa density was in KI cells compared with WT cells (Figure 4C) in absence of 
Ca2+ chelator. These data suggest that intracellular Ca2+ alteration can induce decrease in 
ICa in KI mice, which could account for the slowing of SAN pacing rate.  
 
Ca2+ clock 
We recorded fluorescence Ca2+ images of SAN cells within the tissue in the line-scan mode 
to gain time resolution. Figure 5A shows such images from one cell of each group. The 
[Ca2+]i transient amplitude was smaller in KI than in WT cells (Figure  5B). In addition, while 
the time constant of decay (obtained by fitting the decay fluorescence trace to a single 
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exponential) was significantly faster in KI animals (Figure 5C), the [Ca2+]i transients recorded 
in KI animals had a longer time to peak (Figure 5D).  
The Ca2+ clock has been ascribed as local [Ca2+]i transients (which can be seen as a “feet” 
or “ramp” the before the [Ca2+]i transient) precede the global [Ca2+]i transient, which 
corresponds to the late diastolic depolarization. The percentage of cells presenting ramp 
was higher KI SAN cells than WT (Figure 5E)  
 
SR Ca2+ content 
Diastolic Ca2+ release, measured as ramp, instead of activating the [Ca2+]i transient could 
unload the SR, slowing the Ca2+ clock. The caffeine-evoked transient inward current (Figure 
6A), which is carried by NCX working in forward mode, was significantly reduced in the KI 
SAN cells. This was not related to alteration of NCX protein expression (Figure 6B), 
suggesting that the SR Ca2+ load is reduced. Thus, enhanced diastolic Ca2+ leak causing 
reduced SR Ca2+ load seems a likely mechanism to explain why the Ca2+ clock slows down 
in KI SAN.  
 
RyR2 expression level 
 
The observed modifications in Ca2+ handling of KI SAN might be due alteration in the RyR2 
expression (happloinsufficiency) and/or its phosphorylation status. We evaluated the total 
RyR2 expression level by western blots (examples shown in Figure 6C). Neither the total 
amount of RyR2 nor their relative phosphorylation at the 2808 equivalent nor at 2914 
equivalent sites was significantly different among groups (Figure 6D-F). These data points to 
an intrinsic defect of the RyR2
R420Q function rather than expression or basal phosphorylation 
difference. 
 
Ca2+ sparks 
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Because the presence of the CPVT mutation did not alter neither the expression level nor 
the phosphorylation status of the protein, we next addressed the function of the channel 
evaluation. In order to do that, we analysed Ca2+ sparks that can be registered during the 
diastolic period. Figure 7 A (left) shows representative examples of confocal images 
presenting Ca2+ sparks in WT and KI SAN cells. Ca2+ sparks frequency, which is an estimate 
of RyR2 open probability, was augmented in KI cells (Figure 7A, right). Of note, the increase 
in Ca2+ sparks frequency was more modest than that reported in the literature regarding 
CPVT, including our data of the RyR2
R4496C mutation, located at the C-terminal region15, 24, 25. 
We then analyzed Ca2+ sparks characteristics, in order to estimate the total Ca2+ leak 
through Ca2+ sparks. Ca2+ sparks in KI male exhibited a markedly higher amplitude (Figure 
7B), longer duration at half maximum (Figure 7C), but also a thinner width at half maximum 
(Figure 7D) than WT mice. Although the narrowing of the Ca2+ sparks in RyR2
R420Q cells was 
statistically significant, the difference is so small that it may not have functional 
consequences. Similar alterations were found in female mice, except for the peak amplitude 
and width that was not significantly altered in KI female (Figure 7B-D). The most striking 
effect of the RyR2
R420Q mutation in Ca2+ sparks was a marked prolongation of their duration. 
We then went deeper into the Ca2+ sparks kinetics by using a resonant scanner confocal 
microscope, which allows us to get enough points to measure the time to peak. Figure 7E 
shows that regardless of sex, the RyR2
R420Q mice presented Ca2+ sparks with marked 
prolongation of the time to peak. Thus, in summary, RyR2
R420Q produces some more Ca2+ 
sparks of abnormal characteristics than the WT channel. 
The altered characteristics of Ca2+ sparks could modify the total Ca2+ leak through them. 
Thus we calculated Ca2+ spark mass by multiplying Ca2+ spark characteristics (amplitude x 
D50 x W50 ) (Figure 7F), and then by frequency, obtaining an indicative of the Ca
2+ released 
every second through Ca2+ sparks in each group. Figure 7G shows that SAN cells from both, 
male and female KI mice present more diastolic Ca2+ release through Ca2+ sparks than WT. 
The KI male presented most dramatic differences, supporting the presence of gender 
differences. 
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Discussion 
This manuscript uncovers a new arrhythmogenic mechanism in a CPVT mutation located at 
the N-terminal portion of the channel, the RyR2
R420Q. Besides polymorphic ventricular 
tachycardia upon stress, the individuals bearing this mutation, as many others CPVT 
patients, present supraventricular arrhythmias and slow sinus rate at resting conditions. This 
mutation in the RyR2 produces prolonged Ca
2+ sparks, which unloads the SR of Ca2+ at the 
SAN and also inactivates the L type Ca2+ channel, slowing the firing rate of the pacemaker 
cells. 
Some studies have shown gender difference in cardiac function, such as in excitation-
contraction coupling, or in β-adrenergic responsiveness of action potentials26, 27. The sex-
dependent difference has also been shown in RyR2-related CPVT patients, so that male 
CPVT patients have a higher risk of cardiac events 20. In this study, we found some 
differences in basal heart rate both in-vivo and in-vitro. In basal conditions, HR is faster in 
women than in men due to the smaller heart size, and our data in mice are reminiscent of 
this sex difference. Our data in healthy family members and in WT mice are consistent with 
these conclusions. However, the autonomic tone has shown some gender differences 
suggesting higher sympathetic activity in men than in women 28, 29. In fact, we found that HR 
response to isoproterenol is higher in female than in male mice the opposite regarding 
carbachol effect. Moreover, data on dissected SAN support the higher sympathetic tone in 
males, as the HR is faster (smaller cycle length), as shown in Figure 2. This observation is 
consistent with the previous hypothesis that cAMP might be higher in male ventricles, due, 
at least partially, to the lower phosphodiesterase (PDE) PDE4B expression in males 26. 
However While the differences between males and females is not the subject of this study, 
we found that the presence of the RyR2
R420Q mutation affects both equally, slowing the 
spontaneous activity of the SAN.  
Bradycardia and sinus dysfunction are common in CPVT patients. However, the 
mechanisms are not clear. As most CPVT related mutations concern a gain of function, an 
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acceleration of the calcium clock should be expected. However, the mechanism underlying 
the gain of function vary in different mutations. We previously analyzed Ca2+ handling in 
cardiac myocytes from the RyR2
R4496C mutation, which is located at the C terminal part of the 
channel. The defect we identified consisted in enhanced Ca2+ sensitivity of the channel24. 
Other mechanisms have been invoked in mutations located at other hotspots. In myocytes 
from KI mice harboring CPVT mutations in the central region (such as the RyR2
R2474S), the 
functional mechanism underlying the proarrhythmic behavior of the mutation is an altered 
binding of the mutated RyR2 to FKBP12.6 (protein that binds RyR2 and stabilizes it in the 
closed state) 30. Additionally, the zipping-unzipping mechanism (mediated by the N-terminal 
and central region interaction) plays a crucial role and has been shown to be disturbed by 
this RyR2
R2474S mutation, which induces conformational changes and favors the unzipped 
state.  Although most proposed functional alterations caused by the RyR2 mutations result in 
a gain of function, recently a mice model harboring a mutation in the C-terminal portion 
exhibits loss of function31. Here we analyzed cells from a mice model harboring the 
RyR2
R420Q mutation, which we previously identified in a large Spanish family4. Previously, 
another mutation in the same residue was identified in several CPVT families32, 33, and 
besides our family4, two additional reports in the literature connect CPVT with the RyR2
R420Q 
mutation21, 34. Thus the 420 site seems to be important for the RyR2 function. In fact, it is a 
highly conserved residue among species. Structural analyses have shown that this residue 
plays an important role in the channel conformation 35, 36. The RyR2
R420Q losses the capacity 
to bind Cl-, which maintains in place the three regions (A, B, and C) of the N terminal 
domain35, although the functional consequences remain unknown. Here we show that the 
Ca2+ sparks in RyR2
R420Q myocytes are abnormally prolonged, mainly due to a longer time to 
peak. As the time to peak depends on the open time of the RyR2, our data is compatible with 
long openings of the RyR2
R420Q channel. 
Instead of accelerating the calcium clock, the aberrant Ca2+ leak through RyR2
R420Q channels 
unloads the SR of Ca2+, slowing the calcium clock, and inactivates the neighboring L type 
Ca2+ channels, inactivating them and slowing the voltage clock. When the SAN does not fire, 
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or do it at a smaller pace, there is more probability that ectopic foci are developed, thus 
augmenting the risk of ventricular tachycardia. 
In summary, we have found a new mechanism of bradycardia in a new mice model carrying 
the RyR2
R420Q CPVT mutation. This mutation induces longer channel openings, augmenting 
the Ca2+ leak within each Ca2+ spark, affecting both calcium and voltage clocks.  
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Materials and methods 
KI mice. RyR2
R420Q mice were created by the Institute Clinique de la Souris. Mutation 
conversed arginine residue at amino acid 420 to glutamine.  
Experiments were performed on male and female mice heterozygous for RyR2
R420Q  and 
their wild-type (WT) littermates (aged about 6 months)  in accordance with the ethics 
principles laid down by the French Ministry of Agriculture and ECC directive 86/609/ECC. 
In vivo telemetric ECG recording. To monitor ECGs in awake free-moving mice, the 
transmitters (7 ETA-F10) were implanted subcutaneously to the mice. The negative lead 
was placed on the upper right chest, and the positive lead was placed on the left abdomen 
below the left diaphragm and below the heart. During the subcutaneous implantation of ECG 
transmitter the mouse was placed on a warm pad (37°C). Anesthesia was induced with an 
Isoflurane (2.5%) inhalation apparatus for anesthesia induction. During surgery, the animal 
was continuously receiving isofluorane (1.5%). At least 7 days after surgery, ECGs were 
recorded in resting conditions and 5min after epinephrine/caffeine (2/120 mg/kg, i.p.) or iso 
(1 mg/kg, i.p.) challenge. Data were collected with a signal transmitter receiver (DSI) 
connected to a data acquisition system, and analyzed with ECG auto software (EMKA 
Technologies).  
In vitro intact SAN cells recording. Mice were anesthetized by sodium pentobarbital (50 
mg/kg i.p.). The hearts were quickly removed from the animal and placed in Tyrode solution 
(NaCl 140 mM, KCl 5.4 mM, CaCl2 1.8 mM, MgCl2 1 mM, HEPES 5 mM, and glucose 5.5 
mM, pH 7.4, titrated with NaOH). The solution was oxygenated to saturation and maintained 
at 37°C. SAN and some surrounding atrial tissue were dissected and pinned down with the 
endocardial side up in home-made optical chambers bathed with Tyrode solution as 
previously described15. The tissue was loaded with fluo-4 AM (30 μM) during 60 min at 37ºC. 
Images were recorded with a resonant scanning confocal microscope Leica SP5, equipped 
with a white laser fitted to 500 nm. Excitation was collected at >510nm. 2 D and xt images 
were recorded from the primary pacemaker region. Experiments and recordings were 
performed at 37ºC. Analysis was made in IDL (Exelis Visual Inc.) by homemade routines. 
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Western blot. SAN samples were lysed by Bertin homogenizer with RIPA lysis buffer, run on 
4%-20% discontinuous gradient polyacrylamide gels and transferred to PVDF membranes. 
PVDF membranes were incubated with blocking buffer of TBS with Tween-20 (1%) and 
nonfat dry milk (5%). Membranes were then incubated with primary antibodies diluted in 5% 
milk TBS overnight at 4°C, followed by the secondary antibodies. HCN4 primary antibody 
was a generous sample from Alomone Labs (APC-052). Antigen complexes were visualized 
with ChemiDoc and quantified with Image J.  
Isolation of Sinoatrial Node Myocytes 
SAN myocytes were isolated from WT and RyR2
R420Q KI mice as previously described 37. 
Briefly, mice were anesthetized using 0.01 mg/g xylazine (2% Rompun; Bayer AG) and 0.1 
mg/g ketamine (Imalgène; Merial), and beating hearts were quickly removed. 
The SAN regions were excised in prewarmed (35 °C) Tyrode’s solution containing (in mM/L): 
140 NaCl, 5.4 KCl, 1.8 CaCl2, 1 MgCl2, 5 Hepes-NaOH, and 5.5 D-glucose; adjusted to pH 
7.4 with NaOH. SAN tissue strips were then transferred into a “low-Ca2+-low-Mg2+” solution 
containing (in mM/L): 140 NaCl, 5.4 KCl, 0.5 MgCl2, 0.2 CaCl2, 1.2 KH2PO4, 50 taurine, 5.5 
D-glucose, 1  mg/mL BSA, and 5 HEPES-NaOH; adjusted to pH 6.9 with NaOH. Tissue was 
digested by Liberase TH (229 U/mL; Roche), elastase (1.9 U/mL; Boehringer Mannheim), 
and 200 μM CaCl2. Digestion was carried out for 9–13 min at 35 °C, under manual 
mechanical agitation. Tissue strips were then washed and transferred into a modified 
“Kraftbrühe” (KB) medium containing (in mM/L): 70 L-glutamic acid, 20 KCl, 80 KOH, 10 
(±)D-β-OH-butyric acid, 10 KH2PO4, 10 taurine, 1 mg/mL BSA, and 10 Hepes-KOH; adjusted 
to pH 7.4 with KOH. Single SAN myocytes were then isolated by agitation in KB solution at 
35 °C. Cellular automaticity was restored by readapting the cells to a physiological 
extracellular Ca2+concentration by addition of a solution containing (in mM/L): 10 NaCl, 1.8 
CaCl2, and normal Tyrode’s solution containing BSA (1 mg/mL). The final cell storage 
solution contained (in mM/L): 100 NaCl, 35 KCl, 1.3 CaCl2, 0.7 MgCl2, 14 L-glutamic acid, 2 
(±)D-β-OH-butyric acid, 2 KH2PO4, 2 taurine, 1 mg/mL BSA (pH 7.4). 
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Patch-clamp recordings of SAN myocytes. The extracellular Tyrode’s solution used in all 
recordings contained (in mM): 140.0 NaCl, 5.4 KCl, 1.8 CaCl2, 1.0 MgCl2, 5.0 HEPES-
NaOH, 5.5 and d-glucose (adjusted to pH 7.4 with NaOH).  
If and ICaL were recorded under standard whole-cell configuration. Patch-clamp electrodes 
had a resistance of 4–5MΩ when filled with an intracellular solution containing (mM): K+-
aspartate 130, NaCl 10.0, ATP-Na+ salt 2.0, creatine phosphate 6.6, GTP-Mg2+ 0.1, CaCl2 
0.04 (pCa 7.0) and HEPES-KOH 10.0 (adjusted to pH 7.2 with KOH).. To properly quantify If 
current densities 2 mM BaCl2 was added to standard Tyrode to block IK1. For ICaL recording, 
10 mmol/L BAPTA was added when requested by the protocol.  
The inward current evoked by rapid application (spritz) of caffeine 10mM was measured at 
holding potential of -45mV. All currents were recorded using an Axopatch 700B amplifier 
(Molecular Devices), acquired with Clampex (pClamp9; Molecular Devices), and analyzed 
with Prism 6 software (GraphPad software). Signals were sampled at 10 kHz and low-pass 
filtered at 5 kHz. The recording temperature was set to 36°. All chemicals were from SIGMA 
(St Quentin Fallavier, France). 
Statistics.  
2-way ANOVA was used for multiple comparisons. An unpaired t test was used to compare 
2 independent groups. A paired t test was used to compare measurements made in the 
same mice or in the same cells under 2 different conditions. A value of P<0.05 was 
considered significant. Results are expressed as mean±SEM.  
Study approval 
Animal study was approved by the French Ministry (Ministère de l’Éducation Nationale, de 
l’Enseignement supérieur et de la recherche) nº B9201901. Written consent was given by 
the patients prior to the inclusion in this study. 
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Figure 1. KI RyR2
R420Q mice have CPVT phenotype and sinus dysfunction. A. Exercise test 
in a family member positive for the RyR2
R420Q mutation. B. heart rate (beats per minute, bpm) 
of the family members without the mutation (-/-) or heterozygous for the RyR2
R420Q mutation 
(+/-), male (M) and females (F). Only data before any b-blocker was taken. We did not 
include two babies (3 and 24 months at the time of the recording) and 4 brothers who were 
marathon runners. N in data is 3 M-/-, 5M+/-, 6F-/-, and 5 F+/-.  2 way ANOVA revealed a 
genotype statistical difference at p=0.006. C. Representative examples of ECG recordings 
obtained before (top panels) and following (bottom panels) epinephrine (2 mg/Kg) + caffeine 
(120 mg/Kg) injection (i.p.) in a WT mouse (left) and a KI mouse (right). The KI mouse 
shows BVT after epinephrine/caffeine administration, characteristic of CPVT mice. D. After 
injection, all of the KI mice (n=7) show BVT, but none of the WT (n=5). E. PP intervals 
recorded during daytime. Female KI mice (n=9) beat slower than WT (n=10) during daytime. 
No difference was found for the males (WT n=10 vs. KI n=11). F. Isoproterenol (ISO, 1 
mg/kg) decreased the RR interval in both males (n=6) and females (n=6), the KI females 
decreased proportionally more than WT. G. Carbachol (CCH, 0.25 mg/kg) increased the RR 
intervals in both males (n=7) and females (n=6). H. Example of ECG of a KI mice after 
isoproterenol injection showing a junctionnal escape beat (JE) marked by the arrow 
overcoming a transient severe decrease in sinus rate. Scale bar 10s. Below a portion of the 
same ECG is shown, with scale bar = 200 ms. G. Proportion of animals presenting junctional 
escapes after ISO injection. *p<0.05; **p<0.01. 
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Figure 2. KI mice show sinus dysfunction after emotional stress. A. RR intervals during 
emotional stress protocol in a WT (top) and a KI (bottom) mice. Red dashed line indicates 
the beginning of the 15s of warm air blowing, 45s rest was allowed before the next air 
blowing. B. An example of ECG recorded from a KI mouse, which died after the blowing 
stress. On the left, a time reference is provided. Horizontal scale 1s. After ventricular 
tachycardia and a progressively slower ventricular escape rhythm, the mouse died in 
asystolia. 
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Figure 3. Cycle length (CL) in sinoatrial node (SAN) cells is longer in KI than in WT animals. 
A. Example of 2D confocal images (left) of SAN cells within the intact SAN and the 
corresponding fluorescence traces (right) in WT (upper) and KI (lower) SAN cell. B. The CLs 
of male WT (n=44 cells from 7 mice) and KI (n=37 cells from 6 mice), and female WT (n=61 
cells from 8 mice) and KI mice (n=50 cells from 8 mice). KI mice have markedly longer CL 
than WT. C. ISO decreases CL in all type of SAN, while the response in KI SAN (male: n=18 
cells from  3 mice, female: n=22 cells from 3 mice) is larger than in WT (male: n=19 cells 
from 3 mice, female: n=25 cells from 4 mice). D. CCH increases CL in all SAN cells, and no 
difference between genotype nor sex was observed (WT, male: n=26 cells from 3 mice, 
female: n=41 cells from 4 mice; KI, male: n=30 cells from 3 mice, female: n=25 cells from 3 
mice). *p<0.05; **p<0.01; ***p<0.001. Two way ANOVA. 
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Figure 4. If is normal, but ICa is depressed in KI SAN cells. A, left, family traces of If in a WT 
(top) and KI (middle) cell. Below is the voltage protocol. If current-voltage relationship in WT 
cells (open circles) and KI cells (black circles). B.  Averaged current-voltage curves of ICa in 
isolated SAN cells in unbuffered intrapippete solution. C. The same as in C but with *** mM 
BAPTA in the intracellular solution. *p<0.05; **p<0.01; ***p<0.001. 
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Figure 5.  Characteristics of [Ca2+]i transients are altered in SAN cells from KI mice. A. 
Examples of line-scan confocal images showing [Ca2+]i transients from WT (upper) and KI 
(lower) SAN cells. B. [Ca2+]i transient amplitude (measured as peak, F/F0, where F is the 
fluorescence trace and F0 the fluorescence during the diastolic period). C. KI SAN cells have 
significant smaller decay time constant (obtained by fitting the decay portion of the 
fluorescence trace to a single exponential). D. Time to peak is longer in KI SAN cells. WT n= 
102 cells from 15 mice; KI n=81 cells from 14 mice. E. Percentage of cells that present a 
ramp (late diastolic Ca2+ release). WT, white bars; KI, red bars *p<0.05  
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Figure 6. Caffeine-evoked inward current was significantly smaller in KI than in WT SAN 
cells. A. Averaged transient inward current evoked by rapid caffeine application to WT SAN 
cells and KI cells. B. NCX expression is unchanged between KI and WT. C. Examples of 
blots obtained for total or phosphorylated RyR2. D-F. Total RyR2 expression (C) and 
phosphorylated (S2814, E and S2808, F) RyR2 expression are unaltered. N = 4 mice each. 
White bar, WT, black bar, KI. *p<0.05 
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Figure 7. KI SAN cells show enhanced Ca2+ release through Ca2+ sparks. A. Left: Examples 
of line-scan images of SAN cells within the intact SAN in WT and KI mice (left: WT, right: KI, 
Top: males, bottom: females). Right: Ca2+ sparks frequency (number of sparks / s /100 μm) 
recorded from 38 cells of 7 WT males, 37 cells from 6 KI males, 47 cells from 8 WT females 
and 44 cells from 8 KI females. B Ca2+ sparks amplitude (measured as peak F/F0 as in 
Fig.5) C. Duration at 50% of maximum amplitude, D. Width at 50% of maximum amplitude. 
Females KI mice present Ca2+ sparks of longer duration (D) than WT. E. Time to peak. F. 
Ca2+ spark mass (amplitude * width * duration).  G. Total Ca2+ leak through Ca2+ sparks 
(Ca2+ spark mass * frequency). White bars, male WT; red bars, male KI; gray bars, female 
WT; dark red bars, female KI. *p<0.05; **p<0.01; ***p<0.001.  
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3.1.2. Additional data on RyR2
R420Q SAN. 
Sex differences in RyR2
R420Q mice. 
As explained in the manuscript, in order to test the CPVT phenotype in RyR2
R420Q mice, we 
injected epi+caff (2mg/Kg+120mg/Kg), and measured ECG starting 5 minutes after injection to 
have comparable levels in the circulating blood and have them recovered from the hanling and 
injection stress. All RyR2
R420Q mice showed bidirectional ventricular tachycardia, characteristic of 
CPVT in mice. The ECG was continuously recorder over night. We also measured the time in 
which the animals stayed in tachycardia after the injection. Figure 34 shows that males KI mice 
stayed in the arrhythmic state for longer time, showing a sex-dependent difference.  
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Figure 34. Duration of BVT. Female KI mice (n=2) stayed less time in BVT than males (n=4). 
Autonomic modulation of SAN Ca2+ handling 
When analyzing the effect of ISO and CCH on spontaneous SAN activity, I also analyzed the 
effect on [Ca2+]i transients characteristics and Ca
2+ sparks. Fig. 35 shows [Ca2+]i transient 
amplitudes in WT and KI cells under basal conditions and during 20nM ISO or 500 nM CCH. Both 
ISO and CCH had the tendency to decrease [Ca2+]i transient amplitude in both WT and KI SAN 
cells. However, ISO had no significant effect, while CCH only significantly decreased [Ca2+]i 
transient amplitude in KI mice SAN cells, but not in WT. 
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Figure 35. ISO and CCH effects on [Ca2+]i  transient amplitudes.  Bar graph showing peak [Ca
2+]i transient amplitudes 
measured as peak F/F0 where F is the fluorescence trace and F0 the basal fluorescence during diastolic period.  
Numbers in each bar indicate cell number (animals: basal, 15 WT vs. 14 KI; ISO, 7 WT vs. 6KI; CCH, 7 WT vs. 6KI). 
WT, wildtype SAN. WT.ISO, wildtype SAN during ISO application. WT.CCH, wildtype SAN during carbachol 
application. KI, knock-in SAN. KI.ISO, knock-in SAN during ISO application. KI.CCH, knock-in SAN during 
carbachol application. *p<0.05, compared before and after ISO/CCH stimulation. †p<0.05, compared between 
genotypes.  
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Figure 36. ISO and CCH effect on [Ca2+]i transient time to peak. Cell and mice numbers, and labels are as in Fig. 35. 
*p<0.05, **P<0.01, ***P<0.001, compared before and after ISO/CCH stimulation. †p<0.05, ††P<0.01, †††P<0.001, 
compared between genotypes. 
Next we addressed the analyses of [Ca2+]i transient kinetics under sympathetic and 
parasimapthetic stimulation. Figure 36 and 37 show the time to peak and the decay time constant 
for the [Ca2+]i transient.  The time to peak was shortenned by ISO in WT, but prolonged in KI, 
96 
 
suggesting the defect in ISO response. In contrast, CCH decreased [Ca2+]i transient time to peak in 
both WT and KI SAN cells. Decay time constant was accelerated by ISO in both genotypes, 
although CCH had no effect. 
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Figure 37. ISO and CCH effect on [Ca2+]i transient decay time. Bar graph showing [Ca
2+]i transient decay time (Tau) 
obtained by fitting the descending portion of the fluorescence trace to a single exponential. Cell and mice numbers, and 
labels are as in Fig. 35. *p<0.05, ***P<0.001, compared before and after ISO/CCH stimulation. †p<0.05, ††P<0.01, 
compared between genotypes. 
In SAN tissue, not all cells show the late diastolic Ca2+ release, measured as a ramp. The 
percentage of cells in which this ramp was recorded is presented in Fig 38A. WT had more ramp 
occurance than KI as we discussed previously in basal condition as described in manuscript. ISO 
significantly enhanced ramp occurrence in both genoytpes, while KI had much more than WT. In 
contrast, CCH did not alter ramp occurrence in WT and KI, but KI still had more than WT. In basal 
condition, KI has significant weaker ramp peak than WT. ISO increased ramp peak in KI SAN cells 
reaching the same level as WT, but this effect is not observed in WT (Figure 38B). Ramp peak is 
decreased significantly by CCH in WT, but not in KI resulting in the relatively greater ramp peak in 
KI after CCH stimulation. Ramp time to peak was unaltered by ISO regardless WT or KI (Figure 
38C). However, CCH causes converse response in WT and KI. WT has significantly decreased 
ramp time to peak, but KI showed opposite results. 
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Figure 38. ISO and CCH effect on [Ca2+]i transient ramp. A. Percentage of cells where ramp was observed at least once 
over the 20 s recording period.  Total number of cells in each group is the same than in Fig. 35. B. Maximum value of 
Ca2+ ramp, just before the upstroke of [Ca2+]i transient, measured as in Fig. 35. Numbers in each bar indicate number of 
cells with ramp (from mice: basal, 15 WT vs. 14 KI; ISO, 7 WT vs. 6KI; CCH, 7 WT vs. 6KI). C. Time to peak of 
ramp, measured from the same Cells as in panel B. *p<0.05, ***P<0.001, compared before and after ISO/CCH 
stimulation. †p<0.05, ††P<0.01, compared between genotypes. Labels are as in Fig. 35. 
Under ISO, the [Ca2+]i transient enhanced frequency and the extremely high diastolic Ca
2+ 
release precluded us to accurately measure individual Ca2+ sparks. Ca2+ sparks analysis under CCH 
application is presented in Fig 39. CCH decreased Ca2+ spark frequency only in KI females, while 
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the others have no change. Ca2+ spark amplitude is decreased in WT male and female after CCH 
stimulation, but increased in KI male and female. Besides, Ca2+ spark duration is shortened in both 
WT and KI by CCH, but KI still have longer sparks than WT. Eventually, Ca2+ release as sparks 
(per spark, Figure 39 E; per second per 100µm, Figure 39 F) during DD is significantly higher in KI 
than in WT cells.  
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Figure 39. CCH effect on Ca2+ spark, normalized by the sparks from the same SAN in basal condition. A. Frequency of 
Ca2+ sparks expressed as percentage of number of Ca2+ sparks per second per 100 µm in the presence of charbacol with 
respect to the same node before charbachol. Numbers in each bar indicate cells (4 WT female and 3 WT male vs. 3 KI 
female and 3 KI male). B. Percentage of Ca2+ spark amplitude (measured as peak F/F0 as in Fig. 35). C. Percentage of 
Ca2+ spark duration at 50% of maximum amplitude. D. Percentage of Ca2+ spark mass (amplitude*width*duration). E. 
Percentage of total Ca2+ leak through Ca2+ spark (Ca2+ spark mass*frequency). Numbers in each bar of panel B 
indicated number of Ca2+ sparks, which are the same for panel C-E. WT.M, wildtype male. WT.F, wildtype female. 
KI.M, knock-in male. KI.F, knock-in female. *p<0.05, **P<0.01, ***P<0.001, compared with basal condition (100%). 
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†p<0.05, ††P<0.01, †††P<0.001, compared between genotypes. 
Mechanism of RyR2
R420Q dysfunction 
In order to evaluate the RyR2
R420Q dysfunction, we addressed two hypothesis based on other 
published data in CPVT RyR2 mutations from us and other authors. We started by analyzing the  
Ca2+ sensitivity by analyzing Ca2+ sparks frequency in permeabilized cardiomyocytes perfused with 
different [Ca2+]i. We did this experiment in ventricular cardiomyocytes as they have the same 
RyR2
R420Q and the cell isolation provides more cells. Myocytes were permeabilized by 90 s 
exposure to saponin (0.01%). Ca2+ sparks were recorded in intracellular solution with fixed [Ca2+]i 
calculated by Max chelator. Figure 40 shows that KI cardiomyocytes were slightly more sensitive to 
Ca2+ than WT at 100nM [Ca2+]i. As the RyR2
R420Q migh have some enhanced Ca2+ sensitivity 
although at most analyzed concentrations the response was similar, it may not be the main 
mechanism.  
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Figure 40. Ca2+ spark frequency measured as the number of Ca2+ sparks per second per 100μm at different [Ca2+]i. 
Numbers of cells are included close to the data points.  
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Figure 41. Dantrolene effect on knock-in (KI) SAN cells. A. Averaged duration of two consecutive beatings during 30 s 
recording (Cycle length, CL). Numbers in the bars indicate cells from 5 SAN before and during dantrolene application. 
B-D. [Ca2+]i transient peak, time to peak and decay time constant, measured as in Fig 35, 36 and 37 respectively and 
measured from the same cells as panel A. Red bar: knock-in SAN in basal condition. Blue bar: the same knock-in SAN 
during dantrolene application.  
Other proposed mechanism is the alteration of zipping unzipping mechanism. Zipping is 
interaction between N and central domains which stabilizes the channel in the closed estate. 
Because RyR2
R420Q is located at the N-terminal region, it could be a possible mechanism. It has 
been postulated that dantrolen stabilizes the zypping state. Thus we analyzed dantrolene effects on 
RyR2
R420Q SAN. Figure 41 shows the effect in CL and the whole [Ca2+]i transients. The spontaneous 
[Ca2+]i transient frequency (Figure 41A) and characteristics (Figure 41B-D) were not significantly 
different before and during dantrolene application. Ca2+ sparks occurrence was depressed by 
dantrolene, like the Ca2+ spark duration (Figure 42), but without changes in Ca2+ spark amplitude or 
width. Thus dantrolene showed some improvement in KI SAN, however the effect was too small to 
explain zipping unzipping as the mechanism of R420Q dysfunction. 
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Figure 41. Dantrolene effects on Ca2+ spark frequency and characteristics, normalized by basal condition in each SAN. 
Numbers indicated cells (frequency) or Ca2+ spark number (peak, duration and width) from 5 SAN. *p<0.05 compared 
with basal condition (100%).  
Discussion of this additional data 
This additional part of results includes the sex-dependent response, ISO and CCH effect on 
[Ca2+]i transient and Ca
2+ spark, Ca2+ sensitivity and dentrolene effect, further revealed the 
arrhythmogenic mechanism of mutation RyR2
R420Q.  
The shorter duration of BVT after epinephrine and caffeine injection in KI females than KI 
males indicates a cardio-protection in female, which was reported in severe cardiac diseases, such 
as heart failure.301-303. Besides, this observation is consistent with a previous research suggesting 
that female patients have a lower risk of cardiac events.442  
ISO increases cAMP level and protein phosphorylation level which should increase [Ca2+]i 
transient amplitude. But in SAN, the resultant ISO response also accelerates the pacemaking rhythm 
and leaves less time for SR to refill, resulting in the similar even a tendency of smaller [Ca2+]i 
transient amplitude. In contrast, CCH slows pacemaking rhythm associated with depressed protein 
phosphorylation level (ICa,L, PLB, RyR2), cAMP level (depress If) and activated IKACh. Thus, the 
longer SR refill time is balanced with the other responses, causing the tendency of smaller (WT) or 
significant smaller (KI) [Ca2+]i transient amplitude.  
ISO shortened [Ca2+]i transient time to peak in WT SAN cells, corresponding to the enhanced 
cAMP and phosphorylation level. However, the ones in KI SAN cells were prolonged. This 
opposite response in [Ca2+]i transient time to peak between WT and KI suggests a defect in KI SAN 
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and impaired ISO response. In contrast, CCH decreased [Ca2+]i transient time to peak in both 
genotypes, in respect that CCH decreases cAMP level and activates IKACh.  
Decay time constant was accelerated by ISO in both WT and KI SAN cells, as it is expected, by 
the PKA phosphorylation of phospholamban. In contrast, CCH did not alter decay time in either 
WT or KI.  
ISO also increased ramp occurrence in both genotypes, probably because of the enhanced 
phosphorylation of RyR2. Eventually KI SAN cells had more possibility to have ramp not only in 
basal condition, also during ISO stimulation, with enhanced ramp amplitude. In contrast, CCH did 
not alter ramp occurrence in either genotype. The CCH resulted decrease in ramp peak and time to 
peak in WT were absent in KI, and the ramp time to peak in KI was even significant prolonged, 
suggesting an impaired coupled-clock. During CCH application, KI (male and female) SAN cells 
still had more Ca2+ leak as Ca2+ sparks, indicating the defect in RyR2 channel is maintained under 
parasympathetic tone.  
The slightly enhanced Ca2+ spark frequency in permeabilized ventricular myocytes only at 
100nM [Ca2+]i revealed that the mutant RyR2 may behave as with increased Ca
2+ sensitivity, but it 
does not have a shift in the curve, disregarding enhanced Ca2+ sensitivity as the main defect. 
Dantrolene decreased Ca2+ spark frequency and duration yielding some improvement. However, 
dantrolene failed to regain the CL and [Ca2+]i transient characteristics, which is unlikely to explain 
zipping unzipping as the mechanism of R420Q dysfunction. 
This part of results allows us to further understand R420Q mutation in addition to the 
manuscript, and also provides insight to clinical therapy. 
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Chapter 4 Discussion 
SAN is the primary pacemaker of the heart. It spontaneously generates the electrical signal 
resulting in the contraction of the heart, which further pumps blood throughout the body and 
sustains life. Many pathological conditions favor SAN dysfunction, such as heart failure, 
hypertension, atrial fibrillation, etc.414 Considering that RyR2 has a critical role in SAN automaticity 
generation alteration on its function may underlie SAN dysfunction. In particular, CPVT patients 
presenting RyR2 mutations frequently show SAN dysfunction, such as bradycardia, and inducible 
atrial tachyarrhythmias.454, 455, 632 However, its molecular basis is not fully understood. Our team 
investigated the SAN dysfunction in a CPVT mouse model bearing RyR2 C-terminal mutation 
(R4496C).458 The mechanism of SAN dysfunction attributed to other RyR2 mutations has never 
being published before. In this thesis, we used transgenic animal (RyR2
R420Q) to address this 
important issue, and characterized the molecular basis of the SAN dysfunction in a KI mouse model 
of CPVT carrying this novel mutation in RyR2, located at the N-terminal region.  
RyR2 N-terminal mutation R420Q 
Unlike mutation R4496C, mutation R420Q only increases Ca2+ spark frequency slightly, but 
meanwhile dramatically causes prolongation of the spark duration in SAN cells, showing distinct 
modifications and contributions of the two mutations. Indeed, R4496 is located in the C-terminal 
portion of the channel (cytosolic side), close to the proposed molecular region involved in Ca2+-
dependent activation (residues 4485 to 4494).633-636 Thus, it is reasonable that R4496C enhanced 
RyR2 open probability by enhancing Ca
2+ sensitivity. However, R420 is located on the top of the 
cytosolic domain, stabilizing the structure of N-terminal region of mice/human RyR2. As mentioned 
in introduction, Arginine 420 participates to the binding of a Cl- which holds the three parts of the 
N-terminal region in position. RyR2
R420Q  mutation ablates chloride binding in mice, resulting in 
reorientations of the first two regions relative to the third one.520 Based on our data in Ca sparks, 
these changes likely interfere with channel closing, contributing to the longer sparks. R420 is a 
highly conserved residue, being common in all species analyzed, including humans.462  
Gain-of-function and loss-of-function mutation 
Mutations on RyR2 could result in protein gain-of-function or loss-of-function effect that 
increase or decrease channel activity respectively. In ventricular myocytes, the gain-of-function 
mutations promote SR Ca2+ leak during diastole and DADs (delayed afterdepolarizations), 
triggering arrhythmogenic disorders.637 In respect of that, Thomas et al. analyzed four SCD-(sudden 
cardiac death) related CPVT/ARVD2 mutations (L433P, N2386I, R176Q, T2504M), and found that 
three SCD-related mutations (N2386I, R176Q, T2504M) exhibit a gain-of-function phenotype.638 
However, the SCD-related mutation L433P was less sensitive than the WT, suggesting that loss-of-
function mutation could also promote arrhythmias.637, 638 Moreover, a recent research reported that 
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CPVT mutation RyR2
A4860G is a loss-of-function and also arrhythmogenic mutation, as mentioned in 
introduction.464 Thus, both gain-of-function and loss-of-function mutations are capable to induce 
arrhythmogenic disorders in ventricular myocytes.  
The RyR2 N-terminal mutations are not well studied, while lack of animal model restricts the 
further investigation. There is one research studied a mouse model carrying N-terminal mutation 
R176Q .468 This mutation is a gain-of-function mutation, found together with other mutation 
(T2504) in a family of arrhythmogenic right ventricular dysplasia (ARVD). However, this mutation 
is located in domain A. The only mouse model carrying RyR2 N-terminal C-domain mutation was 
reported by Okudaira et al. that the homogeneous RyR2
R420W mutation caused the abnormal calcium 
dynamics and arrhythmogenesis in mutated mouse ventricular myocytes. However, this research did 
not investigate the RyR2
R420W behavior, and whether the arrhythmogenesis effect of RyR2 
R420W was 
induced by RyR2 gain-of-function or loss-of-function was not known.
639 Tang et al. studied 
RyR2
R420W behavior in inducible HEK293 cell line.521 However, R420W mutation adopts a 
conformation pointing to the solvent and avoids significant structural changes of RyR2, which 
differs from R420Q mutation.462, 520 In this thesis, we for the first time reported an increased Ca2+ 
release effect of an N-terminal C-domain mutant RyR2 in a mouse model, and demonstrated that 
R420Q is a gain-of-function mutation, likely not only by a gain in its open probability but also by a 
loss in its closing capabilities, or an increase in the open time. The biophysical properties of single 
RyR2
R420Q are being analyzed, while the analysis of Ca2+ sparks shows a marked increase in the 
time to peak. When a cluster of RyRs opens to produce a Ca2+ spark, the released Ca2+ is around it 
and the Ca2+ concentration increases during the time there is release. Then the channels close and 
Ca2+ decreases mainly by diffusion.  Thus the enhanced time to peak is reminiscent of prolonged 
open times.  
It was also reported that loss-of-function mutation A4860G induced sinus bradycardia in 
heterozygous mutated mice.464 Besides, inhibition of RyR2 reduces the SAN pacemaker activity. 
One may expect that gain of function mutation on RyR2 could induce accelerated SAN activity, 
taking into account that increased Ca2+ release could enhance NCX current and depolarize the 
membrane. However, the RyR2-induced CPVT patients are frequently associated with sinus 
bradycardia, as well as in gain-of-function mutation R4496C carriers.458 Our team investigated the 
RyR2
R4496C behavior both in ventricular and in SAN cells. It was found that Ca2+ spark frequency 
was increased by 2-fold in RyR2
R4496C SAN cells, associated with prolonged cycle length and 
impaired isoproterenol response.458 However this mutation is located in C-terminal of the RyR2, and 
this is also the only research that studied the mechanism of the SAN dysfunction induced by the 
CPVT-related RyR2 mutation. Thus, this thesis for the first time investigated the SAN function in a 
mouse model carrying N-terminal RyR2 mutation. In RyR2
R420Q SAN, we found enhanced Ca2+ 
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release during diastolic depolarization, indicating a gain-of-function effect in SAN. This gain-of-
function mutation resulted in the slower pacemaking activity in female KI mice, in dissected KI 
mice SAN, as well as R420Q carrying patients.457  
It seems that both gain-of-function and loss-of-function RyR2 mutations could induce slower 
pacemaking activity, but the mechanisms are probably distinct. The enhanced Ca2+ leak during 
diastole may have at least 2 mechanisms to reduce automaticity: one is partially unloading the SR of 
Ca2+. In this respect, Satoh showed that high concentrations (over 5 mM) of caffeine that would 
unload the SR with Ca2+ induce a negative chronotropic effect in SAN cells.640, 641 Moreover, the 
Ca2+ release inactivates the L-Type Ca2+ current (ICa,L), which is also involved in AP generation in 
SAN. In this respect, it has been recently shown that mice with less ICa,L present bradycardia.
112, 464 
R420Q induced SAN dysfunction 
Human RyR2
R420Q carriers present higher incidence of sinus bradycardia compared with 
genotype-negative individuals (78% vs. 25%, P = 0.030). These results revealed the SAN 
dysfunction induced by RyR2 mutation R420Q.
457  
In genetic modified mice, RyR2
R420Q female mice had lower heart rate than WT females during 
the day, indicating the SAN dysfunction in this mouse model. Consistent with this observation, 
dissected SAN from both male and female KI mice presented slower pacemaker activity compared 
with the relevant WT. The slower pacing rate in KI SAN cells was accompanied with more Ca2+ 
release during diastolic depolarization. The ISO response of dissected SAN was greater in R420Q 
KI than in WT, indicating an enhanced sensitivity to -AR response. The SAN dysfunction in 
CPVT patients gives risk of sudden death by letting time to ectopic foci to form, probably favors the 
ventricular disorder. Moreover, it may limit the dose of -blocker tolerated and impair the efficacy 
of ICD (implantable cardioverter defibrillator) therapy for CPVT. 
Correct RyR2 function is required for normal SAN automaticity 
As inhibition of RyR2 reduces the SAN pacemaker activity, it is well accepted that RyR2 is 
important for generation of SAN automaticity. However, the effect of point mutations on RyR2 on 
SAN automaticity is not well studied. Besides, the RyR2-induced CPVT patients are frequently 
associated with sinus bradycardia, which was seen in N-terminal mutation R420Q carriers. Thus, it 
is necessary to identify the mechanism of SAN dysfunction induced by RyR2 point mutation.  
Suprevantricular arrhythmia has been reported in many CPVT families, including sinus 
bradycardia at rest.455 In a previous work, our team458 found that mice carrying the RyR2
R4496C 
mutation  presented heart rates similar between the KI RyR2
R4496C mice and the WT. However, the 
KI mice displayed a dramatic increase in the incidence of SAN pauses during sudden reduced sinus 
rhythm periods after intraperitoneal injection of isoproterenol, which were overcame by atrial 
and/or junctional escape beats. The dissected RyR2
R4496C SAN presented significantly slower 
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pacemaker activity and impaired chronotropic response to -adrenergic stimulation, accompanied 
by the appearance of pauses (in spontaneous [Ca2+]i transients and action potentials) in 75% of the 
cases. Ca2+ spark frequency was increased by 2-fold in RyR2
R4496C SAN, which is consistent with 
the finding of leaky RyR2
R4496C in ventricular myocytes.466, 634 Isolated RyR2
R4496C SAN cells 
showed reduced ICa,L density ~50%, indicating a modified membrane clock. Isoproterenol 
dramatically increased the frequency of Ca2+ sparks and waves by ~5 and ~10-fold, respectively. 
The SR Ca2+ content was significantly reduced in RyR2
R4496C SAN cells in the presence of 
isoproterenol, which may contribute to the SAN pauses by stopping the “Ca2+ clock” rhythm 
generation. Thus, R4496C mutation decreased SR Ca2+ content via enhanced RyR2 Ca
2+ release 
influencing the Ca2+ clock, and R4496C mutation also induced reduced ICa,L density indirectly 
depressing the membrane clock. Via the effects on both clocks, it is expected that R4496C mutation 
slowed the SAN pacemaking activity. 
In contrast to RyR2
R4496C mice, RyR2
R420Q female mice had lower heart rate than WT females 
during the day. Dissected SAN also presented slower pacemaker activity compared with WT as 
seen in RyR2
R4496C SAN, but accompanied with longer sparks with smaller increase in Ca2+  spark 
frequency. Eventually, the SR Ca2+ content was reduced in both RyR2
R4496Cand RyR2
R420Q SAN 
cells. Besides, as seen in the RyR2
R4496C SAN cells, isolated RyR2
R420Q SAN cells also showed 
significant smaller ICa,L. The ISO response of dissected SAN to 20 nM ISO was greater in 
RyR2
R420Q KI than in WT, and similar response is also seen in female KI mice, different from the 
impaired response from RyR2
R4496C SAN cells. As seen from R4496C mutation, R420Q mutation 
also impact both Ca2+ clock and membrane clock. For the Ca2+ clock it is likely that via increased 
Ca2+ release, R420Q mutation retards the SR Ca2+ restoration, and prevents the achievement of SR 
Ca2+ content threshold for [Ca2+]i transient initiation.
16 Indeed, the SR Ca2+ content is reduced in 
RyR2
R420Q SAN cells, which is consistent with the previous hypothesis. Similar data has been 
reported by using SERCA blocker (cyclopiazonic acid) which blocks SR Ca2+ recovery and thus 
reduced SAN pacemaker activity.229 Besides the reduced ICa,L, the increased cytosolic [Ca
2+]i also 
inhibited the activation of ICa,L disturbing the membrane clock, while pharmacological inhibition or 
genetic deficiency of LTCC in SAN results in slower pacemaker activity.112 Thus, R420Q probably 
affects the pacemaker activity through slowing generation of periodic Ca2+ oscillations (i.e. Ca2+ 
clock) and interfered membrane clock resulting in the defective coupled-clock, without 
modification in If density. Thereby, via different mechanisms, both mutation R4496C and R420Q 
promote SAN dysfunction via distinct RyR2 behaviors and mechanisms.  
Thus, single point mutation on RyR2 is sufficient to produce sick SAN activity and -AR 
response. On the other hand, extremely correct RyR2 function is required by normal SAN 
automaticity.  
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Ca2+ regulation by Ca2+ in SAN 
Ca2+ released from RyR2 could regulate Ca
2+ behavior and pacemaker activity of SAN cells as 
mentioned previously in introduction, as application of Ca2+ (or Ca2+ chelator) accelerates (or 
inhibits) SAN automaticity. Ca2+ directly regulates ion channels involved in membrane clock, 
meanwhile, promotes PKA-/CaMKII-dependent protein phosphorylation that drive the coupled 
clock function. 
In RyR2
R4496C SAN, it is likely that the enhanced Ca2+ release inhibited the ICa,L, as it is known 
that LTCC could be inhibited by Ca2+, while compensated effects (such as changed protein 
expression pattern) might also exist. Thus diastolic Ca2+ release, regulating the Ca2+ entry via LTCC 
and Ca2+ release via modified SR Ca2+ content, reduces both Ca2+ and membrane clock resulting in 
the expected suppressed SAN automaticity.  
In RyR2
R420Q mice, the increased diastolic Ca2+ release influenced the SAN automaticity also 
via changed Ca2+ homeostasis. As seen in RyR2
R4496C, ICa,L was also reduced in RyR2
R420Q SAN 
cells. To exclude the Ca2+ inactivation of LTCC, we repeated the experiments with a Ca2+ chelator 
in the pipette solution, and no significant difference was found in ICa,L between KI and WT. These 
data suggest that intracellular Ca2+ alteration can induce decrease in ICa,L in KI mice, which could 
account for the slowing of SAN pacing rate. Besides, the increased Ca2+ release retards SR refill 
and depresses Ca2+ clock, together with the damaged membrane clock, resulting in the slower SAN 
automaticity. 
In spite of the different mechanisms, R4496C and R420Q are both RyR2 mutations that through 
altered Ca2+ behavior influence SAN automaticity, indicating the critical role of Ca2+ regulation in 
SAN automaticity. 
R420Q mutation on mouse and human RyR2 
RyR2
R420Q mouse model presents CPVT phenotype after typical CPVT test (epinephrine plus 
caffeine injection), indicating that this genetically modified mouse model is effectual to be used as a 
preclinical model. However, there is still some difference of this mouse model compared to human 
patients.   
From the vivo basal ECG recordings, only RyR2
R420Q female displays significant difference 
compared to WT female, but not RyR2
R420Q male. These data differ from the human clinical 
observation that SAN dysfunction (such as sinus bradycardia) was shown in both male and female 
CPVT patients. This difference could be due to the different adrenergic tone, which is higher in 
mice than in human (session 1.5). In support of this hypothesis, both dissected male and female 
SAN (lacks autonomic innervation, in this case, sympathetic tone particularly) from KI mice had 
slower basal pacemaker activity.  
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SAN automaticity in male and female mice 
From previous data, the team found some significant differences between male and females in 
Ca2+ sparks.642, 643 In this study, the in-vivo basal PP interval in WT male was longer than WT 
female during both day and night. However, the in-vitro WT male cycle length was shorter than in 
relevant WT female in dissected SAN cells, and WT male SAN cells have more Ca2+ release during 
diastolic depolarization than the WT female. This observation is consistent with a previous 
hypothesis that cAMP level is higher in male ventricles (session 1.4.3.4), due, at least partially, to 
the lower PDE4B expression.283 The contradictory results in genders between in-vivo and in-vitro 
indicate multiple and compromised actions. Hypothetically the cAMP level is higher in males,283 
resulting in faster beating rate in vitro. However, the heart size is smaller in females, what needs to 
enhance the heart rate to maintain good ejection fraction in vivo. But interestingly, as shown in the 
in-vivo data from KI mice, the difference in PP intervals between KI male and KI female is almost 
absent (non-significant), because of the relatively longer PP interval in KI females compared to WT 
females. As the longer cycle length in KI mice in vitro persisted in vivo KI females but lost between 
males, it is more likely that KI males have relatively shorter PP intervals, suggesting a more 
complicated and compensated sympathetic/parasympathetic system in KI males. Hypothetically, in 
contrast with the KI females, the KI males probably have relatively higher adrenergic tone than WT 
males in vivo, resulting in the similar PP interval as WT males. This hypothesis could also explain 
the greater CCH response in KI males than WT males in vivo, which was not observed in vitro, as 
when the heart rate is increased by sympathetic stimulation the vagal stimulus is considerably 
greater.237 However, the WT and KI females were thought to have greater adrenergic tone than 
males, but their CCH responses were only a bit greater than WT males (not statistically different) 
and smaller than KI males, probably attributed to the lower cAMP level in females. Although, more 
complicated and compensated effect may exist. 
It was reported that sex-related differences existed in RyR2-induced CPVT patients: male 
patients have a higher risk of cardiac events.442 The cardio-protection in female conferring survival 
benefits was also reported in severe cardiac diseases, such as heart failure.301-303 Consistent with 
these observations, we found a significant shorter duration of BVT after epinephrine and caffeine 
injection in KI females than KI males, also indicating a more complicated and severe effect in KI 
males.  
In contrast with the in-vitro ISO responses in dissected SAN, which were greater in both male 
and female KI mice than in WT, the in-vivo response was only preserved between KI females and 
WT females, not between males. ISO shortened RR interval more dramatically in KI female in vivo 
than WT females. However, a different ISO response was not observed in KI males in vivo, 
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probably due to the lower adrenergic tone (compared to females) resulting in an insufficient ISO 
dosage in males.  
Sympathetic and parasympathetic stimulation 
It seems like that in dog and human vagal tone is dominant as combined muscarinic plus -
adrenoceptor blockage accelerates the heart rate.2, 6 In contrast, mice show sympathetic 
predominance as the isolated SAN beats significantly slower than the heart rate in vivo.6 
In this thesis, in vivo sympathetic stimulation (isoproterenol injection) induced significant 
responses (heart rate increase) in all types of mice, but the response was greater in KI female than in 
WT female. The in vivo parasympathetic stimulation (carbachol injection) also induced significant 
response (heart rate decrease) in all type of mice, and the response was greater in KI male than in 
WT male. Consistent with the in-vivo observation, the SAN dissected from all types of mice 
increased pacing rate significantly after ISO stimulation, although the response is significant greater 
in all KI mice than the relevant WT mice. Carbachol also prolonged the pacing rate in all types of 
dissected SAN, but no differences between KI and WT mice in vivo.  
In summary, in this thesis, we investigated the novel RyR2 N-terminal mutation R420Q. We 
found that this mutation induced sinus bradycardia and SAN dysfunction in human patient and in 
mouse model, and further investigation suggests that the mutation interferes RyR2 channel closing 
resulting in longer [Ca2+]i sparks and SR replenishment, accounting for the sick SAN function and 
ISO response. The SAN dysfunction may in turn favor the initiation of ectopic foci. Our work for 
the first time reported the gain-of-function effect resulted by an N-terminal C-domain mutation 
R420Q, and for the first time investigated the SAN dysfunction induced by RyR2 N-terminal 
mutation and found a novel mechanism (defect in channel closing) caused SAN dysfunction. Our 
work provides a new mechanism to CPVT related SAN dysfunction and insight to CPVT therapy.  
However, it is still unknown about the behaviors of other N-terminal mutation related RyR2, the 
resultant SAN function, SAN -AR response and gender-dependent effect. The contribution of loss-
of-function RyR2 to SAN function is also desirable. 
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Anexe 
Reconciling depressed Ca2+ sparks occurrence with enhanced RyR2 activity in failing mice 
cardiomyocytes  
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I N T R O D U C T I O N
Cardiovascular disease is the leading cause of death in 
the world (Dahlöf, 2010; Lloyd-Jones, 2010). Heart fail-
ure (HF) supports an important percentage of the car-
diovascular diseases with serious clinical complications 
including cardiac arrhythmias, in many cases derived 
from calcium (Ca2+)-handling impairment. Among oth-
ers, Ca2+ is a key factor of electrical activation, ion chan-
nel gating, and excitation–contraction (EC) coupling in 
the cardiac muscle. During cardiac EC coupling, Ca2+ 
inlux via sarcolemmal L-type Ca2+channels triggers Ca2+ 
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Ca2+ ATPase.
release from the SR by RyRs, increasing the cytosolic Ca2+ 
concentration ([Ca2+]i), which activates myocyte contrac-
tion (Fabiato and Fabiato, 1975; Bers, 2002). Cytosolic 
[Ca2+]i transient results from spatial and temporal summa-
tion of elementary Ca2+ events named Ca2+ sparks (Cheng 
et al., 1993). This [Ca2+]i elevation is transient, because 
Ca2+ is promptly extruded to the extracellular medium 
by the sodium–calcium exchanger (NCX) and pumped 
back to the SR by the sarco-endoplasmic reticulum Ca2+ 
ATPase (SERCA), whose activity is controlled by phos-
pholamban (PLB). Other systems participate in regain-
ing diastolic [Ca2+]i but to a minor degree (Bers, 2002).
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Abnormalities in cardiomyocyte Ca2+ handling contribute to impaired contractile function in heart failure (HF). 
Experiments on single ryanodine receptors (RyRs) incorporated into lipid bilayers have indicated that RyRs from 
failing hearts are more active than those from healthy hearts. Here, we analyzed spontaneous Ca2+ sparks (brief, 
localized increased in [Ca2+]i) to evaluate RyR cluster activity in situ in a mouse post-myocardial infarction (PMI) 
model of HF. The cardiac ejection fraction of PMI mice was reduced to 30% of that of sham-operated (sham) 
mice, and their cardiomyocytes were hypertrophied. The [Ca2+]i transient amplitude and sarcoplasmic reticulum 
(SR) Ca2+ load were decreased in intact PMI cardiomyocytes compared with those from sham mice, and spontane-
ous Ca2+ sparks were less frequent, whereas the fractional release and the frequency of Ca2+ waves were both in-
creased, suggesting higher RyR activity. In permeabilized cardiomyocytes, in which the internal solution can be 
controlled, Ca2+ sparks were more frequent in PMI cells (under conditions of similar SR Ca2+ load), conirming the 
enhanced RyR activity. However, in intact cells from PMI mice, the Ca2+ sparks frequency normalized by the SR 
Ca2+ load in that cell were reduced compared with those in sham mice, indicating that the cytosolic environment 
in intact cells contributes to the decrease in Ca2+ spark frequency. Indeed, using an internal “failing solution” with 
less ATP (as found in HF), we observed a dramatic decrease in Ca2+ spark frequency in permeabilized PMI and 
sham myocytes. In conclusion, our data show that, even if isolated RyR channels show more activity in HF, con-
comitant alterations in intracellular media composition and SR Ca2+ load may mask these effects at the Ca2+ spark 
level in intact cells. Nonetheless, in this scenario, the probability of arrhythmogenic Ca2+ waves is enhanced, and 
they play a potential role in the increase in arrhythmia events in HF patients.
© 2015 Ruiz-Hurtado et al. This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the irst six months after the publi-
cation date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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even if RyRs were more active, this would decrease the 
SR Ca2+ load, depressing RyR activity, until reaching 
new equilibrium. Moreover, higher activity of RyRs does 
not exclusively mean more Ca2+ sparks. Some authors 
have reported an increase in the Ca2+ spark frequency 
in HF animal models (Belevych et al., 2011), whereas 
others demonstrated a signiicant decrease in the Ca2+ 
spark frequency of isolated cardiomyocytes from patients 
with terminal HF compared with non-failing individuals 
(Lindner et al., 2002). But the RyR activity not only de-
pends on its phosphorylation state, but also on its envi-
ronment, which can be altered in HF. For example, ATP 
level, which activates the RyR (Laver, 2006), is depressed 
in HF (Neubauer, 2007). To clarify this point, we hypoth-
esize that the increased activity of RyRs may be masked 
in intact cardiomyocytes by other alterations, but might 
be unmasked in permeabilized myocytes where the cyto-
solic environment is tightly controlled by the used internal 
solution. Here we show, for the irst time, a comparison 
between Ca2+ spark recordings in intact versus permea-
bilized cardiomyocytes in a mouse model of cardiac dys-
function post-myocardial infarction (PMI).
M A T E R I A L S  A N D  M E T H O D S
All experiments were performed according to the ethical prin-
ciples laid down by the French Ministry of Agriculture and the 
European Union Council Directives (2010/63/EU) for the care 
of laboratory animals.
Induction of myocardial infarction
Myocardial infarction was induced by left coronary artery ligation 
under anesthesia (2% isolurane/O2; AErrane; Baxter) in 16 male 
C57BL/6J mice (9 wk of age) placed under mechanical ventila-
tion. Left anterior descending coronary artery was visualized and 
ligated 1–2 mm from the top of the left atrium. A subcutaneous 
injection of buprenorphine (0.3 mg/ml) was administered for post-
operative analgesia. Sham mice (n = 14) were subjected to the same 
surgical procedure but without coronary artery ligation. 4–6 wk 
after surgery, cardiac contractile function was assessed by M-mode 
echocardiography. Only PMI hearts that showed a transmural scar 
greater than four (number of parts occupied by the scar from a 
total of six, as assessed by visual division of the left ventricle–free 
wall, as we did before) were used (Perrier et al., 2004).
Echocardiography
Transthoracic echocardiography was performed using a 15-MHz 
transducer (Vivid 9; GE Healthcare) under 3% isolurane gas an-
esthesia. Two-dimensional echocardiography was used to deter-
mine left ventricular ejection fraction using a modiied version of 
Simpson’s monoplane analysis (Milliez et al., 2009).
Ventricular myocytes isolation
Ventricular myocytes from sham and PMI mice were isolated 
using an enzymatic perfusion method (Ruiz-Hurtado et al., 2007; 
Fernández-Velasco et al., 2011). In brief, mice pretreated with 
1,000 U/kg heparin were anaesthetized with 50 mg/kg sodium 
pentobarbital administered intraperitoneally. Hearts were removed 
and placed in ice-cold oxygenated Tyrode’s solution containing 
(in mmol/liter): 130 NaCl, 0.4 NaH2PO4, 5.8 NaHCO3, 0.5 MgCl2, 
5.4 KCl, 22 glucose, 25 HEPES, and 103 insulin, pH 7.4 with NaOH. 
The aorta was cannulated above the aortic valve and perfused by 
A signiicant decrease in the [Ca2+]i transient ampli-
tude is a common feature observed in human and animal 
models of HF and contributes to depressed contractile 
function (Beuckelmann et al., 1992; Kubo et al., 2001; 
Piacentino et al., 2003). The global [Ca2+]i transient de-
pends on several factors: the trigger L-type Ca2+ current 
(ICaL), the amount of Ca
2+ stored in the SR, and the RyR 
function. ICaL density has been found unaltered in human 
(Beuckelmann et al., 1992; Piacentino et al., 2003) and 
most experimental models of HF (Bénitah et al., 2002). 
However, a defect in the eficacy of ICaL to release Ca
2+ has 
been manifested as a signiicant reduction in the amount 
of Ca2+ sparks triggered by ICaL (Gómez et al., 1997, 2001). 
This defect in EC coupling can be related to structural 
alteration of the remodeled cardiomyocyte, which ef-
fectively increases the distance between the L-type Ca2+ 
channels and RyRs, as it was irst suggested (Gómez et al., 
1997), and lately supported by alteration of T-tubular 
structure and increase in the orphaned RyRs (Wagner 
et al., 2012). Concomitantly, the reduction in SR Ca2+ 
load in the failing myocyte is an important determinant 
for the reduced amplitude of the [Ca2+]i transient am-
plitude in systole. This reduction has been ascribed to an 
impairment in the SR Ca2+ uptake, related to depressed 
SERCA function and expression in HF (Mercadier et al., 
1990; Meyer et al., 1995; Gaughan et al., 1999) and in-
creased ratio of PLB/SERCA expression and/or PLB 
hypophosphorylation (Reiken et al., 2003). The NCX 
expression has also been found to be increased in many 
HF models, and although its contribution to unload the 
SR Ca2+ is unclear (Bénitah et al., 2002; Gómez et al., 2002; 
Piacentino et al., 2003), it may participate to deplete Ca2+ 
stores. The reduction in the SR Ca2+ load in HF could also 
be caused by an increase in the Ca2+ leak during diastole 
(Fischer et al., 2013), which has been related to an in-
crease in the RyR phosphorylation status by PKA (Marx 
et al., 2000; Reiken et al., 2003) or Ca2+/calmodulin-
dependent protein kinase II (Ai et al., 2005).
Diastolic Ca2+ leak occurs in several forms: as Ca2+ sparks, 
Ca2+ waves, or even as image-imperceptible RyR open-
ings (Zima et al., 2010). What remains unclear today is 
how HF might affect Ca2+ spark occurrence in quiescent 
myocytes. If all other elements of EC coupling were un-
affected, enhanced RyR activity might be viewed as an 
increased occurrence of spontaneous Ca2+ sparks. For 
example, the frequency of Ca2+ sparks is greatly enhanced 
in a pro-arrhythmogenic model caused by RyR point mu-
tation (Fernández-Velasco et al., 2009). In healthy cardio-
myocytes, an acute increase in RyR activity only produces 
transient effects: in a few twitches, the SR Ca2+ load is 
depressed so the [Ca2+]i transient returns to control val-
ues (Trafford et al., 1998). However, in HF, with numerous 
concomitants alterations, no consensus data have been 
reported regarding spontaneous Ca2+ spark frequency. 
In fact, the frequency of Ca2+ sparks is also dependent 
on the SR Ca2+ load (Györke and Terentyev, 2008). Thus, 
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Ca2+ load. Fractional SR release was measured by normalizing the 
steady state of the Ca2+ transient (peak F/F0) by the caffeine-evoked 
intracellular Ca2+ transient (peak F/F0 evoked by 10 mmol/liter 
of rapid caffeine application). Post-rest potentiation was calculated 
by normalizing the irst intracellular Ca2+ transient (peak F/F0) after 
a period of rest from 2 min to reach the steady-state [Ca2+]i tran-
sient (Ruiz-Hurtado et al., 2012a).
Ca2+ spark recording
To record spontaneous Ca2+ sparks and Ca2+ waves in intact quies-
cent cells, after [Ca2+]i transient recordings, each myocyte was 
scanned 12 times for 1.5 s at 1.5 ms per line. Ca2+ sparks were de-
tected as localized, rapid, and brief elevations in Ca2+ luorescence. 
Ca2+ sparks were detected using an automated detection system 
(homemade in IDL; Exelis Visual Information Solutions) and a 
criterion that limited the detection of false events while detecting 
most Ca2+ sparks (Fernández-Velasco et al., 2009). Abnormal spon-
taneous Ca2+ release manifested as Ca2+ waves were quantiied by 
the percentage of occurrence. Ca2+ wave was identiied as an in-
crease in the Ca2+ luorescence starting locally and propagated to 
one or both sides of the cell (Fernández-Velasco et al., 2009).
In permeabilized myocytes, the basic control internal solu-
tion used contained (in mmol/liter): 120 K-aspartate, 10 HEPES, 
3 MgATP, 0.5 EGTA, 10 Na phosphocreatine, 5 U/ml creatine 
phosphokinase, and 0.75 MgCl2, and 8% dextran, pH 7.2. After 
permeabilization with saponin (0.01% wt/vol for 60 s), this 
solution was supplemented with 50 µmol/liter K5-Fluo-3 and 
enough CaCl2 to reach 50 nmol/liter of free Ca
2+, calculated with 
MAXCHELATOR. Ca2+ sparks were recorded after a period of 
1 min of stabilization in this internal solution.
In a set of experiments to mimic the pathological conditions 
of a failing heart, a “failing” internal solution was used, of similar 
gravity at 37°C with preoxygenated Tyrode’s solution contain-
ing 0.1 mmol/liter EGTA for 2 min. Enzyme solution with 1 g/liter 
collagenase Type II (Worthington Biochemical Corporation) or 
5 g/liter Liberase (TM Research Grade; Roche) in Tyrode’s solu-
tion supplemented with 0.1 mmol/liter CaCl2 was then perfused 
until the aortic valve was digested, as assessed by increased eflux. 
Hearts were removed, cut in small pieces, and gently shaken in 
enzyme solution supplemented with 2 g/liter BSA for 2 min at 
37°C to disperse individual myocytes. Myocytes were then iltered 
through a 250-µm nylon mesh and centrifuged at 20 g for 2 min. 
A pellet containing myocytes was resuspended in Tyrode’s solu-
tion supplemented with 0.5 mmol/liter CaCl2 and 2 g/liter BSA, 
and then centrifuged again. The inal pellet was resuspended in 
storage solution containing Tyrode’s solution supplemented with 
1 mmol/liter CaCl2.
[Ca2+]i transients and SR Ca
2+ load
We used 14 control mice and 16 PMI animals. Isolated ventricular 
myocytes were loaded with the membrane-permeant Fluo-3 AM, 
as described previously (Pereira et al., 2012; Ruiz-Hurtado et al., 
2012b). Confocal Ca2+ images were obtained by exciting the cell 
at 488 nm, and emission was collected at >505 nm using a laser 
scanning confocal microscope (LSM510; Carl Zeiss, or SP5; Leica) 
equipped with a 63× N.A. 1.2 water-immersion objective in the line-
scan mode. To record intracellular Ca2+ ([Ca2+]i) transients, myo-
cytes were electrically ield stimulated by two Pt electrodes at 2 Hz. 
Before recording, Fluo-3–loaded myocytes were stimulated for 1 min 
to reach steady state. The luorescence values (F) were normal-
ized by the basal luorescence (F0) to obtain F/F0. For SR Ca
2+ 
load estimation, intact ventricular myocytes were rapidly perfused 
with 10 mmol/liter caffeine just after ield stimulation. The am-
plitude of caffeine-evoked Ca2+ transients was used to assess SR 
Figure 1. Myocardial infarction induces a decrease in [Ca2+]i transients. (A) Ejection fraction measured by echocardiography in control 
(white bar; n = 12) and coronary artery occlusion (PMI; red bar; n = 12)–operated mice. (B) Cardiomyocyte area expressed in square 
micrometers for sham (white bar; n = 14 cells from three animals) and PMI (red bar; n = 11 cells from three animals). (C) Line-scan 
images during ield stimulation at 2 Hz of one ventricular myocyte from sham (top) or PMI (bottom) mice. (D–F) Intracellular [Ca2+]i 
transient peak (D), decay time (E), and cell shortening (F; 34 cells from eight sham mice and 30 cells from eight PMI mice) in ventricu-
lar myocytes. Peak expressed as maximum F/F0, where F is the luorescence trace and F0 is the luorescence during the diastolic period. 
*, P < 0.05; **, P < 0.01; ***, P < 0.001 versus myocytes from sham mice. Error bars represent the SEM.
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compared with hearts from sham mice (Fig. 1 A). Cel-
lular hypertrophy was assessed by cardiomyocyte area 
measured by confocal microscopy images of isolated 
ventricular myocytes. Cardiomyocytes from PMI mice 
showed signiicantly higher cellular area than myocytes 
from sham-operated animals, indicating hypertrophy at 
the cellular level (Fig. 1 B). To determine whether intra-
cellular Ca2+ handling was altered in hypertrophied 
myocytes from PMI mice, we analyzed [Ca2+]i transients. 
Fig. 1 C shows representative line-scan images of evoked 
[Ca2+]i transients from sham (top) and PMI (bottom) 
cardiomyocytes. The [Ca2+]i transients recorded in PMI 
myocytes were smaller in amplitude than those recorded 
in control myocytes. The average amplitude of [Ca2+]i 
transients showed a signiicant reduction in myocytes 
from PMI mice compared with myocytes from sham-
operated mice (Fig. 1 D). [Ca2+]i transient decay time 
(Fig. 1 E) was signiicantly prolonged in myocytes from 
PMI mice compared with those from sham-operated 
mice, suggesting slower Ca2+ uptake by the SERCA pump. 
Cellular shortening was also signiicantly decreased in 
myocytes from PMI mice (Fig. 1 F). Because SR Ca2+ load 
is determinant in [Ca2+]i transient amplitude, we mea-
sured SR Ca2+ content by rapid caffeine application, as 
composition to the basic control solution, but ATP and creatine 
phosphokinase were reduced by half, and inorganic phosphates 
were added (6.5 mmol/liter K2HPO4) (Ingwall, 2006, 2009). To 
maintain the total amount of Mg, while reducing MgATP concen-
trations, the amount of MgCl2 was increased to 2.25 mmol/liter.
SR Ca2+ load in permeabilized myocytes was estimated by rapid 
20-mmol/liter caffeine application (solved in basic or failing solu-
tion) after Ca2+ spark recording.
Statistical analyses
Data are presented as means ± SEM. Statistical signiicance was 
evaluated by Student’s t test. For statistical comparison of occur-
rence, Ca2+ waves and triggered activity Gaussian Fisher’s 2 test 
was used. Preliminary descriptive analyses included frequencies 
for categorical variables and mean ± SD for continuous variables. A 
conditional hierarchical linear model was used (SAS/UNIX statisti-
cal software; PROC MIXED; SAS Institute) to compare continuous 
variables between groups to take into account the multiple obser-
vations per animal. The group was a ixed effect, and animals were a 
random effect nested in the group; in the case of repeated mea-
surements on cells, we added a random effect for cells in animals.
R E S U L T S
Ca2+ release and SR Ca2+ load after myocardial infarction
Hearts from PMI mice showed a signiicant reduction in 
the ejection fraction, measured by echocardiography, 
Figure 2. Myocardial infarction 
induces a decrease in SR Ca2+ 
load. (A) Line-scan images of caf-
feine-evoked intracellular Ca2+ 
transients after ield stimulation 
at 2 Hz in one ventricular myocyte 
from sham (left) or PMI (right) 
mice obtained by the applica-
tion of 10 mmol/liter caffeine. 
(B) Averaged caffeine-evoked Ca2+ 
transient peak (F/F0) of myocytes 
from sham (white bar; n = 43 cells 
from six animals) and PMI (red 
bar; n = 21 cells from ive ani-
mals) mice. (C) Averaged decay 
time constant of the caffeine-
evoked Ca2+ transient (34 cells 
from six sham animals; 13 cells 
from ive PMI animals). (D) Frac-
tional SR Ca2+ release during 
ield stimulation at 2 Hz in con-
trol myocytes (white bar; n = 36 
cells from three animals) and 
in cells from PMI mice (red bar; 
n = 20 cells from three animals). 
(E) Post-rest potentiation (white 
bar; n = 36 cells from three ani-
mals) and in cells from PMI mice 
(red bar; n = 20 cells from three 
animals). Error bars represent 
the SEM. *, P < 0.05; **, P < 0.001 
PMI versus sham.
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known as Ca2+ spark (Cheng et al., 1993). We therefore 
recorded Ca2+ sparks in quiescent cells, as exempliied 
in Fig. 3 A in cardiac myocytes from sham (left) and 
PMI mice (right). Surprisingly, contrary to the sup-
posed increased activity of RyR based on the fractional 
release data (Fig. 2 D), cardiomyocytes from PMI hearts 
showed a signiicant decrease in Ca2+ spark frequency 
(Fig. 3 A, bottom).
However, single-channel data have shown higher ac-
tivity of RyR in failing hearts (Marx et al., 2000), so an 
increase in Ca2+ sparks was expected. To resolve this 
discrepancy, we analyzed Ca2+ sparks in permeabilized 
myocytes (Pereira et al., 2006). Under these conditions, 
sarcolemmal luxes (NCX, ICaL) are invalidated. More-
over, this maneuver allows us to analyze Ca2+ sparks in the 
same cytoplasmic environment for both cell types (same 
ATP, Ca2+, Mg concentration). Fig. 3 B illustrates Ca2+ 
spark occurrence in myocytes from the sham mouse (left) 
and PMI mouse (right). After permeabilization, myocytes 
from PMI mice did exhibit signiicantly higher Ca2+ spark 
frequency than control myocytes (Fig. 3 B, bottom).
To asses biophysical characteristics of Ca2+ sparks, we 
analyzed their amplitude (measured as the peak F/F0), 
full duration at half-maximum (FDHM), and full width 
exempliied in Fig. 2 for one sham myocyte (left) and one 
hypertrophied myocyte from PMI mouse (right). The 
averaged caffeine-evoked [Ca2+]i transients were smaller in 
PMI myocytes compared with sham myocytes (Fig. 2 B). 
Thus, the decrease in [Ca2+]i transient amplitude might 
be related, at least in part, to the decrease in SR Ca2+ 
load. Caffeine-evoked [Ca2+]i transient decay was signii-
cantly accelerated in myocytes from PMI mice (Fig. 2 C), 
suggesting faster Ca2+ extrusion through the NCX. We 
also estimated the fractional release in electrically evoked 
beats by normalizing [Ca2+]i transient amplitude by the 
SR Ca2+ load (see Materials and methods). We observed 
that myocytes from PMI mice showed increased fractional 
release compared with sham myocytes (Fig. 2 D), suggest-
ing higher RyR activity, even if the [Ca2+]i transient is 
depressed. However, the capacity of the SR to accumu-
late Ca2+ during rest, as estimated by the post-rest poten-
tiation, was decreased in PMI cardiomyocytes (Fig. 2 E).
Opposite effect in spark-mediated Ca2+ leak in intact 
versus permeabilized myocytes after myocardial infarction
The increase in fractional release may relect a higher sen-
sitivity of RyRs to Ca2+ in PMI mice. The opening of a RyR 
cluster induces rapid, local, and brief [Ca2+]i elevation 
Figure 3. Ca2+ spark frequency in intact versus permeabilized myocytes after myocardial infarction. (A; top) Line-scan images obtained 
in intact myocytes from sham (left) or from PMI (right) mice. (Bottom) Bar graph showing the Ca2+ spark frequency in intact cells from 
sham (n = 59 from ive animals) and PMI mice (n = 41 from seven animals). (B; top) Line-scan images obtained in permeabilized at 
50 nmol/liter [Ca2+]i myocytes from sham (left) or from PMI (right) mice. (Bottom) Bar graph showing the increased Ca
2+ spark fre-
quency in permeabilized cells from PMI mice (n = 27 cells from three animals) compared with myocytes from sham mice (n = 26 cells 
from three animals). ***, P < 0.001 versus myocytes from sham mice. Error bars represent the SEM.
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contributes to depression of Ca2+ spark rate in intact PMI 
cells. In fact, normalizing in each cell the Ca2+ spark oc-
currence by the amount of Ca2+ stored in the SR, we 
found in permeabilized myocytes that the frequency of 
Ca2+ spark by a given amount of Ca2+ stored in the SR 
is signiicantly higher in PMI than in sham myocytes 
(Fig. 5 B), whereas similar analysis in intact cells showed 
that the Ca2+ spark frequency remains decreased in PMI 
intact myocytes, even after normalizing it to the SR load 
(Fig. 5 C). This suggested that even if the SR Ca2+ load 
decrease may participate in the reduced Ca2+ spark oc-
currence, other mechanisms might also contribute. As 
ATP modiies RyR function (Meissner et al., 1986; Laver, 
2010; Tencerová et al., 2012), and its levels are known to 
be decreased in HF (Ingwall, 2006, 2009), we repeated 
the Ca2+ spark measurements in permeabilized cardio-
myocytes irst with control intracellular media and then 
with a decreased energetic source media, which mim-
icked failing status (see Materials and methods). Fig. 6 A 
shows examples of the same cells from sham (left) and 
PMI heart (right) in control (top) and “failing” (bottom) 
solutions, illustrating that Ca2+ sparks were reduced 
in failing solution. On average (Fig. 6 B), the modiied 
inter nal solution to mimic HF environment signii-
cantly reduced Ca2+ spark frequency in both sham and 
at half-maximum (FWHM) in intact and permeabilized 
myocytes from sham and PMI mice. Fig. 4 A shows that 
Ca2+ spark amplitudes were smaller in intact PMI myo-
cytes than in intact sham myocytes. Duration was also 
considerably reduced in intact PMI myocytes (Fig. 4 B), 
whereas no signiicant change was observed with respect 
to half-width (Fig. 4 C). A similar trend was observed 
in Ca2+ spark characteristics in permeabilized cardio-
myocytes (Fig. 4, D–F), suggesting that alteration in 
the intrinsic RyR cluster activity or structural organiza-
tion is behind alterations of Ca2+ spark characteristics 
in HF.
RyR environment in intact cells reduces probability  
of Ca2+ sparks
To investigate the discrepancy between Ca2+ spark occur-
rence in intact versus permeabilized PMI myocytes, we 
addressed two possible mechanisms. It is well known that 
the amount of Ca2+ stored in the SR inluences Ca2+ spark 
frequency (Györke and Terentyev, 2008). We found that 
the SR Ca2+ load is signiicantly reduced in intact PMI 
cells (Fig. 2). However, as shown in Fig. 5 A, in permea-
bilized myocytes, the SR load was not signiicantly dif-
ferent (P = 0.08) between myocytes isolated from sham 
or PMI mice, suggesting that the SR Ca2+ load depletion 
Figure 4. Difference in the Ca2+ spark char-
acteristics between intact versus permeabilized 
myocytes after myocardial infarction. (A–C) Ca2+ 
spark amplitude (A; peak F/F0), duration at 
half-peak amplitude (B; FDHM), and width 
at half-peak amplitude (C; FWHM) in intact 
myocytes from sham (n = 442 Ca2+ sparks, 
from 22 cells, from three hearts) and PMI mice 
(n = 160 Ca2+ sparks, from 24 cells, from 
three hearts). (D–F) Same as A–C but in per-
meabilized myocytes from sham (n = 7,806 
Ca2+ sparks, from 26 cells, from three hearts) 
and PMI (n = 9,783 Ca2+ sparks, from 27 cells, 
from three hearts) mice. **, P < 0.01; ***, P < 
0.001 versus myocytes from sham mice. Error 
bars represent the SEM.
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of triggered activity than myocytes from sham mice, 
and this effect was enhanced by -adrenergic stimula-
tion (Fig. 7 B).
D I S C U S S I O N
In this paper, we have analyzed Ca2+ sparks in a mouse 
model of HF after myocardial infarction and demon-
strated that even if RyRs showed signs of enhanced ac-
tivity, Ca2+ sparks in intact cardiomyocytes were less 
frequent in PMI myocytes, although more Ca2+ waves were 
formed. Cell permeabilization unmasked the defect, 
unveiling enhanced Ca2+ spark occurrence in failing 
cardiomyocytes. The alterations in the SR Ca2+ load and 
cytosolic environment contributed to the depression in 
Ca2+ spark occurrence in intact myocytes from HF mice.
In the model we used herein, the hearts presented 
big transmural infarctions, ventricular myocytes were 
hypertrophied, and echocardiography measurements 
showed a depressed contractile function of the heart 
PMI myocytes. In this condition, the SR Ca2+ load was 
unchanged between permeabilized cells from sham and 
PMI heart (Fig. 6 B). In addition, biophysical character-
istics of Ca2+ sparks, namely amplitude (Fig. 6 C), dura-
tion (Fig. 6 D), and spatial spread (Fig. 6 E), remained 
reduced in PMI cells compared with sham cells in the 
failing solution.
Ca2+ waves and triggered activity after 
myocardial infarction
To determine whether the depressed Ca2+ spark occur-
rence in intact cells may be protective of the cells from 
arrhythmia, we checked for Ca2+ waves and triggered ac-
tivity during the rest period after one stimulation train 
(at 2 Hz) in the absence or presence of -adrenergic 
stimulation (1 µmol/liter isoproterenol). Fig. 7 A shows 
that the occurrence of Ca2+ waves was signiicantly higher 
in myocytes from PMI mice compared with those from 
sham-operated mice during the diastolic period. More-
over, myocytes from PMI showed a higher occurrence 
Figure 5. Permeabilized myo-
cytes from PMIs show sim ilar 
Ca2+ load but higher Ca2+ sparks 
per load unit than sham cells. 
(A; top) Line-scan images of 
representative caffeine-evoked 
Ca2+ release in permeabilized 
myocytes from sham (left) or 
from PMI (right) mice. (Bot-
tom) Caffeine-evoked Ca2+ 
transient peak (F/F0) of per-
meabilized myocytes from 
sham (gray bar; n = 14 cells 
from three animals) and PMI 
(dark red bar; n = 15 cells from 
three animals) mice. (B) Ca2+ 
spark frequency normalized to 
SR load in permeabilized cells 
from sham (gray bar; n = 13 
from three animals) and PMI 
mice (dark red bar; n = 12 cells 
from three animals). (C) Ca2+ 
spark frequency normalized to 
SR load in intact cells from 
sham (white bar; n = 10 from 
four animals) and PMI mice 
(red bar; n = 9 cells from four 
animals). *, P < 0.05 versus my-
ocytes from sham mice. Error 
bars represent the SEM.
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where the cardiac function was normal, thus without 
signs of HF. The confounding results regarding the oc-
currence on Ca2+ sparks was further complicated by the 
observation that single RyR channel activity, measured 
in isolated RyR incorporated into lipid bilayers, showed 
higher activity in failing hearts (Marx et al., 2000). Ca2+ 
sparks are described as the elementary events of SR Ca2+ 
release through RyRs, which can be visualized using ap-
propriated techniques. Thus, an increase in RyR activity 
by either PKA (Marx et al., 2000) or calmodulin-depen-
dent protein kinase II (Ai et al., 2005) phosphorylation, 
FKBP12.6 down-regulation (Marx et al., 2000), or RyR 
oxidation (Terentyev et al., 2008), among others, should 
be translated into a higher than normal Ca2+ spark fre-
quency. In our experiments, we did not ind increased, 
(Fig. 1). At the cellular level, the amplitude of the [Ca2+]i 
transient was reduced, and the decay time prolonged, 
in agreement with decreased SR Ca2+ load (Fig. 2). In-
terestingly, spontaneous Ca2+ sparks recorded during rest 
period were less frequent in PMI than in control cells 
(Fig. 3), which is consistent with the depressed SR Ca2+ 
load but inconsistent with the reported higher RyR2 
activity (Marx et al., 2000).
Since the irst report on Ca2+ sparks in an animal model 
of HF (Gómez et al., 1997), conlicting results have been 
reported regarding the Ca2+ sparks. Although the irst 
study found a decrease in evoked Ca2+ sparks in two rat 
HF models (Gómez et al., 1997), a later one showed an 
increase (Shorofsky et al., 1999). However, the latter study 
concerned a model of compensated cardiac hypertrophy, 
Figure 6. RyR metabolic environment inluences Ca2+ spark release in PMI mice. (A; top) Representative line-scan images of Ca2+ sparks 
obtained in permeabilized myocytes from sham (left) or from PMI (right) mice, with the same cell irst in control (C.Sol.; top) and 
then “failing” (F.Sol.; bottom) solutions. (Bottom) Bar graph showing the average data of Ca2+ spark frequency in permeabilized cells 
from sham (n = 6) and PMI mice (n = 8) in control (Ct.Sol.; gray and dark red bars for sham and PMI, respectively) and failing solutions 
(F.Sol.; dark green for sham and dark cyan bar for PMI). (B; top) Line-scan examples of caffeine-evoked Ca2+ release in permeabilized 
myocytes in failing solution from sham (left) or from PMI (right) mice. (Bottom) Averaged caffeine-evoked Ca2+ transient peak (F/F0) 
of permeabilized myocytes from sham (dark green bar; n = 6 cells from two animals) and PMI (blue bar; n = 8 cells from two animals) 
mice. (C–E) Ca2+ spark characteristics, Ca2+ spark amplitude (peak F/F0; C), Ca
2+ spark duration at half-peak amplitude (FDHM; D), and 
Ca2+ spark width at half-peak amplitude (FWHM; E) of permeabilized myocytes from sham (dark green bar; n = 1,263 Ca2+ sparks, from 
six cells, from two hearts) and PMI (dark cyan bar; n = 1,391 sparks, from eight cells, from two hearts) mice in failing solutions. *, P < 0.05 
versus myocytes from sham mice; ***, P < 0.001 versus Sham cells in control solution; ###, P < 0.001 versus the same group of myocytes in 
control solution. Error bars represent the SEM.
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in the SR) is signiicantly higher in PMI cells, indicating 
favored Ca2+ release when triggered. Cells from small 
rodents such as mice accumulate Ca2+ inside the SR dur-
ing resting periods, which depend, among others factors, 
on the balance between Ca2+ leak and SERCA activity. 
We have measured this property as post-rest potentiation, 
a measurement of the enhancement of the [Ca2+]i tran-
sient amplitude after a rest period compared with 
the average [Ca2+]i transient amplitude in steady state 
during continued electrical stimulation. We found that 
the post-rest potentiation is less important in PMI car-
diomyocytes, suggesting that the Ca2+ leak during rest 
may be more important. This is not incompatible with 
the decreased frequency of Ca2+ sparks in intact PMI 
but rather decreased, Ca2+ spark frequency, which is con-
sistent with the depression in SR Ca2+ content (Fig. 2). 
In fact, Ca2+ spark frequency is highly dependent on Ca2+ 
content in the SR (Zima et al., 2010). However, our data 
did show hints indicating that the RyR is more active in 
HF cardiomyocytes. In fact, in Fig. 7 we evidenced an 
enhanced diastolic leak in the form of Ca2+ waves in PMI 
myocytes. This indicates a higher propensity for Ca2+ re-
leased in a RyR cluster to activate neighboring clusters 
and propagate throughout the cell in arrhythmogenic 
Ca2+ waves. Thus, diastolic Ca2+ release is higher in PMI 
cells, although Ca2+ sparks are not. Moreover, the frac-
tional release (calculated as the amount of Ca2+ released 
in each twitch normalized to the amount of Ca2+ stored 
Figure 7. Myocardial infarction 
induces pro-arrhythmogenic Ca2+ 
release. (A; top) Line-scan images 
of representative spontaneous 
Ca2+ wave release during diastole 
(top) in one ventricular myocyte 
from sham (left) or PMI (right) 
mice. (Bottom) Occurrence of 
Ca2+ waves expressed as percent-
age (bottom) in cells from sham 
mice (white bar; n = 22) and in 
cells from PMI mice (red bar; 
n = 24). (B; top) Line-scan image of 
one ventricular myocyte isolated 
from PMI mice during electric 
stimulation at 2 Hz and during iso-
proterenol application. Red lines 
indicate electrical stimulation, 
and violet arrows indicate spon-
taneous triggered activity during 
diastole. (Bottom) Occurrence 
of abnormal triggered activity in 
myocytes from sham (white bar; 
n = 10) or PMI (red bar; n = 13) 
mice, and in myocytes from sham 
or PMI mice in the presence of 
1 µmol/liter isoproterenol (or-
ange bar for sham, n = 10; cross-
hatched orange bar for PMI, 
n = 13). n = 3 hearts per group. 
**, P < 0.01; ***, P < 0.001 ver-
sus myocytes from sham mice; ##, 
P < 0.01 versus myocytes from 
PMI mice.
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sensitivity to Ca2+ of the RyR in HF may favor propagation 
of Ca2+ sparks into Ca2+ waves, which contrary to Ca2+ 
sparks, are arrhythmogenic by activating NCX current.
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Résumé :  
Le canal calcique de libération du Ca2+, appelé 
récepteur à la ryanodine (RyR) est localisé dans la 
membrane du réticulum sarcoplasmique des 
cardiomyocytes, en incluant ceux du pacemaker, et a 
un rôle important dans le couplage excitation 
contraction et la génération du rythme cardiaque. 
Des mutations dans leur gène sont responsables de la 
tachycardie catécholergique (CPVT), qui est une 
maladie létale, manifestée par des syncopes ou mort 
subite lors de stress émotionnel ou physique. Au 
repos, ces patients ont un électrocardiogramme 
normal, mais une tendance plus importante à la 
bradycardie. 
Nos collaborateurs ont identifié la mutation 
RyR2
R420Q dans une famille espagnole atteinte de 
CPVT. Nous avons construit une souris portant cette 
mutation et étudié l’activité du nœud sinoatrial 
(NSA, pacemaker principale) afin d’élucider les 
mécanismes.  
 
Nous avons trouvé que les cellules du NSA 
présentent une activité spontanée plus lente que les 
souris sauvages (WT). Dans la cellule in situ, on peut 
étudier l’activité des RyRs par l’analyse des  « 
sparks » Ca2+, qui sont des évenements élémentaires 
produits par l’activation d’un cluster des RyRs. Nos 
analyses en microscopie confocale sur des NSA 
disséquées on montré que la fréquence des sparks 
Ca2+ était légèrement augmentée. Par contre, la 
longueur de ces sparks est fortement prolongée dans 
les cellules KI. Ceci produit une libération plus 
importante de Ca2+ pendant la diastole dans les 
cellules KI qui réduit l’automatisme, en réduisant la 
charge en Ca2+ du réticulum sarcoplasmique et en 
inactivant le courant calcique type L. Donc les 
thérapies en  étude qi favoriseraient la stabilisation 
du RyR2 en état fermé pourraient ne pas Être 
efficaces, et il faudra plutôt essayer des thérapies qui 
faciliteraient la fermeture du canal, une fois il est 
ouvert. 
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Abstract :  
The cardiac type-2 ryanodine receptor (RyR2) 
encodes a Ca2+ release channel on sarcoplasmic 
reticulum (SR) membrane in cardiomyocytes, 
including sinoatrial node (SAN) myocytes, and 
releases Ca2+ required for contraction and SAN 
spontaneous rhythm. Its genetic defects are related to 
catecholaminergic polymorphic ventricular 
tachycardia (CPVT), which is a lethal heritable 
disease characterized by exercise/stress-induced 
syncope and/or sudden cardiac death. Interestingly, 
CPVT patients frequently present SAN dysfunction 
as bradycardia at rest.  
In a previous study, a novel CPVT-related RyR2 
mutation (RyR2
R420Q) in a Spanish family, associated 
with SAN dysfunction was reported. R420 is located 
at the N-terminal portion of the channel and seems to 
be an important site for maintaining a stable A/B/C 
domain of N-terminus in RyR2. As N-terminal  
 
mutation resultant RyR2 behaviour and SAN function 
are never analyzed before, we created the KI mice 
model bearing mutation R420Q to understand the 
underlying mechanism. 
In this thesis, we found increased Ca2+ release during 
diastole, indicating a gain-of-function effect of RyR2 
N-terminal mutation R420Q. Interestingly, this 
defect may not be only an enhanced activity, as the 
Ca2+ sparks frequency was only slightly increased in 
KI, but also the closing mechanism, producing longer 
Ca2+ sparks. That is, the number of Ca2+ sparks is 
increased by the RyR2
R420Q mutation, and meanwhile 
the amount of Ca2+ released in each Ca2+ spark is 
also dramatically enhanced. This increased Ca2+ 
release retards SR Ca2+ replenishment, disrupting the 
Ca2+ clock and the coupled clock, resulting in the 
slower SAN function. Thus favouring RyR 
stabilization in the closing state might not be an 
adequate therapy but accelerating its closure. 
 
 
